WO2014098046A1 - Method for producing 1,2-dihydroquinoline synthetic intermediate - Google Patents
Method for producing 1,2-dihydroquinoline synthetic intermediate Download PDFInfo
- Publication number
- WO2014098046A1 WO2014098046A1 PCT/JP2013/083666 JP2013083666W WO2014098046A1 WO 2014098046 A1 WO2014098046 A1 WO 2014098046A1 JP 2013083666 W JP2013083666 W JP 2013083666W WO 2014098046 A1 WO2014098046 A1 WO 2014098046A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- formula
- salt
- acid
- compound represented
- Prior art date
Links
- PHIFGUAYVILRHC-UHFFFAOYSA-N CC1(C)Nc2ccc(-c3ccccc3OC3=O)c3c2C(C)=C1 Chemical compound CC1(C)Nc2ccc(-c3ccccc3OC3=O)c3c2C(C)=C1 PHIFGUAYVILRHC-UHFFFAOYSA-N 0.000 description 2
- MQEDFFUKYHEXTG-UHFFFAOYSA-N Nc1ccc(-c(c(OC2=O)c3)ccc3O)c2c1 Chemical compound Nc1ccc(-c(c(OC2=O)c3)ccc3O)c2c1 MQEDFFUKYHEXTG-UHFFFAOYSA-N 0.000 description 2
- 0 CC(C)(C=C1*2)Nc(cc3)c1c2c3Br Chemical compound CC(C)(C=C1*2)Nc(cc3)c1c2c3Br 0.000 description 1
- VOPRWFXTSLOXNI-UHFFFAOYSA-N CC(C)(C=C1C)Nc(cc2)c1c(C(O)=O)c2Br Chemical compound CC(C)(C=C1C)Nc(cc2)c1c(C(O)=O)c2Br VOPRWFXTSLOXNI-UHFFFAOYSA-N 0.000 description 1
- HZORPEUOUNHVFE-UHFFFAOYSA-N COC(c1cc(N)ccc1-c(ccc(OC)c1)c1OC)=O Chemical compound COC(c1cc(N)ccc1-c(ccc(OC)c1)c1OC)=O HZORPEUOUNHVFE-UHFFFAOYSA-N 0.000 description 1
- SSUWZYLEMAEAPP-UHFFFAOYSA-N COC(c1cc([N+]([O-])=O)ccc1-c(ccc(OC)c1)c1OC)=O Chemical compound COC(c1cc([N+]([O-])=O)ccc1-c(ccc(OC)c1)c1OC)=O SSUWZYLEMAEAPP-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Nc1ccccc1 Chemical compound Nc1ccccc1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
Definitions
- the present invention relates to a method for producing a synthetic intermediate of a 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity.
- Patent Document 1 a synthetic intermediate of a 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity
- Patent Document 1 uses 8-amino-3-hydroxybenzo [c] chromen-6-one as a raw material and iodine and acetone.
- a synthesis method using a reaction for forming a 1,2-dihydroquinoline skeleton is described. Since the post-treatment of the method required a purification step by column chromatography (hereinafter also referred to as column purification), there was a problem in industrial production.
- the compound represented by the formula (2) or a salt thereof is p-methoxybenzylated or benzyloxymethylated without performing column purification to give the formula (3)
- R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group.
- iodine remains in the reaction system, a side reaction occurs, and the compound represented by formula (3) or a salt thereof is efficiently produced. It was difficult to do.
- An object of the present invention is to find a new production method suitable for industrial production of a synthetic intermediate of a 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity.
- the compound or its salt represented by Formula (2) was obtained from the compound or its salt represented by Formula (4). Further, by treating the compound represented by the formula (5) or a salt thereof with p-toluenesulfonic acid, hydrochloric acid or bromic acid, p-toluenesulfone of the compound represented by the formula (1) having good filterability The present invention was completed by finding that it can be obtained as an acid salt, a hydrochloride or a bromate. That is, the present invention is as follows.
- Formula (1) Or a salt thereof, (A) an acid selected from the group consisting of p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrobromic acid and pyridine hydrobromide and / or (B) from pyridine and N, N-dimethylaniline A base selected from the group consisting of: (C) in the presence of water; Reacting with 2,2-dialkoxypropane or isopropenyl alkyl ether, Formula (2) Or a salt thereof.
- a base selected from the group consisting of: (C) in the presence of water; Reacting with 2,2-dialkoxypropane or isopropenyl alkyl ether, Formula (2) Or a salt thereof.
- a compound represented by the formula (2) or a salt thereof is obtained, and then the compound represented by the formula (2) or a salt thereof is represented by the formula in the presence of at least one selected from the group consisting of an acid and a base.
- R 0 X [Wherein R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group, and X represents a leaving group. ] Characterized by reacting with a compound represented by the formula: Formula (3) [Wherein R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group. ] Or a salt thereof.
- an 8-amino-benzo [c] chromen-6-one derivative having a hydroxy group is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether in the presence of an acid and / or base and water.
- a compound represented by the formula (2) or a salt thereof which is a synthetic intermediate of a 1,2-dihydroquinoline derivative, can be obtained without using iodine.
- the compound represented by the formula (2) or a salt thereof is p-methoxybenzylated or benzyloxymethylated without performing column purification to obtain a compound represented by the formula (3). Or a salt thereof can be efficiently obtained without column purification.
- the compound represented by Formula (2) or its salt can be obtained from the compound represented by Formula (4) or its salt. Further, by treating the compound represented by the formula (5) or a salt thereof with p-toluenesulfonic acid, hydrochloric acid or bromic acid, p-toluenesulfone of the compound represented by the formula (1) having good filterability It can be obtained as an acid salt, hydrochloride or bromate.
- Halogen atom refers to a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.
- the “lower alkyl group” refers to a straight or branched alkyl group having 1 to 8, preferably 1 to 6, and particularly preferably 1 to 4 carbon atoms.
- Specific examples include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, n-heptyl group, n-octyl group, isopropyl group, isobutyl group, sec-butyl group. , Tert-butyl group, isopentyl group and the like.
- the “lower alkoxy group” refers to a group in which a hydrogen atom of a hydroxy group is substituted with a lower alkyl group. Specific examples include methoxy, ethoxy, n-propoxy, n-butoxy, n-pentoxy, n-hexyloxy, n-heptyloxy, n-octyloxy, isopropoxy, isobutoxy, sec-butoxy, tert-butoxy or isopentoxy group Etc.
- the “lower alkylcarbonyl group” refers to a group in which a hydrogen atom of a formyl group is substituted with a lower alkyl group.
- Specific examples include methylcarbonyl group, ethylcarbonyl group, n-propylcarbonyl group, n-butylcarbonyl group, n-pentylcarbonyl group, n-hexylcarbonyl group, isopropylcarbonyl group, isobutylcarbonyl group, sec-butylcarbonyl group, Examples thereof include a tert-butylcarbonyl group and an isopentylcarbonyl group.
- Examples of the “amino group” include —NH 2 group, an amino group substituted with 1 or 2 lower alkyl groups, and the like.
- Leaving group refers to a substituent that is eliminated by a reaction.
- halogen atoms such as fluorine atom, chlorine atom, bromine atom, iodine atom
- lower alkylsulfonyloxy group such as methanesulfonyloxy group, chloromethylsulfoxyoxy group, trifluoromethanesulfonyloxy group, benzenesulfonyloxy group, Arylsulfonyloxy groups such as p-toluenesulfonyloxy group, cyano group, nitro group, trichloroacetimidate and the like can be mentioned.
- the raw materials, reagents, and other compounds described in the present specification used in the present invention may form “salts” with acids or bases.
- Specific examples include salts with inorganic acids such as hydrochloric acid, hydrobromic acid, bromic acid, hydroiodic acid, nitric acid, sulfuric acid, phosphoric acid, carbonic acid, acetic acid, fumaric acid, maleic acid, succinic acid, citric acid, tartaric acid , Adipic acid, gluconic acid, glucoheptic acid, glucuronic acid, terephthalic acid, methanesulfonic acid, lactic acid, hippuric acid, 1,2-ethanedisulfonic acid, isethionic acid, lactobionic acid, oleic acid, pamoic acid, polygalacturonic acid, stearin Acid, tannic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic
- the raw materials, reagents, and other compounds described in the present specification used in the present invention may be in the form of hydrates or solvates.
- geometrical isomers or optical isomers exist in the raw materials, reagents, and other compounds described in the present specification, such isomers are also included in the scope of the present invention.
- proton tautomerism exists in the raw materials, reagents and other compounds described in the present specification used in the present invention, such tautomers are also included in the present invention.
- the raw materials, reagents, other compounds described in the present specification, hydrates or solvates thereof used in the present invention may be crystals, and crystal polymorphs and crystal polymorph groups (crystal polymorphs) are included in the crystals.
- crystal polymorphs and crystal polymorph groups are also included in the present invention.
- the crystal polymorph group refers to various crystal forms depending on the conditions and states of production, crystallization, storage, etc. of these crystals (including the formulated state in this state). It means the crystal form and the whole process at each stage when changing.
- Step 1 Synthesis route 1-1
- Step 1 is a step of producing a compound represented by the formula (1) or a salt thereof by reacting a compound represented by the formula (5) or a salt thereof with p-toluenesulfonic acid, hydrochloric acid or bromic acid. is there.
- the compound represented by Formula (5) or its salt can be obtained according to description of the international publication 2012/108455 pamphlet.
- p-Toluenesulfonic acid, hydrochloric acid or bromic acid is 0.1 equivalent or more, preferably 1 to 6 equivalents, more preferably 3 to 4 equivalents, relative to the compound represented by the formula (5) or a salt thereof. Used.
- the solvent used in this step is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent.
- aromatic hydrocarbons such as benzene, toluene, xylene; dichloromethane, chloroform, Halogenated hydrocarbons such as carbon tetrachloride, dichloroethane, chlorobenzene, dichlorobenzene; ethers such as diethyl ether, diisopropyl ether, tetrahydrofuran, cyclopentyl methyl ether, methyl-tert-butyl ether, dioxane, dimethoxyethane, diethylene glycol dimethyl ether Ters; lower alkyl carboxylic acid esters such as ethyl acetate and isopropyl acetate; formamide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidinone, Amides such as oxamethyl phospho
- reaction temperature varies depending on the raw material compound and the reaction reagent, it is carried out at 0 ° C. to 100 ° C., preferably 0 ° C. to 50 ° C.
- reaction time varies depending on the reaction temperature, raw material compound, reaction reagent or the type of solvent used, it is generally 1 min to 48 hr, preferably 15 hr to 24 hr.
- the target compound is allowed to cool, and while stirring under ice cooling, a solvent such as water, aqueous ammonia or methanol is added, and the precipitated solid is filtered or extracted.
- the obtained target compound can be purified by a conventional method such as recrystallization and reprecipitation.
- the target compound can also be obtained as p-toluenesulfonate, hydrochloride or bromate.
- step 2 the compound represented by the formula (1) or a salt thereof is selected from the group consisting of (A) p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrobromic acid and pyridine hydrobromide. And (B) a base selected from the group consisting of pyridine and N, N-dimethylaniline, and (C) a reaction with 2,2-dialkoxypropane or isopropenyl alkyl ether in the presence of water.
- R 2 represents a lower alkyl group, preferably a methyl group.
- the acid (A) used in this step is preferably p-toluenesulfonic acid or pyridinium p-toluenesulfonate, and more preferably p-toluenesulfonic acid.
- the acid (A) used in this step is 0.10 equivalents or more, preferably 0.5 to 2.0 equivalents, more preferably 0.00 equivalents, relative to the compound represented by the formula (1) or a salt thereof. 90 to 1.10 equivalents are used.
- the base (B) used in this step is preferably pyridine.
- the acid (B) used in this step is 0.10 equivalents or more, preferably 0.5 to 2.0 equivalents, more preferably 0.8 equivalents, relative to the compound represented by the formula (1) or a salt thereof.
- (A) and (B) may be used.
- a combination using p-toluenesulfonic acid as (A) and pyridine as (B) is preferable.
- (A) or (B) may be used.
- (A) it is preferable to use pyridinium p-toluenesulfonate.
- the water (C) used in this step is used in an amount of 5 equivalents or more, preferably 10 to 30 equivalents, more preferably 15 to 25 equivalents, relative to the compound represented by the formula (1) or a salt thereof. It is done.
- Examples of the 2,2-dialkoxypropane used in this step include 2,2-dimethoxypropane and 2,2-diethoxypropane.
- the compound represented by the formula (1) or its It is used in an amount of 10 equivalents or more, preferably 30-100 equivalents, more preferably 50-60 equivalents, relative to the salt.
- Examples of the isopropenyl alkyl ether used in this step include isopropenyl methyl ether and isopropenyl ethyl ether.
- the compound represented by the formula (1) or a salt thereof is 10 equivalents or more. The amount is preferably 30 to 100 equivalents, more preferably 50 to 60 equivalents.
- the solvent used in this step is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent.
- aromatic hydrocarbons such as benzene, toluene, xylene; dichloromethane, chloroform, Halogenated hydrocarbons such as carbon tetrachloride, dichloroethane, chlorobenzene, dichlorobenzene; ethers such as diethyl ether, diisopropyl ether, tetrahydrofuran, cyclopentyl methyl ether, methyl-tert-butyl ether, dioxane, dimethoxyethane, diethylene glycol dimethyl ether Lower alkyl carboxylic acid esters such as ethyl acetate and isopropyl acetate; formamide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidone, Amides such as samethyl phosphorotriamide
- reaction temperature varies depending on the raw material compound and the reaction reagent, it is carried out at 0 ° C. to 150 ° C., preferably 25 ° C. to 130 ° C., more preferably 40 ° C. to 110 ° C.
- reaction time varies depending on the reaction temperature, raw material compound, reaction reagent or the type of solvent used, it is generally 12 to 96 hours, preferably 24 to 84 hours.
- the target compound is allowed to cool, and while stirring under ice-cooling, a solvent such as water, aqueous ammonia or methanol is added, and the precipitated solid is filtered or concentrated / extracted.
- the residue obtained after the concentration can be obtained by adding a recrystallizable solvent such as toluene, n-hexane or n-heptane and filtering and drying the precipitated solid.
- the precipitated solid is preferably filtered and then washed with toluene, n-hexane, n-heptane, water or the like.
- the obtained target compound can be purified by a conventional method such as recrystallization and reprecipitation.
- the compound represented by the formula (3) or a salt thereof can be produced according to the following synthesis route 2.
- Synthesis route 2 That is, the compound represented by the formula (1) or a salt thereof is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether by using the production method according to ⁇ Step 2> of the production method 1 above. 2) or a salt thereof is obtained.
- the compound represented by the formula (2) or a salt thereof can be obtained without performing column purification.
- a salt By reacting with a salt, the compound represented by the formula (3) or a salt thereof can be produced.
- the compound represented by the formula (3) or a salt thereof can be obtained without performing column purification.
- R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group.
- X represents a leaving group, and any substituent can be used as long as it is eliminated by reaction.
- a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom or an iodine atom
- methane Lower alkylsulfonyloxy groups such as sulfonyloxy group, chloromethylsulfoxyoxy group, trifluoromethanesulfonyloxy group, arylsulfonyloxy groups such as benzenesulfonyloxy group, p-toluenesulfonyloxy group, cyano group, nitro group, trichloroacetate
- Examples thereof include imidate and carbonyldioxyphenyl, preferably a halogen atom, more preferably a chlorine atom.
- the compound represented by the formula (a) or a salt thereof is 1 equivalent or more, preferably 1 to 2 equivalents, more preferably 1.2 to 1.5 equivalents
- Examples of the acid used in this step include inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, hydrogen bromide, and hydrofluoric acid; trifluoroacetic acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p- Examples thereof include organic acids such as toluenesulfonic acid and aminosulfonic acid; Lewis acids such as boron tribromide, boron trichloride, boron trifluoride and aluminum chloride.
- the acid used in this step is used in an amount of 1 equivalent or more, preferably 1 to 5 equivalents, more preferably 2 to 3 equivalents, relative to the compound represented by the formula (2) or a salt thereof.
- Examples of the base used in this step include alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate and lithium carbonate; alkali metal hydrogen carbonates such as sodium hydrogen carbonate, potassium hydrogen carbonate and lithium hydrogen carbonate; Alkali metal hydroxides such as sodium, potassium hydroxide, barium hydroxide, and lithium hydroxide; Alkali metal hydrides such as lithium hydride, sodium hydride, and potassium hydride; such as sodium fluoride and potassium fluoride Inorganic bases such as alkali metal fluorides; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide, potassium t-butoxide, lithium methoxide; N-methylmorpholine, triethylamine, tri Propyl Min, tributylamine, diisopropylethylamine, dicyclohexylamine, N-methylpiperidine, pyridine, 4-pyrrolidinopyridine,
- the base used in this step is used in an amount of 1 equivalent or more, preferably 1 to 5 equivalents, more preferably 2 to 3 equivalents, relative to the compound represented by the formula (2) or a salt thereof.
- the solvent used in this step is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent.
- aromatic hydrocarbons such as benzene, toluene, xylene; dichloromethane, chloroform, Halogenated hydrocarbons such as carbon tetrachloride, dichloroethane, chlorobenzene, dichlorobenzene; ethers such as diethyl ether, diisopropyl ether, tetrahydrofuran, cyclopentyl methyl ether, methyl-tert-butyl ether, dioxane, dimethoxyethane, diethylene glycol dimethyl ether Lower alkyl carboxylic acid esters such as ethyl acetate and isopropyl acetate; formamide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidinone, Amides such as samethyl phosphorotriamide; Sulfoxides such as dimethyl sulfoxide and sulfolane; Lower alcohols such as m
- reaction temperature varies depending on the raw material compound and the reaction reagent, it is carried out at 0 ° C. to 100 ° C., preferably 0 ° C. to 50 ° C.
- reaction time varies depending on the reaction temperature, raw material compound, reaction reagent or the type of solvent used, it is generally 1 hour to 48 hours, preferably 2 hours to 5 hours.
- the target compound is allowed to cool, and while stirring under ice cooling, a solvent such as water, aqueous ammonia or methanol is added, and the precipitated solid is filtered or extracted.
- the obtained target compound can be purified by a conventional method such as recrystallization and reprecipitation.
- the compound represented by the formula (1) or a salt thereof is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether by using the production method according to ⁇ Step 2> of the production method 1 above. 4) or a salt thereof, and a compound represented by formula (4) or a salt thereof obtained by using a production method according to ⁇ Step 2> of production method 1 above.
- a compound represented by the formula (2) or a salt thereof can be produced by reacting with 2-dialkoxypropane or isopropenyl alkyl ether.
- the compound represented by the formula (1) or a salt thereof is reacted with the compound represented by the formula (a) R 0 X or a salt thereof in the presence of at least one selected from the group consisting of an acid and a base.
- a compound represented by the formula (8) or a salt thereof is obtained.
- the obtained compound represented by the formula (8) or a salt thereof is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether using the production method according to ⁇ Step 2> of the production method 1 above.
- the compound represented by the formula (3) or a salt thereof can be produced.
- reaction for producing the compound represented by the formula (3) or the salt thereof from the compound represented by the formula (8) or a salt thereof is generated in the course of the reaction (4b) It may be carried out via a compound represented by the formula:
- R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group.
- the compound (13a) is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether using the production method according to ⁇ Step 2> of the production method 1 to obtain the compound (14a).
- the carboxyl group of the obtained compound (14a) is methyl esterified to obtain the compound (15a), and the resulting compound (15a) and the corresponding boronic acid (b) are mixed with a base such as sodium carbonate in a solvent such as DMF.
- Compound (12a) is obtained by reacting in the presence of a catalyst such as bis (triphenylphosphine) palladium (II) dichloride.
- the resulting compound (12a) can be cyclized to produce compound (2a).
- Compound (15a) can also be obtained by reacting compound (16a) with 2,2-dialkoxypropane or isopropenyl alkyl ether using the production method according to ⁇ Step 2> of production method 1 above. .
- R 1 can include a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amino group, a nitro group, or a cyano group.
- p may be an integer of 0 to 4, preferably 1 to 2.
- the reaction solution was allowed to cool and cooled, concentrated, and the residue was extracted with tetrahydrofuran (17.5 mL), ethyl acetate (24.5 mL), and water (21.0 mL).
- the aqueous layer was extracted with ethyl acetate (24.5 ml), and the organic layers were combined, washed twice with water (21.0 ml), washed with 4% aqueous sodium hydrogen carbonate solution (21.0 ml), and the organic layer was concentrated. .
- the concentrated residue was purified several times by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (1.30 g, yield 48%).
- the reaction mixture was allowed to cool and cooled, concentrated, and the residue was extracted with ethyl acetate-tetrahydrofuran (3: 2, 100.0 mL) and saturated aqueous sodium hydrogen carbonate (50.0 mL).
- the aqueous layer was extracted twice with ethyl acetate-tetrahydrofuran (3: 2, 50.0 mL), and the organic layers were combined, washed three times with a saturated aqueous sodium hydrogen carbonate solution (50.0 mL), and the organic layer was concentrated.
- N, N-dimethylformamide (60.0 mL) was added to the concentrated residue and concentrated several times to remove pyridine.
- N, N-dimethylformamide was added so that the concentration residue was 60.0 mL, potassium carbonate (7.61 g, 55.1 mmol) and water (3.00 mL) were added, and the mixture was stirred at room temperature.
- 4-Methoxybenzyl chloride (3.90 mL, 28.6 mmol) was added to the mixture, and the mixture was stirred at an external temperature of 40 ° C. for 3 hours and 25 minutes.
- the reaction solution was stirred under ice-cooling, water (300.0 mL) was added, the mixture was stirred for 1 hour and 15 minutes, filtered, and washed with water (100.0 mL).
- the reaction mixture was allowed to cool and cooled, concentrated under reduced pressure, and ethyl acetate (313 g), tetrahydrofuran (222 g), and water (300 g) were added to the residue to separate the layers.
- the organic layer was washed twice with water (300 g), 4% aqueous sodium hydrogen carbonate solution (300 g), tetrahydrofuran (222 g) was added, and the mixture was washed with 4% aqueous sodium hydrogen carbonate solution (302 g).
- N, N-dimethylformamide (327.30 g) was added to the organic layer, and the mixture was concentrated under reduced pressure.
- N N-dimethylformamide was added so that the residue was 327.05 g, potassium carbonate (42.51 g, 307.59 mmol) and water (14.70 g) were added, and the mixture was stirred at room temperature.
- 4-Methoxybenzyl chloride 25.07 g, 160.08 mmol was added to the mixture, and the mixture was stirred at an internal temperature of 40-41 ° C. for 4 hours.
- the reaction mixture was cooled to room temperature, ethyl acetate (232 g), tetrahydrofuran (686 g), 28% aqueous ammonia (705 g) were added, and the mixture was stirred and separated.
- Ethyl acetate (310 g) was added to the aqueous layer and the layers were separated. All the organic layers were combined, washed once with 5% brine (786 g), washed twice with 5% brine (393 g), washed once with water (400 g), and the organic layer was concentrated under reduced pressure. Toluene (213 g) was added and concentrated under reduced pressure three times. Toluene (221.34 g) and ethyl acetate (35.4 g) were added to the concentrated residue, and the mixture was stirred at an internal temperature of 84 to 90 ° C. for 31 minutes. The mixture was stirred at ⁇ 10 ° C. for 18 hours, and the precipitated solid was filtered.
- the obtained mixture of wet crystals and toluene (128 g) was stirred at an internal temperature of 85 ° C. for 1 hour and 13 minutes, and then cooled. After stirring at an internal temperature of 1 to 10 ° C. for 2 hours and 59 minutes, the mixture was filtered, washed with toluene (20 g) three times, and dried under reduced pressure at 50 ° C. for 2 hours and 15 minutes to give the title compound (19.41 g, yield 36.3). %).
- the organic layer was washed with water (4.50 ml), and the aqueous layer was collected and extracted with ethyl acetate (5.50 ml). The organic layer was collected, washed with 4% aqueous sodium hydrogen carbonate solution (4.50 ml), and anhydrous. After drying with magnesium sulfate, the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.37 g, yield 51.2%).
- Chloroform was added to the filtered solid for dissolution and concentration, and the precipitated crystals were filtered, and then the filtrate was concentrated. Chloroform was added to the concentration residue and dissolved and concentrated, the precipitated crystals were filtered, and the filtrate was concentrated. Each concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane), and the fractions were combined to obtain the title compound (1.17 g, yield 37%).
- the concentrated residue was purified by silica gel column chromatography (chloroform) and subsequently purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the crude title compound (0.018 g).
- Toluene-normal heptane (0.36 ml) was added to the crude product, and the solid was filtered and washed with toluene-normal heptane (0.54 ml) to obtain the title compound (0.010 g, yield 0.95%). .
- the reaction mixture was concentrated and extracted by adding ethyl acetate (30.0 mL) and water (60.0 mL). The aqueous layer was extracted with ethyl acetate (30.0 ml), and the organic layers were combined. After extraction by adding ethyl acetate (30.0 ml) and water (60.0 ml), the organic layer was washed with water (60.0 ml) three times. Washed. The organic layer was concentrated and the residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.78 g, yield 33%).
- the reaction solution was allowed to cool and cooled, and extracted by adding ethyl acetate (40.0 mL) and water (40.0 mL).
- the aqueous layer was extracted with ethyl acetate (8.0 ml), and the organic layers were combined, washed twice with water (40.0 ml), washed twice with 4% aqueous sodium bicarbonate (40.0 ml), and the organic layer was concentrated.
- Chloroform (16.0 mL) was added to the concentration residue, the solid was filtered, washed with chloroform (5.0 mL), and the filtrate was concentrated.
- the concentrated residue was purified by silica gel column chromatography (chloroform) to obtain the title compound (0.0092 g, yield 1.15%).
- the filtrate was extracted with ethyl acetate (200.0 mL) and water (100.0 mL).
- the aqueous layer was extracted twice with ethyl acetate (100.0 mL), the organic layers were combined, washed 6 times with 5% aqueous sodium chloride solution (200.0 ml), the organic layer was dried over anhydrous magnesium sulfate and concentrated.
- the concentrated residue was purified twice by silica gel column chromatography (chloroform-methanol) to obtain the title compound (2.60 g, yield 72%).
- 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid (14a) 6-Bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid (14a) and 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-7-carboxylic acid
- a mixture of isomers (1.00 g, 3.38 mmol) and low-moisture solvent methanol (80.0 ml) was stirred at an external temperature of 4 ° C., thionyl chloride (2.30 mL, 31.7 mmol) was added for 73 hours. Stir for 10 minutes.
- the reaction mixture was concentrated and extracted by adding ethyl acetate (80.0 mL) and 4% aqueous sodium hydrogen carbonate solution (180.0 mL).
- the aqueous layer was extracted with ethyl acetate (50.0 ml), the organic layers were combined, washed twice with 4% aqueous sodium hydrogen carbonate solution (100.0 ml), and the organic layer was concentrated to obtain an isomer compound.
- the aqueous layer was collected, concentrated hydrochloric acid (14.7 mL) was added, extracted with ethyl acetate (400.0 mL), and concentrated to obtain the title compound (0.56 g) in which the isomer remained.
- the above operation was repeated three times to obtain the title compound (0.26 g, yield 25%).
- the concentrated residue was purified three times by silica gel column chromatography (ethyl acetate-hexane) and then purified twice by silica gel column chromatography (chloroform) to obtain the title isomer mixture (1.50 g, yield 28%). Obtained.
- the reaction mixture was concentrated and extracted by adding ethyl acetate (80.0 mL) and water (80.0 mL). The aqueous layer was extracted twice with ethyl acetate (80.0 ml), the organic layers were combined, washed with 4% aqueous sodium hydrogen carbonate solution (80.0 ml), and the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) three times to obtain the title compound (1.29 g, yield 23%).
- the reaction mixture was allowed to cool to room temperature, concentrated, and extracted with ethyl acetate (15.0 mL) and water (10.0 mL). The organic layer was extracted with 4% aqueous sodium hydrogen carbonate solution (10.0 ml), and then the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.0095 g, yield 1.00%).
- a synthetic intermediate of a 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity can be produced industrially and is useful.
- diseases involving glucocorticoid receptors that is, metabolic disorders such as diabetes and obesity, inflammatory diseases such as enteritis and chronic obstructive pulmonary disease, rheumatoid arthritis, autoimmune diseases such as collagen disease, asthma, Allergic diseases such as atopic dermatitis and allergic rhinitis, central nervous system diseases such as psychosis, Alzheimer, drug use disorders, cardiovascular diseases such as hypertension, hypercalcemia, hyperinsulinemia, hyperlipidemia It is useful for the prevention or treatment of homeostasis-related diseases and glaucoma that cause abnormal balance of nerve, immunity and endocrine.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
A method for producing a compound represented by formula (2) or a salt thereof, characterized in that a compound represented by formula (1) or a salt thereof is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether in the presence of (A) an acid selected from the group consisting of p-toluenesulfonic acid, pyridinium-p-toluenesulfonate, hydrobromic acid, and pyridine hydrobromide, and/or (B) a base selected from the group consisting of pyridine and N,N-dimethylaniline, and (C) water. This production method is suited to the industrial production of a synthetic intermediate of a 1,2-dihydroquinoline derivative having glucocorticoid receptor-binding activity.
Description
本発明は、グルココルチコイド受容体結合活性を有する1,2-ジヒドロキノリン誘導体の合成中間体の製造方法に関する。
The present invention relates to a method for producing a synthetic intermediate of a 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity.
式(2)
で表される化合物またはその塩は、例えばグルココルチコイド受容体結合活性を有する1,2-ジヒドロキノリン誘導体の合成中間体として有用であることが知られている(特許文献1)。上記式(2)で表される化合物またはその塩を合成する方法として、特許文献1には、8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オンを原料として、ヨウ素およびアセトンを用いて、1,2-ジヒドロキノリン骨格を形成する反応を用いた合成方法が記載されている。その方法の後処理にはカラムクロマトグラフィーによる精製工程(以下、カラム精製ともいう)を必要としていたため、工業的製造において課題を有していた。そこで、上記反応後に、カラム精製をすることなく式(2)で表される化合物またはその塩のフェノール性水酸基をp-メトキシベンジル化またはベンジルオキシメチル化することで、式(3)
[式(3)中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示す。]
で表される化合物またはその塩を製造することを試みたが、反応系中にヨウ素が残留しているため、副反応が生じ、式(3)で表される化合物またはその塩を効率よく製造することが困難であった。 Formula (2)
Or a salt thereof is known to be useful as, for example, a synthetic intermediate of a 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity (Patent Document 1). As a method for synthesizing the compound represented by the above formula (2) or a salt thereof, Patent Document 1 uses 8-amino-3-hydroxybenzo [c] chromen-6-one as a raw material and iodine and acetone. Thus, a synthesis method using a reaction for forming a 1,2-dihydroquinoline skeleton is described. Since the post-treatment of the method required a purification step by column chromatography (hereinafter also referred to as column purification), there was a problem in industrial production. Therefore, after the above reaction, the compound represented by the formula (2) or a salt thereof is p-methoxybenzylated or benzyloxymethylated without performing column purification to give the formula (3)
[In the formula (3), R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group. ]
However, since iodine remains in the reaction system, a side reaction occurs, and the compound represented by formula (3) or a salt thereof is efficiently produced. It was difficult to do.
で表される化合物またはその塩は、例えばグルココルチコイド受容体結合活性を有する1,2-ジヒドロキノリン誘導体の合成中間体として有用であることが知られている(特許文献1)。上記式(2)で表される化合物またはその塩を合成する方法として、特許文献1には、8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オンを原料として、ヨウ素およびアセトンを用いて、1,2-ジヒドロキノリン骨格を形成する反応を用いた合成方法が記載されている。その方法の後処理にはカラムクロマトグラフィーによる精製工程(以下、カラム精製ともいう)を必要としていたため、工業的製造において課題を有していた。そこで、上記反応後に、カラム精製をすることなく式(2)で表される化合物またはその塩のフェノール性水酸基をp-メトキシベンジル化またはベンジルオキシメチル化することで、式(3)
[式(3)中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示す。]
で表される化合物またはその塩を製造することを試みたが、反応系中にヨウ素が残留しているため、副反応が生じ、式(3)で表される化合物またはその塩を効率よく製造することが困難であった。 Formula (2)
Or a salt thereof is known to be useful as, for example, a synthetic intermediate of a 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity (Patent Document 1). As a method for synthesizing the compound represented by the above formula (2) or a salt thereof, Patent Document 1 uses 8-amino-3-hydroxybenzo [c] chromen-6-one as a raw material and iodine and acetone. Thus, a synthesis method using a reaction for forming a 1,2-dihydroquinoline skeleton is described. Since the post-treatment of the method required a purification step by column chromatography (hereinafter also referred to as column purification), there was a problem in industrial production. Therefore, after the above reaction, the compound represented by the formula (2) or a salt thereof is p-methoxybenzylated or benzyloxymethylated without performing column purification to give the formula (3)
[In the formula (3), R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group. ]
However, since iodine remains in the reaction system, a side reaction occurs, and the compound represented by formula (3) or a salt thereof is efficiently produced. It was difficult to do.
本発明は、グルココルチコイド受容体結合活性を有する1,2-ジヒドロキノリン誘導体の合成中間体の工業的製造に適した新たな製造方法を見出すことを目的とする。
An object of the present invention is to find a new production method suitable for industrial production of a synthetic intermediate of a 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity.
本発明者は、かかる実情を鑑み、鋭意検討した結果、ヒドロキシ基を有する8-アミノ-ベンゾ[c]クロメン-6-オン誘導体を特定の酸および/または塩基、および水存在下、2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させることにより、ヨウ素を使用せずに、1,2-ジヒドロキノリン誘導体の合成中間体である式(2)で表される化合物またはその塩が得られることを見出した。さらに、当該反応後に、カラム精製をすることなく、式(2)で表される化合物またはその塩のフェノール性水酸基をp-メトキシベンジル化またはベンジルオキシメチル化することで、式(3)で表される化合物またはその塩をカラム精製することなく効率よく得られることを見出した。
また、式(2)で表される化合物またはその塩は、式(4)で表される化合物またはその塩から得られることも見出した。
さらに、式(5)で表される化合物またはその塩を、p-トルエンスルホン酸、塩酸または臭素酸で処理することにより、ろ過性のよい式(1)で表される化合物のp-トルエンスルホン酸塩、塩酸塩または臭素酸塩として得られることを見出し、本発明を完成するに至った。
すなわち、本発明は以下のとおりである。 As a result of intensive studies in view of such circumstances, the present inventor obtained an 8-amino-benzo [c] chromen-6-one derivative having a hydroxy group in the presence of a specific acid and / or base and water in the presence of 2,2 -By reacting with a dialkoxypropane or isopropenyl alkyl ether, a compound represented by the formula (2) which is a synthetic intermediate of a 1,2-dihydroquinoline derivative or a salt thereof can be obtained without using iodine. I found out. Further, after the reaction, the compound represented by the formula (2) or a salt thereof is p-methoxybenzylated or benzyloxymethylated without performing column purification to give the compound represented by the formula (3). It was found that the obtained compound or a salt thereof can be efficiently obtained without column purification.
Moreover, it discovered that the compound or its salt represented by Formula (2) was obtained from the compound or its salt represented by Formula (4).
Further, by treating the compound represented by the formula (5) or a salt thereof with p-toluenesulfonic acid, hydrochloric acid or bromic acid, p-toluenesulfone of the compound represented by the formula (1) having good filterability The present invention was completed by finding that it can be obtained as an acid salt, a hydrochloride or a bromate.
That is, the present invention is as follows.
また、式(2)で表される化合物またはその塩は、式(4)で表される化合物またはその塩から得られることも見出した。
さらに、式(5)で表される化合物またはその塩を、p-トルエンスルホン酸、塩酸または臭素酸で処理することにより、ろ過性のよい式(1)で表される化合物のp-トルエンスルホン酸塩、塩酸塩または臭素酸塩として得られることを見出し、本発明を完成するに至った。
すなわち、本発明は以下のとおりである。 As a result of intensive studies in view of such circumstances, the present inventor obtained an 8-amino-benzo [c] chromen-6-one derivative having a hydroxy group in the presence of a specific acid and / or base and water in the presence of 2,2 -By reacting with a dialkoxypropane or isopropenyl alkyl ether, a compound represented by the formula (2) which is a synthetic intermediate of a 1,2-dihydroquinoline derivative or a salt thereof can be obtained without using iodine. I found out. Further, after the reaction, the compound represented by the formula (2) or a salt thereof is p-methoxybenzylated or benzyloxymethylated without performing column purification to give the compound represented by the formula (3). It was found that the obtained compound or a salt thereof can be efficiently obtained without column purification.
Moreover, it discovered that the compound or its salt represented by Formula (2) was obtained from the compound or its salt represented by Formula (4).
Further, by treating the compound represented by the formula (5) or a salt thereof with p-toluenesulfonic acid, hydrochloric acid or bromic acid, p-toluenesulfone of the compound represented by the formula (1) having good filterability The present invention was completed by finding that it can be obtained as an acid salt, a hydrochloride or a bromate.
That is, the present invention is as follows.
[1] 式(1)
で表される化合物またはその塩を、
(A)p-トルエンスルホン酸、p-トルエンスルホン酸ピリジニウム、臭化水素酸およびピリジン臭化水素酸塩からなる群より選択される酸及び/又は
(B)ピリジンおよびN,N-ジメチルアニリンからなる群より選択される塩基、及び
(C)水の存在下、
2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させることを特徴とする、
式(2)
で表される化合物またはその塩の製造方法。 [1] Formula (1)
Or a salt thereof,
(A) an acid selected from the group consisting of p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrobromic acid and pyridine hydrobromide and / or (B) from pyridine and N, N-dimethylaniline A base selected from the group consisting of: (C) in the presence of water;
Reacting with 2,2-dialkoxypropane or isopropenyl alkyl ether,
Formula (2)
Or a salt thereof.
で表される化合物またはその塩を、
(A)p-トルエンスルホン酸、p-トルエンスルホン酸ピリジニウム、臭化水素酸およびピリジン臭化水素酸塩からなる群より選択される酸及び/又は
(B)ピリジンおよびN,N-ジメチルアニリンからなる群より選択される塩基、及び
(C)水の存在下、
2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させることを特徴とする、
式(2)
で表される化合物またはその塩の製造方法。 [1] Formula (1)
Or a salt thereof,
(A) an acid selected from the group consisting of p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrobromic acid and pyridine hydrobromide and / or (B) from pyridine and N, N-dimethylaniline A base selected from the group consisting of: (C) in the presence of water;
Reacting with 2,2-dialkoxypropane or isopropenyl alkyl ether,
Formula (2)
Or a salt thereof.
[2] 上記[1]の方法により、
式(2)で表される化合物またはその塩を得、次いで当該式(2)で表される化合物またはその塩を、酸及び塩基からなる群から選択される少なくとも1種の存在下で、式(a)R0X
[式中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示し、Xは脱離基を示す。]
で表される化合物またはその塩と反応させることを特徴とする、
式(3)
[式中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示す。]
で表される化合物またはその塩の製造方法。 [2] By the method [1] above,
A compound represented by the formula (2) or a salt thereof is obtained, and then the compound represented by the formula (2) or a salt thereof is represented by the formula in the presence of at least one selected from the group consisting of an acid and a base. (A) R 0 X
[Wherein R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group, and X represents a leaving group. ]
Characterized by reacting with a compound represented by the formula:
Formula (3)
[Wherein R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group. ]
Or a salt thereof.
式(2)で表される化合物またはその塩を得、次いで当該式(2)で表される化合物またはその塩を、酸及び塩基からなる群から選択される少なくとも1種の存在下で、式(a)R0X
[式中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示し、Xは脱離基を示す。]
で表される化合物またはその塩と反応させることを特徴とする、
式(3)
[式中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示す。]
で表される化合物またはその塩の製造方法。 [2] By the method [1] above,
A compound represented by the formula (2) or a salt thereof is obtained, and then the compound represented by the formula (2) or a salt thereof is represented by the formula in the presence of at least one selected from the group consisting of an acid and a base. (A) R 0 X
[Wherein R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group, and X represents a leaving group. ]
Characterized by reacting with a compound represented by the formula:
Formula (3)
[Wherein R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group. ]
Or a salt thereof.
[3] 上記[1]の式(1)で表される化合物またはその塩から式(2)で表される化合物またはその塩を製造する反応が、反応途中で生成する式(4)で表される化合物またはその塩を介して行われる上記[1]又は[2]の製造方法。
式(4)
[3] The reaction for producing the compound represented by formula (2) or the salt thereof from the compound represented by formula (1) of the above [1] or a salt thereof is represented by the formula (4) generated during the reaction. The production method of [1] or [2], which is carried out through a compound or a salt thereof.
Formula (4)
式(4)
[3] The reaction for producing the compound represented by formula (2) or the salt thereof from the compound represented by formula (1) of the above [1] or a salt thereof is represented by the formula (4) generated during the reaction. The production method of [1] or [2], which is carried out through a compound or a salt thereof.
Formula (4)
[4] 式(1)で表される化合物またはその塩が、
式(5)
で表される化合物またはその塩を、p-トルエンスルホン酸、塩酸または臭素酸と反応させて製造される上記[1]~[3]の製造方法。 [4] A compound represented by the formula (1) or a salt thereof,
Formula (5)
The method of [1] to [3] above, wherein the compound represented by the formula or a salt thereof is reacted with p-toluenesulfonic acid, hydrochloric acid or bromic acid.
式(5)
で表される化合物またはその塩を、p-トルエンスルホン酸、塩酸または臭素酸と反応させて製造される上記[1]~[3]の製造方法。 [4] A compound represented by the formula (1) or a salt thereof,
Formula (5)
The method of [1] to [3] above, wherein the compound represented by the formula or a salt thereof is reacted with p-toluenesulfonic acid, hydrochloric acid or bromic acid.
[5] 式(1)で表される化合物の塩が、式(1)で表される化合物のp-トルエンスルホン酸塩、塩酸塩または臭素酸塩である上記[1]~[4]の製造方法。
[6] 式(6)
[式中、R1は、ハロゲン原子、低級アルキル基、ヒドロキシ基、低級アルコキシ基、低級アルキルカルボニル基、カルボキシル基、アミノ基、ニトロ基またはシアノ基を示し;pは0~4の整数を示す。]
で表される化合物またはその塩を、
(A)p-トルエンスルホン酸、p-トルエンスルホン酸ピリジニウム、臭化水素酸およびピリジン臭化水素酸塩からなる群より選択される酸及び/又は
(B)ピリジンおよびN,N-ジメチルアニリンからなる群より選択される塩基、及び
(C)水の存在下、
2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させることを特徴とする、
式(7)
[式中、R1は、ハロゲン原子、低級アルキル基、ヒドロキシ基、低級アルコキシ基、低級アルキルカルボニル基、カルボキシル基、アミノ基、ニトロ基またはシアノ基を示し;pは0~4の整数を示す。]
で表される化合物またはその塩の製造方法。 [5] The salt of the above-mentioned [1] to [4], wherein the salt of the compound represented by the formula (1) is p-toluenesulfonate, hydrochloride or bromate of the compound represented by the formula (1) Production method.
[6] Formula (6)
[Wherein R 1 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amino group, a nitro group, or a cyano group; p represents an integer of 0 to 4 . ]
Or a salt thereof,
(A) an acid selected from the group consisting of p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrobromic acid and pyridine hydrobromide and / or (B) from pyridine and N, N-dimethylaniline A base selected from the group consisting of: (C) in the presence of water;
Reacting with 2,2-dialkoxypropane or isopropenyl alkyl ether,
Formula (7)
[Wherein R 1 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amino group, a nitro group, or a cyano group; p represents an integer of 0 to 4 . ]
Or a salt thereof.
[6] 式(6)
[式中、R1は、ハロゲン原子、低級アルキル基、ヒドロキシ基、低級アルコキシ基、低級アルキルカルボニル基、カルボキシル基、アミノ基、ニトロ基またはシアノ基を示し;pは0~4の整数を示す。]
で表される化合物またはその塩を、
(A)p-トルエンスルホン酸、p-トルエンスルホン酸ピリジニウム、臭化水素酸およびピリジン臭化水素酸塩からなる群より選択される酸及び/又は
(B)ピリジンおよびN,N-ジメチルアニリンからなる群より選択される塩基、及び
(C)水の存在下、
2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させることを特徴とする、
式(7)
[式中、R1は、ハロゲン原子、低級アルキル基、ヒドロキシ基、低級アルコキシ基、低級アルキルカルボニル基、カルボキシル基、アミノ基、ニトロ基またはシアノ基を示し;pは0~4の整数を示す。]
で表される化合物またはその塩の製造方法。 [5] The salt of the above-mentioned [1] to [4], wherein the salt of the compound represented by the formula (1) is p-toluenesulfonate, hydrochloride or bromate of the compound represented by the formula (1) Production method.
[6] Formula (6)
[Wherein R 1 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amino group, a nitro group, or a cyano group; p represents an integer of 0 to 4 . ]
Or a salt thereof,
(A) an acid selected from the group consisting of p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrobromic acid and pyridine hydrobromide and / or (B) from pyridine and N, N-dimethylaniline A base selected from the group consisting of: (C) in the presence of water;
Reacting with 2,2-dialkoxypropane or isopropenyl alkyl ether,
Formula (7)
[Wherein R 1 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amino group, a nitro group, or a cyano group; p represents an integer of 0 to 4 . ]
Or a salt thereof.
[7] 2,2-ジアルコキシプロパンが2,2-ジメトキシプロパンである上記[1]~[6]の製造方法。
[8] イソプロペニルアルキルエーテルがイソプロペニルメチルエーテルである上記[1]~[6]の製造方法。
[9] ・8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オンのp-トルエンスルホン酸塩、
・8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ヒドロキシベンゾ[c]クロメン-6-オン、
・8-アミノ-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン、
・8-アミノ-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン、
・8-(1,1-ジメチル-3-オキソブチルアミノ)-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン、
・8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン、
・2-(2,4-ジメトキシフェニル)-5-アミノ安息香酸メチル、
・6-(2,4-メトキシ)-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸メチル、
・6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸、
・6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸メチル、
・2-ブロモ-5-(1,1-ジメチル-3-オキソブチルアミノ)安息香酸メチル
から選択される化合物またはその塩。 [7] The production method of the above [1] to [6], wherein the 2,2-dialkoxypropane is 2,2-dimethoxypropane.
[8] The production method of the above [1] to [6], wherein the isopropenyl alkyl ether is isopropenyl methyl ether.
[9]-p-toluenesulfonate of 8-amino-3-hydroxybenzo [c] chromen-6-one,
8- (1,1-dimethyl-3-oxobutylamino) -3-hydroxybenzo [c] chromen-6-one,
8-amino-3- (4-methoxybenzyloxy) benzo [c] chromen-6-one,
8-amino-3-benzyloxymethoxybenzo [c] chromen-6-one,
8- (1,1-dimethyl-3-oxobutylamino) -3- (4-methoxybenzyloxy) benzo [c] chromen-6-one,
8- (1,1-dimethyl-3-oxobutylamino) -3-benzyloxymethoxybenzo [c] chromen-6-one,
-Methyl 2- (2,4-dimethoxyphenyl) -5-aminobenzoate,
6- (2,4-methoxy) -2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate methyl,
6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid,
-Methyl 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate,
A compound selected from methyl 2-bromo-5- (1,1-dimethyl-3-oxobutylamino) benzoate or a salt thereof.
[8] イソプロペニルアルキルエーテルがイソプロペニルメチルエーテルである上記[1]~[6]の製造方法。
[9] ・8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オンのp-トルエンスルホン酸塩、
・8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ヒドロキシベンゾ[c]クロメン-6-オン、
・8-アミノ-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン、
・8-アミノ-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン、
・8-(1,1-ジメチル-3-オキソブチルアミノ)-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン、
・8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン、
・2-(2,4-ジメトキシフェニル)-5-アミノ安息香酸メチル、
・6-(2,4-メトキシ)-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸メチル、
・6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸、
・6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸メチル、
・2-ブロモ-5-(1,1-ジメチル-3-オキソブチルアミノ)安息香酸メチル
から選択される化合物またはその塩。 [7] The production method of the above [1] to [6], wherein the 2,2-dialkoxypropane is 2,2-dimethoxypropane.
[8] The production method of the above [1] to [6], wherein the isopropenyl alkyl ether is isopropenyl methyl ether.
[9]-p-toluenesulfonate of 8-amino-3-hydroxybenzo [c] chromen-6-one,
8- (1,1-dimethyl-3-oxobutylamino) -3-hydroxybenzo [c] chromen-6-one,
8-amino-3- (4-methoxybenzyloxy) benzo [c] chromen-6-one,
8-amino-3-benzyloxymethoxybenzo [c] chromen-6-one,
8- (1,1-dimethyl-3-oxobutylamino) -3- (4-methoxybenzyloxy) benzo [c] chromen-6-one,
8- (1,1-dimethyl-3-oxobutylamino) -3-benzyloxymethoxybenzo [c] chromen-6-one,
-Methyl 2- (2,4-dimethoxyphenyl) -5-aminobenzoate,
6- (2,4-methoxy) -2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate methyl,
6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid,
-Methyl 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate,
A compound selected from methyl 2-bromo-5- (1,1-dimethyl-3-oxobutylamino) benzoate or a salt thereof.
本発明によれば、ヒドロキシ基を有する8-アミノ-ベンゾ[c]クロメン-6-オン誘導体を酸および/または塩基、および水存在下、2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させることにより、ヨウ素を使用せずに、1,2-ジヒドロキノリン誘導体の合成中間体である式(2)で表される化合物またはその塩を得ることができる。また、当該反応後に、カラム精製をすることなく、式(2)で表される化合物またはその塩のフェノール性水酸基をp-メトキシベンジル化またはベンジルオキシメチル化することで、式(3)で表される化合物またはその塩をカラム精製することなく効率よく得ることができる。また、式(2)で表される化合物またはその塩は、式(4)で表される化合物またはその塩から得ることができる。さらに、式(5)で表される化合物またはその塩を、p-トルエンスルホン酸、塩酸または臭素酸で処理することにより、ろ過性のよい式(1)で表される化合物のp-トルエンスルホン酸塩、塩酸塩または臭素酸塩として得ることができる。
According to the present invention, an 8-amino-benzo [c] chromen-6-one derivative having a hydroxy group is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether in the presence of an acid and / or base and water. Thus, a compound represented by the formula (2) or a salt thereof, which is a synthetic intermediate of a 1,2-dihydroquinoline derivative, can be obtained without using iodine. In addition, after the reaction, the compound represented by the formula (2) or a salt thereof is p-methoxybenzylated or benzyloxymethylated without performing column purification to obtain a compound represented by the formula (3). Or a salt thereof can be efficiently obtained without column purification. Moreover, the compound represented by Formula (2) or its salt can be obtained from the compound represented by Formula (4) or its salt. Further, by treating the compound represented by the formula (5) or a salt thereof with p-toluenesulfonic acid, hydrochloric acid or bromic acid, p-toluenesulfone of the compound represented by the formula (1) having good filterability It can be obtained as an acid salt, hydrochloride or bromate.
本明細書中で使用される原子、基、環などの定義について以下に詳しく説明する。また、以下の文言の定義が別の文言の定義に準用される場合、各定義の好ましい範囲および特に好ましい範囲にも準用することができる。
「ハロゲン原子」とは、フッ素原子、塩素原子、臭素原子またはヨウ素原子を示す。
「低級アルキル基」とは、炭素原子数が1~8個、好ましくは1~6個、特に好ましくは1~4個の直鎖または分枝のアルキル基を示す。具体例として、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、n-ヘプチル基、n-オクチル基、イソプロピル基、イソブチル基、sec-ブチル基、tert-ブチル基、イソペンチル基などが挙げられる。 The definitions of atoms, groups, rings and the like used in this specification will be described in detail below. Moreover, when the definition of the following words is applied mutatis mutandis to the definition of another wording, it can apply mutatis mutandis also to the preferable range and especially preferable range of each definition.
“Halogen atom” refers to a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.
The “lower alkyl group” refers to a straight or branched alkyl group having 1 to 8, preferably 1 to 6, and particularly preferably 1 to 4 carbon atoms. Specific examples include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, n-heptyl group, n-octyl group, isopropyl group, isobutyl group, sec-butyl group. , Tert-butyl group, isopentyl group and the like.
「ハロゲン原子」とは、フッ素原子、塩素原子、臭素原子またはヨウ素原子を示す。
「低級アルキル基」とは、炭素原子数が1~8個、好ましくは1~6個、特に好ましくは1~4個の直鎖または分枝のアルキル基を示す。具体例として、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、n-ヘプチル基、n-オクチル基、イソプロピル基、イソブチル基、sec-ブチル基、tert-ブチル基、イソペンチル基などが挙げられる。 The definitions of atoms, groups, rings and the like used in this specification will be described in detail below. Moreover, when the definition of the following words is applied mutatis mutandis to the definition of another wording, it can apply mutatis mutandis also to the preferable range and especially preferable range of each definition.
“Halogen atom” refers to a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.
The “lower alkyl group” refers to a straight or branched alkyl group having 1 to 8, preferably 1 to 6, and particularly preferably 1 to 4 carbon atoms. Specific examples include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, n-heptyl group, n-octyl group, isopropyl group, isobutyl group, sec-butyl group. , Tert-butyl group, isopentyl group and the like.
「低級アルコキシ基」とは、ヒドロキシ基の水素原子が低級アルキル基で置換された基を示す。具体例として、メトキシ、エトキシ、n-プロポキシ、n-ブトキシ、n-ペントキシ、n-ヘキシルオキシ、n-ヘプチルオキシ、n-オクチルオキシ、イソプロポキシ、イソブトキシ、sec-ブトキシ、tert-ブトキシまたはイソペントキシ基などが挙げられる。
「低級アルキルカルボニル基」とは、ホルミル基の水素原子が低級アルキル基で置換された基を示す。具体例として、メチルカルボニル基、エチルカルボニル基、n-プロピルカルボニル基、n-ブチルカルボニル基、n-ペンチルカルボニル基、n-ヘキシルカルボニル基、イソプロピルカルボニル基、イソブチルカルボニル基、sec-ブチルカルボニル基、tert-ブチルカルボニル基またはイソペンチルカルボニル基などが挙げられる。
「アミノ基」としては、‐NH2基、または1もしくは2の低級アルキル基で置換されたアミノ基などが挙げられる。 The “lower alkoxy group” refers to a group in which a hydrogen atom of a hydroxy group is substituted with a lower alkyl group. Specific examples include methoxy, ethoxy, n-propoxy, n-butoxy, n-pentoxy, n-hexyloxy, n-heptyloxy, n-octyloxy, isopropoxy, isobutoxy, sec-butoxy, tert-butoxy or isopentoxy group Etc.
The “lower alkylcarbonyl group” refers to a group in which a hydrogen atom of a formyl group is substituted with a lower alkyl group. Specific examples include methylcarbonyl group, ethylcarbonyl group, n-propylcarbonyl group, n-butylcarbonyl group, n-pentylcarbonyl group, n-hexylcarbonyl group, isopropylcarbonyl group, isobutylcarbonyl group, sec-butylcarbonyl group, Examples thereof include a tert-butylcarbonyl group and an isopentylcarbonyl group.
Examples of the “amino group” include —NH 2 group, an amino group substituted with 1 or 2 lower alkyl groups, and the like.
「低級アルキルカルボニル基」とは、ホルミル基の水素原子が低級アルキル基で置換された基を示す。具体例として、メチルカルボニル基、エチルカルボニル基、n-プロピルカルボニル基、n-ブチルカルボニル基、n-ペンチルカルボニル基、n-ヘキシルカルボニル基、イソプロピルカルボニル基、イソブチルカルボニル基、sec-ブチルカルボニル基、tert-ブチルカルボニル基またはイソペンチルカルボニル基などが挙げられる。
「アミノ基」としては、‐NH2基、または1もしくは2の低級アルキル基で置換されたアミノ基などが挙げられる。 The “lower alkoxy group” refers to a group in which a hydrogen atom of a hydroxy group is substituted with a lower alkyl group. Specific examples include methoxy, ethoxy, n-propoxy, n-butoxy, n-pentoxy, n-hexyloxy, n-heptyloxy, n-octyloxy, isopropoxy, isobutoxy, sec-butoxy, tert-butoxy or isopentoxy group Etc.
The “lower alkylcarbonyl group” refers to a group in which a hydrogen atom of a formyl group is substituted with a lower alkyl group. Specific examples include methylcarbonyl group, ethylcarbonyl group, n-propylcarbonyl group, n-butylcarbonyl group, n-pentylcarbonyl group, n-hexylcarbonyl group, isopropylcarbonyl group, isobutylcarbonyl group, sec-butylcarbonyl group, Examples thereof include a tert-butylcarbonyl group and an isopentylcarbonyl group.
Examples of the “amino group” include —NH 2 group, an amino group substituted with 1 or 2 lower alkyl groups, and the like.
「脱離基」とは、反応により脱離する置換基を示す。具体例として、フッ素原子、塩素原子、臭素原子、ヨウ素原子などのハロゲン原子、メタンスルホニルオキシ基、クロロメチルスルホキシオキシ基、トリフルオロメタンスルホニルオキシ基などの低級アルキルスルホニルオキシ基、ベンゼンスルホニルオキシ基、p-トルエンスルホニルオキシ基などのアリールスルホニルオキシ基、シアノ基、ニトロ基、トリクロロアセトイミデートなどが挙げられる。
本発明において使用する原料、試薬、その他本願明細書に記載の化合物は、酸または塩基と「塩」を形成してもよい。具体例として、塩酸、臭化水素酸、臭素酸、ヨウ化水素酸、硝酸、硫酸、リン酸などの無機酸との塩、炭酸、酢酸、フマル酸、マレイン酸、コハク酸、クエン酸、酒石酸、アジピン酸、グルコン酸、グルコヘプト酸、グルクロン酸、テレフタル酸、メタンスルホン酸、乳酸、馬尿酸、1,2-エタンジスルホン酸、イセチオン酸、ラクトビオン酸、オレイン酸、パモ酸、ポリガラクツロン酸、ステアリン酸、タンニン酸、トリフルオロメタンスルホン酸、ベンゼンスルホン酸、p-トルエンスルホン酸、10-カンファースルホン酸、硫酸ラウリルエステル、硫酸メチル、ナフタレンスルホン酸、スルホサリチル酸などの有機酸との塩、臭化メチル、ヨウ化メチルなどの四級アンモニウム塩、臭素イオン、塩素イオン、ヨウ素イオンなどのハロゲンイオンとの塩、リチウム、ナトリウム、カリウムなどのアルカリ金属との塩、カルシウム、マグネシウムなどのアルカリ土類金属との塩、銅、鉄、亜鉛などとの金属塩、アンモニアとの塩、トリエチレンジアミン、2-アミノエタノール、2,2-イミノビス(エタノール)、1-デオキシ-1-(メチルアミノ)-2-D-ソルビトール、2-アミノ-2-(ヒドロキシメチル)-1,3-プロパンジオール、プロカイン、N,N-ジメチルアニリンまたはN,N-ビス(フェニルメチル)-1,2-エタンジアミンなどの有機アミンとの塩、ピリジンとの塩などが挙げられる。 “Leaving group” refers to a substituent that is eliminated by a reaction. Specific examples include halogen atoms such as fluorine atom, chlorine atom, bromine atom, iodine atom, lower alkylsulfonyloxy group such as methanesulfonyloxy group, chloromethylsulfoxyoxy group, trifluoromethanesulfonyloxy group, benzenesulfonyloxy group, Arylsulfonyloxy groups such as p-toluenesulfonyloxy group, cyano group, nitro group, trichloroacetimidate and the like can be mentioned.
The raw materials, reagents, and other compounds described in the present specification used in the present invention may form “salts” with acids or bases. Specific examples include salts with inorganic acids such as hydrochloric acid, hydrobromic acid, bromic acid, hydroiodic acid, nitric acid, sulfuric acid, phosphoric acid, carbonic acid, acetic acid, fumaric acid, maleic acid, succinic acid, citric acid, tartaric acid , Adipic acid, gluconic acid, glucoheptic acid, glucuronic acid, terephthalic acid, methanesulfonic acid, lactic acid, hippuric acid, 1,2-ethanedisulfonic acid, isethionic acid, lactobionic acid, oleic acid, pamoic acid, polygalacturonic acid, stearin Acid, tannic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, 10-camphorsulfonic acid, lauryl sulfate, methyl sulfate, naphthalenesulfonic acid, salts with organic acids such as sulfosalicylic acid, methyl bromide Quaternary ammonium salts such as methyl iodide, bromine ion, chlorine ion, iodine ion Salt with gen ion, salt with alkali metal such as lithium, sodium, potassium, salt with alkaline earth metal such as calcium, magnesium, metal salt with copper, iron, zinc, salt with ammonia, triethylenediamine, 2-aminoethanol, 2,2-iminobis (ethanol), 1-deoxy-1- (methylamino) -2-D-sorbitol, 2-amino-2- (hydroxymethyl) -1,3-propanediol, procaine , Salts with organic amines such as N, N-dimethylaniline or N, N-bis (phenylmethyl) -1,2-ethanediamine, and salts with pyridine.
本発明において使用する原料、試薬、その他本願明細書に記載の化合物は、酸または塩基と「塩」を形成してもよい。具体例として、塩酸、臭化水素酸、臭素酸、ヨウ化水素酸、硝酸、硫酸、リン酸などの無機酸との塩、炭酸、酢酸、フマル酸、マレイン酸、コハク酸、クエン酸、酒石酸、アジピン酸、グルコン酸、グルコヘプト酸、グルクロン酸、テレフタル酸、メタンスルホン酸、乳酸、馬尿酸、1,2-エタンジスルホン酸、イセチオン酸、ラクトビオン酸、オレイン酸、パモ酸、ポリガラクツロン酸、ステアリン酸、タンニン酸、トリフルオロメタンスルホン酸、ベンゼンスルホン酸、p-トルエンスルホン酸、10-カンファースルホン酸、硫酸ラウリルエステル、硫酸メチル、ナフタレンスルホン酸、スルホサリチル酸などの有機酸との塩、臭化メチル、ヨウ化メチルなどの四級アンモニウム塩、臭素イオン、塩素イオン、ヨウ素イオンなどのハロゲンイオンとの塩、リチウム、ナトリウム、カリウムなどのアルカリ金属との塩、カルシウム、マグネシウムなどのアルカリ土類金属との塩、銅、鉄、亜鉛などとの金属塩、アンモニアとの塩、トリエチレンジアミン、2-アミノエタノール、2,2-イミノビス(エタノール)、1-デオキシ-1-(メチルアミノ)-2-D-ソルビトール、2-アミノ-2-(ヒドロキシメチル)-1,3-プロパンジオール、プロカイン、N,N-ジメチルアニリンまたはN,N-ビス(フェニルメチル)-1,2-エタンジアミンなどの有機アミンとの塩、ピリジンとの塩などが挙げられる。 “Leaving group” refers to a substituent that is eliminated by a reaction. Specific examples include halogen atoms such as fluorine atom, chlorine atom, bromine atom, iodine atom, lower alkylsulfonyloxy group such as methanesulfonyloxy group, chloromethylsulfoxyoxy group, trifluoromethanesulfonyloxy group, benzenesulfonyloxy group, Arylsulfonyloxy groups such as p-toluenesulfonyloxy group, cyano group, nitro group, trichloroacetimidate and the like can be mentioned.
The raw materials, reagents, and other compounds described in the present specification used in the present invention may form “salts” with acids or bases. Specific examples include salts with inorganic acids such as hydrochloric acid, hydrobromic acid, bromic acid, hydroiodic acid, nitric acid, sulfuric acid, phosphoric acid, carbonic acid, acetic acid, fumaric acid, maleic acid, succinic acid, citric acid, tartaric acid , Adipic acid, gluconic acid, glucoheptic acid, glucuronic acid, terephthalic acid, methanesulfonic acid, lactic acid, hippuric acid, 1,2-ethanedisulfonic acid, isethionic acid, lactobionic acid, oleic acid, pamoic acid, polygalacturonic acid, stearin Acid, tannic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, 10-camphorsulfonic acid, lauryl sulfate, methyl sulfate, naphthalenesulfonic acid, salts with organic acids such as sulfosalicylic acid, methyl bromide Quaternary ammonium salts such as methyl iodide, bromine ion, chlorine ion, iodine ion Salt with gen ion, salt with alkali metal such as lithium, sodium, potassium, salt with alkaline earth metal such as calcium, magnesium, metal salt with copper, iron, zinc, salt with ammonia, triethylenediamine, 2-aminoethanol, 2,2-iminobis (ethanol), 1-deoxy-1- (methylamino) -2-D-sorbitol, 2-amino-2- (hydroxymethyl) -1,3-propanediol, procaine , Salts with organic amines such as N, N-dimethylaniline or N, N-bis (phenylmethyl) -1,2-ethanediamine, and salts with pyridine.
本発明において使用する原料、試薬、その他本願明細書に記載の化合物は、水和物または溶媒和物の形態をとっていてもよい。
本発明において使用する原料、試薬、その他本願明細書に記載の化合物に幾何異性体または光学異性体が存在する場合は、その異性体も本発明の範囲に含まれる。
本発明において使用する原料、試薬、その他本願明細書に記載の化合物にプロトン互変異性が存在する場合は、その互変異性体も本発明に含まれる。
本発明において使用する原料、試薬、その他本願明細書に記載の化合物、それらの水和物または溶媒和物は結晶であってもよく、該結晶に結晶多形および結晶多形群(結晶多形システム)が存在する場合には、それらの結晶多形体および結晶多形群(結晶多形システム)も本発明に含まれる。ここで、結晶多形群(結晶多形システム)とは、それら結晶の製造、晶出、保存等の条件および状態(尚、本状態には製剤化した状態も含む)により、結晶形が種々変化する場合の各段階における結晶形およびその過程全体を意味する。 The raw materials, reagents, and other compounds described in the present specification used in the present invention may be in the form of hydrates or solvates.
When geometrical isomers or optical isomers exist in the raw materials, reagents, and other compounds described in the present specification, such isomers are also included in the scope of the present invention.
When proton tautomerism exists in the raw materials, reagents and other compounds described in the present specification used in the present invention, such tautomers are also included in the present invention.
The raw materials, reagents, other compounds described in the present specification, hydrates or solvates thereof used in the present invention may be crystals, and crystal polymorphs and crystal polymorph groups (crystal polymorphs) are included in the crystals. When the system is present, the crystal polymorphs and crystal polymorph groups (crystal polymorph systems) are also included in the present invention. Here, the crystal polymorph group (crystal polymorph system) refers to various crystal forms depending on the conditions and states of production, crystallization, storage, etc. of these crystals (including the formulated state in this state). It means the crystal form and the whole process at each stage when changing.
本発明において使用する原料、試薬、その他本願明細書に記載の化合物に幾何異性体または光学異性体が存在する場合は、その異性体も本発明の範囲に含まれる。
本発明において使用する原料、試薬、その他本願明細書に記載の化合物にプロトン互変異性が存在する場合は、その互変異性体も本発明に含まれる。
本発明において使用する原料、試薬、その他本願明細書に記載の化合物、それらの水和物または溶媒和物は結晶であってもよく、該結晶に結晶多形および結晶多形群(結晶多形システム)が存在する場合には、それらの結晶多形体および結晶多形群(結晶多形システム)も本発明に含まれる。ここで、結晶多形群(結晶多形システム)とは、それら結晶の製造、晶出、保存等の条件および状態(尚、本状態には製剤化した状態も含む)により、結晶形が種々変化する場合の各段階における結晶形およびその過程全体を意味する。 The raw materials, reagents, and other compounds described in the present specification used in the present invention may be in the form of hydrates or solvates.
When geometrical isomers or optical isomers exist in the raw materials, reagents, and other compounds described in the present specification, such isomers are also included in the scope of the present invention.
When proton tautomerism exists in the raw materials, reagents and other compounds described in the present specification used in the present invention, such tautomers are also included in the present invention.
The raw materials, reagents, other compounds described in the present specification, hydrates or solvates thereof used in the present invention may be crystals, and crystal polymorphs and crystal polymorph groups (crystal polymorphs) are included in the crystals. When the system is present, the crystal polymorphs and crystal polymorph groups (crystal polymorph systems) are also included in the present invention. Here, the crystal polymorph group (crystal polymorph system) refers to various crystal forms depending on the conditions and states of production, crystallization, storage, etc. of these crystals (including the formulated state in this state). It means the crystal form and the whole process at each stage when changing.
以下、本発明の製造方法について説明する。
製造方法1
式(2)で表される化合物またはその塩は、以下の工程1(合成経路1-1)および工程2(合成経路1-2)に従い製造することができる。
<工程1>
合成経路1-1 Hereinafter, the production method of the present invention will be described.
Manufacturing method 1
The compound represented by the formula (2) or a salt thereof can be produced according to the following Step 1 (Synthesis route 1-1) and Step 2 (Synthesis route 1-2).
<Step 1>
Synthesis route 1-1
製造方法1
式(2)で表される化合物またはその塩は、以下の工程1(合成経路1-1)および工程2(合成経路1-2)に従い製造することができる。
<工程1>
合成経路1-1 Hereinafter, the production method of the present invention will be described.
Manufacturing method 1
The compound represented by the formula (2) or a salt thereof can be produced according to the following Step 1 (Synthesis route 1-1) and Step 2 (Synthesis route 1-2).
<Step 1>
Synthesis route 1-1
工程1は、式(5)で表される化合物またはその塩を、p-トルエンスルホン酸、塩酸または臭素酸と反応させて、式(1)で表される化合物またはその塩を製造する工程である。なお、式(5)で表される化合物またはその塩は、国際公開2012/108455号パンフレットの記載に準じて得ることができる。
p-トルエンスルホン酸、塩酸または臭素酸は、式(5)で表される化合物またはその塩に対し、0.1等量以上、好ましくは1~6等量、さらに好ましくは3~4等量用いられる。 Step 1 is a step of producing a compound represented by the formula (1) or a salt thereof by reacting a compound represented by the formula (5) or a salt thereof with p-toluenesulfonic acid, hydrochloric acid or bromic acid. is there. In addition, the compound represented by Formula (5) or its salt can be obtained according to description of the international publication 2012/108455 pamphlet.
p-Toluenesulfonic acid, hydrochloric acid or bromic acid is 0.1 equivalent or more, preferably 1 to 6 equivalents, more preferably 3 to 4 equivalents, relative to the compound represented by the formula (5) or a salt thereof. Used.
p-トルエンスルホン酸、塩酸または臭素酸は、式(5)で表される化合物またはその塩に対し、0.1等量以上、好ましくは1~6等量、さらに好ましくは3~4等量用いられる。 Step 1 is a step of producing a compound represented by the formula (1) or a salt thereof by reacting a compound represented by the formula (5) or a salt thereof with p-toluenesulfonic acid, hydrochloric acid or bromic acid. is there. In addition, the compound represented by Formula (5) or its salt can be obtained according to description of the international publication 2012/108455 pamphlet.
p-Toluenesulfonic acid, hydrochloric acid or bromic acid is 0.1 equivalent or more, preferably 1 to 6 equivalents, more preferably 3 to 4 equivalents, relative to the compound represented by the formula (5) or a salt thereof. Used.
この工程で使用される溶媒としては、反応を阻害せず、出発物質をある程度溶解するものであれば特に限定はなく、例えば、ベンゼン、トルエン、キシレンなどの芳香族炭化水素類;ジクロロメタン、クロロホルム、四塩化炭素、ジクロロエタン、クロロベンゼン、ジクロロベンゼンなどのハロゲン化炭化水素類;ジエチルエ-テル、ジイソプロピルエ-テル、テトラヒドロフラン、シクロペンチルメチルエーテル、メチル-tert-ブチルエーテル、ジオキサン、ジメトキシエタン、ジエチレングリコールジメチルエーテルなどのエ-テル類;酢酸エチル、酢酸イソプロピルなどの低級アルキルカルボン酸エステル類;ホルムアミド、N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチル-2-ピロリジノン、ヘキサメチルホスホロトリアミドなどのアミド類;ジメチルスルホキシド、スルホランなどのスルホキシド類;メタノール、エタノール、プロパノール、イソプロパノール、ブタノール、イソブタノール、tert-ブタノールなどの低級アルコール類;水;または、これらの混合溶媒を挙げることができ、好ましくは低級アルコール類と水であり、さらに好ましくはエタノールと水である。
The solvent used in this step is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. For example, aromatic hydrocarbons such as benzene, toluene, xylene; dichloromethane, chloroform, Halogenated hydrocarbons such as carbon tetrachloride, dichloroethane, chlorobenzene, dichlorobenzene; ethers such as diethyl ether, diisopropyl ether, tetrahydrofuran, cyclopentyl methyl ether, methyl-tert-butyl ether, dioxane, dimethoxyethane, diethylene glycol dimethyl ether Ters; lower alkyl carboxylic acid esters such as ethyl acetate and isopropyl acetate; formamide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidinone, Amides such as oxamethyl phosphorotriamide; Sulfoxides such as dimethyl sulfoxide and sulfolane; Lower alcohols such as methanol, ethanol, propanol, isopropanol, butanol, isobutanol and tert-butanol; Water; or a mixed solvent thereof Preferred are lower alcohols and water, and more preferred are ethanol and water.
反応温度は、原料化合物、反応試薬によって異なるが、0℃から100℃で行なわれ、好ましくは、0℃から50℃である。
反応時間は、反応温度、原料化合物、反応試薬または使用される溶媒の種類によって異なるが、通常、1分から48時間で、好ましくは、15時間から24時間である。
目的化合物は、反応終了後、反応液を放冷させ、氷冷下で撹拌しながら、水、アンモニア水、メタノールなどの溶媒を添加し、析出した固体を濾過するか、または抽出操作を行い、濃縮後得られた残渣にトルエン、酢酸エチルなどの再結晶可能な溶媒を添加して析出した固体をろ過、乾燥することで得ることができる。なお、析出した固体をろ過した後、トルエン、酢酸エチル、水などで洗浄することが好ましい。
得られた目的化合物は必要ならば、通常行われる方法、例えば再結晶、再沈殿などによって精製することができる。
また、目的化合物は、p-トルエンスルホン酸塩、塩酸塩または臭素酸塩として得ることができる。 While the reaction temperature varies depending on the raw material compound and the reaction reagent, it is carried out at 0 ° C. to 100 ° C., preferably 0 ° C. to 50 ° C.
While the reaction time varies depending on the reaction temperature, raw material compound, reaction reagent or the type of solvent used, it is generally 1 min to 48 hr, preferably 15 hr to 24 hr.
After completion of the reaction, the target compound is allowed to cool, and while stirring under ice cooling, a solvent such as water, aqueous ammonia or methanol is added, and the precipitated solid is filtered or extracted. It can be obtained by adding a recrystallizable solvent such as toluene or ethyl acetate to the residue obtained after concentration and filtering and drying the precipitated solid. In addition, after filtering the depositing solid, it is preferable to wash | clean with toluene, ethyl acetate, water, etc.
If necessary, the obtained target compound can be purified by a conventional method such as recrystallization and reprecipitation.
The target compound can also be obtained as p-toluenesulfonate, hydrochloride or bromate.
反応時間は、反応温度、原料化合物、反応試薬または使用される溶媒の種類によって異なるが、通常、1分から48時間で、好ましくは、15時間から24時間である。
目的化合物は、反応終了後、反応液を放冷させ、氷冷下で撹拌しながら、水、アンモニア水、メタノールなどの溶媒を添加し、析出した固体を濾過するか、または抽出操作を行い、濃縮後得られた残渣にトルエン、酢酸エチルなどの再結晶可能な溶媒を添加して析出した固体をろ過、乾燥することで得ることができる。なお、析出した固体をろ過した後、トルエン、酢酸エチル、水などで洗浄することが好ましい。
得られた目的化合物は必要ならば、通常行われる方法、例えば再結晶、再沈殿などによって精製することができる。
また、目的化合物は、p-トルエンスルホン酸塩、塩酸塩または臭素酸塩として得ることができる。 While the reaction temperature varies depending on the raw material compound and the reaction reagent, it is carried out at 0 ° C. to 100 ° C., preferably 0 ° C. to 50 ° C.
While the reaction time varies depending on the reaction temperature, raw material compound, reaction reagent or the type of solvent used, it is generally 1 min to 48 hr, preferably 15 hr to 24 hr.
After completion of the reaction, the target compound is allowed to cool, and while stirring under ice cooling, a solvent such as water, aqueous ammonia or methanol is added, and the precipitated solid is filtered or extracted. It can be obtained by adding a recrystallizable solvent such as toluene or ethyl acetate to the residue obtained after concentration and filtering and drying the precipitated solid. In addition, after filtering the depositing solid, it is preferable to wash | clean with toluene, ethyl acetate, water, etc.
If necessary, the obtained target compound can be purified by a conventional method such as recrystallization and reprecipitation.
The target compound can also be obtained as p-toluenesulfonate, hydrochloride or bromate.
<工程2>
合成経路1-2
工程2は、式(1)で表される化合物またはその塩を
(A)p-トルエンスルホン酸、p-トルエンスルホン酸ピリジニウム、臭化水素酸およびピリジン臭化水素酸塩からなる群より選択される酸及び/又は
(B)ピリジンおよびN,N-ジメチルアニリンからなる群より選択される塩基、及び
(C)水の存在下、2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させて式(2)で表される化合物またはその塩を製造する工程である。<工程2>の図中、R2は低級アルキル基を示し、好ましくはメチル基を示す。 <Step 2>
Synthesis route 1-2
In step 2, the compound represented by the formula (1) or a salt thereof is selected from the group consisting of (A) p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrobromic acid and pyridine hydrobromide. And (B) a base selected from the group consisting of pyridine and N, N-dimethylaniline, and (C) a reaction with 2,2-dialkoxypropane or isopropenyl alkyl ether in the presence of water. This is a process for producing a compound represented by formula (2) or a salt thereof. In the figure of <Step 2>, R 2 represents a lower alkyl group, preferably a methyl group.
合成経路1-2
工程2は、式(1)で表される化合物またはその塩を
(A)p-トルエンスルホン酸、p-トルエンスルホン酸ピリジニウム、臭化水素酸およびピリジン臭化水素酸塩からなる群より選択される酸及び/又は
(B)ピリジンおよびN,N-ジメチルアニリンからなる群より選択される塩基、及び
(C)水の存在下、2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させて式(2)で表される化合物またはその塩を製造する工程である。<工程2>の図中、R2は低級アルキル基を示し、好ましくはメチル基を示す。 <Step 2>
Synthesis route 1-2
In step 2, the compound represented by the formula (1) or a salt thereof is selected from the group consisting of (A) p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrobromic acid and pyridine hydrobromide. And (B) a base selected from the group consisting of pyridine and N, N-dimethylaniline, and (C) a reaction with 2,2-dialkoxypropane or isopropenyl alkyl ether in the presence of water. This is a process for producing a compound represented by formula (2) or a salt thereof. In the figure of <Step 2>, R 2 represents a lower alkyl group, preferably a methyl group.
この工程で使用する酸(A)として好ましくはp-トルエンスルホン酸またはp-トルエンスルホン酸ピリジニウムであり、さらに好ましくはp-トルエンスルホン酸である。
この工程で使用する酸(A)は、式(1)で表される化合物またはその塩に対し、0.10等量以上、好ましくは0.5~2.0等量、さらに好ましくは0.90~1.10等量用いられる。
この工程で使用する塩基(B)として好ましくはピリジンである。
この工程で使用する酸(B)は、式(1)で表される化合物またはその塩に対し、0.10等量以上、好ましくは0.5~2.0等量、さらに好ましくは0.90~1.10等量用いられる。
この工程において、(A)および(B)を使用してもよい。かかる場合、(A)としてp-トルエンスルホン酸、(B)としてピリジンを使用する組合せが好ましい。
また、(A)または(B)を使用してもよい。(A)を使用する場合、p-トルエンスルホン酸ピリジニウムを使用するのが好ましい。 The acid (A) used in this step is preferably p-toluenesulfonic acid or pyridinium p-toluenesulfonate, and more preferably p-toluenesulfonic acid.
The acid (A) used in this step is 0.10 equivalents or more, preferably 0.5 to 2.0 equivalents, more preferably 0.00 equivalents, relative to the compound represented by the formula (1) or a salt thereof. 90 to 1.10 equivalents are used.
The base (B) used in this step is preferably pyridine.
The acid (B) used in this step is 0.10 equivalents or more, preferably 0.5 to 2.0 equivalents, more preferably 0.8 equivalents, relative to the compound represented by the formula (1) or a salt thereof. 90 to 1.10 equivalents are used.
In this step, (A) and (B) may be used. In such a case, a combination using p-toluenesulfonic acid as (A) and pyridine as (B) is preferable.
Further, (A) or (B) may be used. When (A) is used, it is preferable to use pyridinium p-toluenesulfonate.
この工程で使用する酸(A)は、式(1)で表される化合物またはその塩に対し、0.10等量以上、好ましくは0.5~2.0等量、さらに好ましくは0.90~1.10等量用いられる。
この工程で使用する塩基(B)として好ましくはピリジンである。
この工程で使用する酸(B)は、式(1)で表される化合物またはその塩に対し、0.10等量以上、好ましくは0.5~2.0等量、さらに好ましくは0.90~1.10等量用いられる。
この工程において、(A)および(B)を使用してもよい。かかる場合、(A)としてp-トルエンスルホン酸、(B)としてピリジンを使用する組合せが好ましい。
また、(A)または(B)を使用してもよい。(A)を使用する場合、p-トルエンスルホン酸ピリジニウムを使用するのが好ましい。 The acid (A) used in this step is preferably p-toluenesulfonic acid or pyridinium p-toluenesulfonate, and more preferably p-toluenesulfonic acid.
The acid (A) used in this step is 0.10 equivalents or more, preferably 0.5 to 2.0 equivalents, more preferably 0.00 equivalents, relative to the compound represented by the formula (1) or a salt thereof. 90 to 1.10 equivalents are used.
The base (B) used in this step is preferably pyridine.
The acid (B) used in this step is 0.10 equivalents or more, preferably 0.5 to 2.0 equivalents, more preferably 0.8 equivalents, relative to the compound represented by the formula (1) or a salt thereof. 90 to 1.10 equivalents are used.
In this step, (A) and (B) may be used. In such a case, a combination using p-toluenesulfonic acid as (A) and pyridine as (B) is preferable.
Further, (A) or (B) may be used. When (A) is used, it is preferable to use pyridinium p-toluenesulfonate.
また、この工程で使用する水(C)は、式(1)で表される化合物またはその塩に対し、5等量以上、好ましくは10~30等量、さらに好ましくは15~25等量用いられる。
また、この工程で使用する2,2-ジアルコキシプロパンとしては、例えば2,2-ジメトキシプロパン、2,2-ジエトキシプロパンなどを挙げることができ、式(1)で表される化合物またはその塩に対し、10等量以上、好ましくは30~100等量、さらに好ましくは50~60等量用いられる。
また、この工程で使用するイソプロペニルアルキルエーテルとしては、例えばイソプロペニルメチルエーテル、イソプロペニルエチルエーテルなどを挙げることができ、式(1)で表される化合物またはその塩に対し、10等量以上、好ましくは30~100等量、さらに好ましくは50~60等量用いられる。 The water (C) used in this step is used in an amount of 5 equivalents or more, preferably 10 to 30 equivalents, more preferably 15 to 25 equivalents, relative to the compound represented by the formula (1) or a salt thereof. It is done.
Examples of the 2,2-dialkoxypropane used in this step include 2,2-dimethoxypropane and 2,2-diethoxypropane. The compound represented by the formula (1) or its It is used in an amount of 10 equivalents or more, preferably 30-100 equivalents, more preferably 50-60 equivalents, relative to the salt.
Examples of the isopropenyl alkyl ether used in this step include isopropenyl methyl ether and isopropenyl ethyl ether. The compound represented by the formula (1) or a salt thereof is 10 equivalents or more. The amount is preferably 30 to 100 equivalents, more preferably 50 to 60 equivalents.
また、この工程で使用する2,2-ジアルコキシプロパンとしては、例えば2,2-ジメトキシプロパン、2,2-ジエトキシプロパンなどを挙げることができ、式(1)で表される化合物またはその塩に対し、10等量以上、好ましくは30~100等量、さらに好ましくは50~60等量用いられる。
また、この工程で使用するイソプロペニルアルキルエーテルとしては、例えばイソプロペニルメチルエーテル、イソプロペニルエチルエーテルなどを挙げることができ、式(1)で表される化合物またはその塩に対し、10等量以上、好ましくは30~100等量、さらに好ましくは50~60等量用いられる。 The water (C) used in this step is used in an amount of 5 equivalents or more, preferably 10 to 30 equivalents, more preferably 15 to 25 equivalents, relative to the compound represented by the formula (1) or a salt thereof. It is done.
Examples of the 2,2-dialkoxypropane used in this step include 2,2-dimethoxypropane and 2,2-diethoxypropane. The compound represented by the formula (1) or its It is used in an amount of 10 equivalents or more, preferably 30-100 equivalents, more preferably 50-60 equivalents, relative to the salt.
Examples of the isopropenyl alkyl ether used in this step include isopropenyl methyl ether and isopropenyl ethyl ether. The compound represented by the formula (1) or a salt thereof is 10 equivalents or more. The amount is preferably 30 to 100 equivalents, more preferably 50 to 60 equivalents.
この工程で使用される溶媒としては、反応を阻害せず、出発物質をある程度溶解するものであれば特に限定はなく、例えば、ベンゼン、トルエン、キシレンなどの芳香族炭化水素類;ジクロロメタン、クロロホルム、四塩化炭素、ジクロロエタン、クロロベンゼン、ジクロロベンゼンなどのハロゲン化炭化水素類;ジエチルエ-テル、ジイソプロピルエ-テル、テトラヒドロフラン、シクロペンチルメチルエーテル、メチル-tert-ブチルエーテル、ジオキサン、ジメトキシエタン、ジエチレングリコールジメチルエーテルなどのエ-テル類;酢酸エチル、酢酸イソプロピルなどの低級アルキルカルボン酸エステル類;ホルムアミド、N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチル-2-ピロリドン、ヘキサメチルホスホロトリアミドなどのアミド類;ジメチルスルホキシド、スルホランなどのスルホキシド類;メタノール、エタノール、プロパノール、イソプロパノール、ブタノール、イソブタノール、tert-ブタノールなどの低級アルコール類;水;または、これらの混合溶媒を挙げることができ、好ましくは低級アルコール類と芳香族炭化水素類であり、さらに好ましくはメタノールとトルエンである。
The solvent used in this step is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. For example, aromatic hydrocarbons such as benzene, toluene, xylene; dichloromethane, chloroform, Halogenated hydrocarbons such as carbon tetrachloride, dichloroethane, chlorobenzene, dichlorobenzene; ethers such as diethyl ether, diisopropyl ether, tetrahydrofuran, cyclopentyl methyl ether, methyl-tert-butyl ether, dioxane, dimethoxyethane, diethylene glycol dimethyl ether Lower alkyl carboxylic acid esters such as ethyl acetate and isopropyl acetate; formamide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidone, Amides such as samethyl phosphorotriamide; Sulfoxides such as dimethyl sulfoxide and sulfolane; Lower alcohols such as methanol, ethanol, propanol, isopropanol, butanol, isobutanol and tert-butanol; Water; or a mixed solvent thereof Preferred are lower alcohols and aromatic hydrocarbons, and more preferred are methanol and toluene.
反応温度は、原料化合物、反応試薬によって異なるが、0℃から150℃で行なわれ、好ましくは、25℃から130℃、さらに好ましくは40℃から110℃である。
反応時間は、反応温度、原料化合物、反応試薬または使用される溶媒の種類によって異なるが、通常、12時間から96時間で、好ましくは、24時間から84時間である。
目的化合物は、反応終了後、反応液を放冷させ、氷冷下で撹拌しながら、水、アンモニア水、メタノールなどの溶媒を添加し、析出した固体を濾過するか、または濃縮・抽出操作を行い、濃縮後得られた残渣にトルエン、n-ヘキサン、n-ヘプタンなどの再結晶可能な溶媒を添加して析出した固体をろ過、乾燥することで得ることができる。なお、析出した固体をろ過した後、トルエン、n-ヘキサン、n-ヘプタン、水などで洗浄することが好ましい。
得られた目的化合物は必要ならば、通常行われる方法、例えば再結晶、再沈殿などによって精製することができる。 While the reaction temperature varies depending on the raw material compound and the reaction reagent, it is carried out at 0 ° C. to 150 ° C., preferably 25 ° C. to 130 ° C., more preferably 40 ° C. to 110 ° C.
While the reaction time varies depending on the reaction temperature, raw material compound, reaction reagent or the type of solvent used, it is generally 12 to 96 hours, preferably 24 to 84 hours.
After completion of the reaction, the target compound is allowed to cool, and while stirring under ice-cooling, a solvent such as water, aqueous ammonia or methanol is added, and the precipitated solid is filtered or concentrated / extracted. The residue obtained after the concentration can be obtained by adding a recrystallizable solvent such as toluene, n-hexane or n-heptane and filtering and drying the precipitated solid. The precipitated solid is preferably filtered and then washed with toluene, n-hexane, n-heptane, water or the like.
If necessary, the obtained target compound can be purified by a conventional method such as recrystallization and reprecipitation.
反応時間は、反応温度、原料化合物、反応試薬または使用される溶媒の種類によって異なるが、通常、12時間から96時間で、好ましくは、24時間から84時間である。
目的化合物は、反応終了後、反応液を放冷させ、氷冷下で撹拌しながら、水、アンモニア水、メタノールなどの溶媒を添加し、析出した固体を濾過するか、または濃縮・抽出操作を行い、濃縮後得られた残渣にトルエン、n-ヘキサン、n-ヘプタンなどの再結晶可能な溶媒を添加して析出した固体をろ過、乾燥することで得ることができる。なお、析出した固体をろ過した後、トルエン、n-ヘキサン、n-ヘプタン、水などで洗浄することが好ましい。
得られた目的化合物は必要ならば、通常行われる方法、例えば再結晶、再沈殿などによって精製することができる。 While the reaction temperature varies depending on the raw material compound and the reaction reagent, it is carried out at 0 ° C. to 150 ° C., preferably 25 ° C. to 130 ° C., more preferably 40 ° C. to 110 ° C.
While the reaction time varies depending on the reaction temperature, raw material compound, reaction reagent or the type of solvent used, it is generally 12 to 96 hours, preferably 24 to 84 hours.
After completion of the reaction, the target compound is allowed to cool, and while stirring under ice-cooling, a solvent such as water, aqueous ammonia or methanol is added, and the precipitated solid is filtered or concentrated / extracted. The residue obtained after the concentration can be obtained by adding a recrystallizable solvent such as toluene, n-hexane or n-heptane and filtering and drying the precipitated solid. The precipitated solid is preferably filtered and then washed with toluene, n-hexane, n-heptane, water or the like.
If necessary, the obtained target compound can be purified by a conventional method such as recrystallization and reprecipitation.
製造方法2
式(3)で表される化合物またはその塩は、以下の合成経路2に従い製造することができる。
合成経路2
すなわち、上記製造方法1の<工程2>に準じた製造方法を用いて式(1)で表される化合物またはその塩を2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させて式(2)で表される化合物またはその塩が得られる。式(2)で表される化合物またはその塩は、カラム精製を行わずに得ることができる。そして、得られた式(2)で表される化合物またはその塩を酸、塩基からなる群から選択される少なくとも1種の存在下で、式(a)R0Xで表される化合物またはその塩と反応させて、式(3)で表される化合物またはその塩を製造することができる。式(3)で表される化合物またはその塩は、カラム精製を行わずに得ることができる。式(a)、(3)中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示す。 Manufacturing method 2
The compound represented by the formula (3) or a salt thereof can be produced according to the following synthesis route 2.
Synthesis route 2
That is, the compound represented by the formula (1) or a salt thereof is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether by using the production method according to <Step 2> of the production method 1 above. 2) or a salt thereof is obtained. The compound represented by the formula (2) or a salt thereof can be obtained without performing column purification. The obtained compound represented by the formula (2) or a salt thereof in the presence of at least one selected from the group consisting of an acid and a base, or a compound represented by the formula (a) R 0 X or a salt thereof By reacting with a salt, the compound represented by the formula (3) or a salt thereof can be produced. The compound represented by the formula (3) or a salt thereof can be obtained without performing column purification. In the formulas (a) and (3), R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group.
式(3)で表される化合物またはその塩は、以下の合成経路2に従い製造することができる。
合成経路2
すなわち、上記製造方法1の<工程2>に準じた製造方法を用いて式(1)で表される化合物またはその塩を2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させて式(2)で表される化合物またはその塩が得られる。式(2)で表される化合物またはその塩は、カラム精製を行わずに得ることができる。そして、得られた式(2)で表される化合物またはその塩を酸、塩基からなる群から選択される少なくとも1種の存在下で、式(a)R0Xで表される化合物またはその塩と反応させて、式(3)で表される化合物またはその塩を製造することができる。式(3)で表される化合物またはその塩は、カラム精製を行わずに得ることができる。式(a)、(3)中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示す。 Manufacturing method 2
The compound represented by the formula (3) or a salt thereof can be produced according to the following synthesis route 2.
Synthesis route 2
That is, the compound represented by the formula (1) or a salt thereof is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether by using the production method according to <Step 2> of the production method 1 above. 2) or a salt thereof is obtained. The compound represented by the formula (2) or a salt thereof can be obtained without performing column purification. The obtained compound represented by the formula (2) or a salt thereof in the presence of at least one selected from the group consisting of an acid and a base, or a compound represented by the formula (a) R 0 X or a salt thereof By reacting with a salt, the compound represented by the formula (3) or a salt thereof can be produced. The compound represented by the formula (3) or a salt thereof can be obtained without performing column purification. In the formulas (a) and (3), R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group.
式(a)中、Xは脱離基を示し、反応により脱離する置換基であればいずれであってもよく、例えば、フッ素原子、塩素原子、臭素原子、ヨウ素原子などのハロゲン原子、メタンスルホニルオキシ基、クロロメチルスルホキシオキシ基、トリフルオロメタンスルホニルオキシ基などの低級アルキルスルホニルオキシ基、ベンゼンスルホニルオキシ基、p-トルエンスルホニルオキシ基などのアリールスルホニルオキシ基、シアノ基、ニトロ基、トリクロロアセトイミデート、カルボニルジオキシフェニルなどが挙げることができ、好ましくはハロゲン原子、さらに好ましくは塩素原子である。
式(a)で表される化合物またはその塩は、式(2)で表される化合物またはその塩に対し1当量以上、好ましくは1~2当量、さらに好ましくは1.2~1.5当量用いられる。 In the formula (a), X represents a leaving group, and any substituent can be used as long as it is eliminated by reaction. For example, a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, methane Lower alkylsulfonyloxy groups such as sulfonyloxy group, chloromethylsulfoxyoxy group, trifluoromethanesulfonyloxy group, arylsulfonyloxy groups such as benzenesulfonyloxy group, p-toluenesulfonyloxy group, cyano group, nitro group, trichloroacetate Examples thereof include imidate and carbonyldioxyphenyl, preferably a halogen atom, more preferably a chlorine atom.
The compound represented by the formula (a) or a salt thereof is 1 equivalent or more, preferably 1 to 2 equivalents, more preferably 1.2 to 1.5 equivalents, relative to the compound represented by the formula (2) or a salt thereof. Used.
式(a)で表される化合物またはその塩は、式(2)で表される化合物またはその塩に対し1当量以上、好ましくは1~2当量、さらに好ましくは1.2~1.5当量用いられる。 In the formula (a), X represents a leaving group, and any substituent can be used as long as it is eliminated by reaction. For example, a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, methane Lower alkylsulfonyloxy groups such as sulfonyloxy group, chloromethylsulfoxyoxy group, trifluoromethanesulfonyloxy group, arylsulfonyloxy groups such as benzenesulfonyloxy group, p-toluenesulfonyloxy group, cyano group, nitro group, trichloroacetate Examples thereof include imidate and carbonyldioxyphenyl, preferably a halogen atom, more preferably a chlorine atom.
The compound represented by the formula (a) or a salt thereof is 1 equivalent or more, preferably 1 to 2 equivalents, more preferably 1.2 to 1.5 equivalents, relative to the compound represented by the formula (2) or a salt thereof. Used.
この工程で使用する酸としては、例えば、塩酸、硫酸、硝酸、リン酸、臭化水素、フッ酸などの無機酸類;トリフルオロ酢酸、メタンスルホン酸、トリフルオロメタンスルホン酸、ベンゼンスルホン酸、p-トルエンスルホン酸、アミノスルホン酸などの有機酸類;三臭化ホウ素、三塩化ホウ素、三フッ化ホウ素、塩化アルミニウムなどのルイス酸などを挙げることができる。
この工程で使用する酸は、式(2)で表される化合物またはその塩に対し1当量以上、好ましくは1~5当量、さらに好ましくは2~3当量用いられる。 Examples of the acid used in this step include inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, hydrogen bromide, and hydrofluoric acid; trifluoroacetic acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p- Examples thereof include organic acids such as toluenesulfonic acid and aminosulfonic acid; Lewis acids such as boron tribromide, boron trichloride, boron trifluoride and aluminum chloride.
The acid used in this step is used in an amount of 1 equivalent or more, preferably 1 to 5 equivalents, more preferably 2 to 3 equivalents, relative to the compound represented by the formula (2) or a salt thereof.
この工程で使用する酸は、式(2)で表される化合物またはその塩に対し1当量以上、好ましくは1~5当量、さらに好ましくは2~3当量用いられる。 Examples of the acid used in this step include inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, hydrogen bromide, and hydrofluoric acid; trifluoroacetic acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p- Examples thereof include organic acids such as toluenesulfonic acid and aminosulfonic acid; Lewis acids such as boron tribromide, boron trichloride, boron trifluoride and aluminum chloride.
The acid used in this step is used in an amount of 1 equivalent or more, preferably 1 to 5 equivalents, more preferably 2 to 3 equivalents, relative to the compound represented by the formula (2) or a salt thereof.
この工程で使用する塩基としては、例えば、炭酸ナトリウム、炭酸カリウム、炭酸セシウム、炭酸リチウムなどのアルカリ金属炭酸塩類;炭酸水素ナトリウム、炭酸水素カリウム、炭酸水素リチウムなどのアルカリ金属炭酸水素塩類;水酸化ナトリウム、水酸化カリウム、水酸化バリウム、水酸化リチウムなどのアルカリ金属水酸化物類;水素化リチウム、水素化ナトリウム、水素化カリウムなどのアルカリ金属水素化物類;弗化ナトリウム、弗化カリウムなどのアルカリ金属弗化物類等の無機塩基類;ナトリウムメトキシド、ナトリウムエトキシド、カリウムメトキシド、カリウムエトキシド、カリウムt-ブトキシド、リチウムメトキシドなどのアルカリ金属アルコキシド類;N-メチルモルホリン、トリエチルアミン、トリプロピルアミン、トリブチルアミン、ジイソプロピルエチルアミン、ジシクロヘキシルアミン、N-メチルピペリジン、ピリジン、4-ピロリジノピリジン、ピコリン、4-(N,N-ジメチルアミノ)ピリジン、2,6-ジ(t-ブチル)-4-メチルピリジン、キノリン、N,N-ジメチルアニリン、N,N-ジエチルアニリン、1,5-ジアザビシクロ[4.3.0]ノナ-5-エン(DBN)、1,4-ジアザビシクロ[2.2.2]オクタン(DABCO)、1,8-ジアザビシクロ[5.4.0]ウンデカ-7-エン(DBU)、N,N,N’,N’,N’’,N’’-ヘキサメチルリン酸トリアミド(HMPA)などの有機塩基類を挙げることができ、好ましくはアルカリ金属炭酸塩類であり、さらに好ましくは炭酸カリウムである。
Examples of the base used in this step include alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate and lithium carbonate; alkali metal hydrogen carbonates such as sodium hydrogen carbonate, potassium hydrogen carbonate and lithium hydrogen carbonate; Alkali metal hydroxides such as sodium, potassium hydroxide, barium hydroxide, and lithium hydroxide; Alkali metal hydrides such as lithium hydride, sodium hydride, and potassium hydride; such as sodium fluoride and potassium fluoride Inorganic bases such as alkali metal fluorides; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide, potassium t-butoxide, lithium methoxide; N-methylmorpholine, triethylamine, tri Propyl Min, tributylamine, diisopropylethylamine, dicyclohexylamine, N-methylpiperidine, pyridine, 4-pyrrolidinopyridine, picoline, 4- (N, N-dimethylamino) pyridine, 2,6-di (t-butyl) -4 -Methylpyridine, quinoline, N, N-dimethylaniline, N, N-diethylaniline, 1,5-diazabicyclo [4.3.0] non-5-ene (DBN), 1,4-diazabicyclo [2.2 .2] Octane (DABCO), 1,8-diazabicyclo [5.4.0] undec-7-ene (DBU), N, N, N ′, N ′, N ″, N ″ -hexamethylphosphorus Organic bases such as acid triamide (HMPA) can be mentioned, preferably alkali metal carbonates, and more preferably potassium carbonate.
この工程で使用する塩基は、式(2)で表される化合物またはその塩に対し1当量以上、好ましくは1~5当量、さらに好ましくは2~3当量用いられる。
この工程で使用される溶媒としては、反応を阻害せず、出発物質をある程度溶解するものであれば特に限定はなく、例えば、ベンゼン、トルエン、キシレンなどの芳香族炭化水素類;ジクロロメタン、クロロホルム、四塩化炭素、ジクロロエタン、クロロベンゼン、ジクロロベンゼンなどのハロゲン化炭化水素類;ジエチルエ-テル、ジイソプロピルエ-テル、テトラヒドロフラン、シクロペンチルメチルエーテル、メチル-tert-ブチルエーテル、ジオキサン、ジメトキシエタン、ジエチレングリコールジメチルエーテルなどのエ-テル類;酢酸エチル、酢酸イソプロピルなどの低級アルキルカルボン酸エステル類;ホルムアミド、N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチル-2-ピロリジノン、ヘキサメチルホスホロトリアミドなどのアミド類;ジメチルスルホキシド、スルホランなどのスルホキシド類;メタノール、エタノール、プロパノール、イソプロパノール、ブタノール、イソブタノール、tert-ブタノールなどの低級アルコール類;水;または、これらの混合溶媒を挙げることができ、好ましくはアミド類と水であり、さらに好ましくはN,N-ジメチルホルムアミドと水である。 The base used in this step is used in an amount of 1 equivalent or more, preferably 1 to 5 equivalents, more preferably 2 to 3 equivalents, relative to the compound represented by the formula (2) or a salt thereof.
The solvent used in this step is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. For example, aromatic hydrocarbons such as benzene, toluene, xylene; dichloromethane, chloroform, Halogenated hydrocarbons such as carbon tetrachloride, dichloroethane, chlorobenzene, dichlorobenzene; ethers such as diethyl ether, diisopropyl ether, tetrahydrofuran, cyclopentyl methyl ether, methyl-tert-butyl ether, dioxane, dimethoxyethane, diethylene glycol dimethyl ether Lower alkyl carboxylic acid esters such as ethyl acetate and isopropyl acetate; formamide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidinone, Amides such as samethyl phosphorotriamide; Sulfoxides such as dimethyl sulfoxide and sulfolane; Lower alcohols such as methanol, ethanol, propanol, isopropanol, butanol, isobutanol and tert-butanol; Water; or a mixed solvent thereof Preferred are amides and water, and more preferred are N, N-dimethylformamide and water.
この工程で使用される溶媒としては、反応を阻害せず、出発物質をある程度溶解するものであれば特に限定はなく、例えば、ベンゼン、トルエン、キシレンなどの芳香族炭化水素類;ジクロロメタン、クロロホルム、四塩化炭素、ジクロロエタン、クロロベンゼン、ジクロロベンゼンなどのハロゲン化炭化水素類;ジエチルエ-テル、ジイソプロピルエ-テル、テトラヒドロフラン、シクロペンチルメチルエーテル、メチル-tert-ブチルエーテル、ジオキサン、ジメトキシエタン、ジエチレングリコールジメチルエーテルなどのエ-テル類;酢酸エチル、酢酸イソプロピルなどの低級アルキルカルボン酸エステル類;ホルムアミド、N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチル-2-ピロリジノン、ヘキサメチルホスホロトリアミドなどのアミド類;ジメチルスルホキシド、スルホランなどのスルホキシド類;メタノール、エタノール、プロパノール、イソプロパノール、ブタノール、イソブタノール、tert-ブタノールなどの低級アルコール類;水;または、これらの混合溶媒を挙げることができ、好ましくはアミド類と水であり、さらに好ましくはN,N-ジメチルホルムアミドと水である。 The base used in this step is used in an amount of 1 equivalent or more, preferably 1 to 5 equivalents, more preferably 2 to 3 equivalents, relative to the compound represented by the formula (2) or a salt thereof.
The solvent used in this step is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. For example, aromatic hydrocarbons such as benzene, toluene, xylene; dichloromethane, chloroform, Halogenated hydrocarbons such as carbon tetrachloride, dichloroethane, chlorobenzene, dichlorobenzene; ethers such as diethyl ether, diisopropyl ether, tetrahydrofuran, cyclopentyl methyl ether, methyl-tert-butyl ether, dioxane, dimethoxyethane, diethylene glycol dimethyl ether Lower alkyl carboxylic acid esters such as ethyl acetate and isopropyl acetate; formamide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidinone, Amides such as samethyl phosphorotriamide; Sulfoxides such as dimethyl sulfoxide and sulfolane; Lower alcohols such as methanol, ethanol, propanol, isopropanol, butanol, isobutanol and tert-butanol; Water; or a mixed solvent thereof Preferred are amides and water, and more preferred are N, N-dimethylformamide and water.
反応温度は、原料化合物、反応試薬によって異なるが、0℃から100℃で行なわれ、好ましくは、0℃から50℃である。
反応時間は、反応温度、原料化合物、反応試薬または使用される溶媒の種類によって異なるが、通常、1時間から48時間で、好ましくは、2時間から5時間である。
目的化合物は、反応終了後、反応液を放冷させ、氷冷下で撹拌しながら、水、アンモニア水、メタノールなどの溶媒を添加し、析出した固体を濾過するか、または抽出操作を行い、濃縮後得られた残渣にトルエン、酢酸エチルなどの再結晶可能な溶媒を添加して析出した固体をろ過、乾燥することで得ることができる。なお、析出した固体をろ過した後、トルエン、酢酸エチル、水などで洗浄することが好ましい。
得られた目的化合物は必要ならば、通常行われる方法、例えば再結晶、再沈殿などによって精製することができる。 While the reaction temperature varies depending on the raw material compound and the reaction reagent, it is carried out at 0 ° C. to 100 ° C., preferably 0 ° C. to 50 ° C.
While the reaction time varies depending on the reaction temperature, raw material compound, reaction reagent or the type of solvent used, it is generally 1 hour to 48 hours, preferably 2 hours to 5 hours.
After completion of the reaction, the target compound is allowed to cool, and while stirring under ice cooling, a solvent such as water, aqueous ammonia or methanol is added, and the precipitated solid is filtered or extracted. It can be obtained by adding a recrystallizable solvent such as toluene or ethyl acetate to the residue obtained after concentration and filtering and drying the precipitated solid. In addition, after filtering the depositing solid, it is preferable to wash | clean with toluene, ethyl acetate, water, etc.
If necessary, the obtained target compound can be purified by a conventional method such as recrystallization and reprecipitation.
反応時間は、反応温度、原料化合物、反応試薬または使用される溶媒の種類によって異なるが、通常、1時間から48時間で、好ましくは、2時間から5時間である。
目的化合物は、反応終了後、反応液を放冷させ、氷冷下で撹拌しながら、水、アンモニア水、メタノールなどの溶媒を添加し、析出した固体を濾過するか、または抽出操作を行い、濃縮後得られた残渣にトルエン、酢酸エチルなどの再結晶可能な溶媒を添加して析出した固体をろ過、乾燥することで得ることができる。なお、析出した固体をろ過した後、トルエン、酢酸エチル、水などで洗浄することが好ましい。
得られた目的化合物は必要ならば、通常行われる方法、例えば再結晶、再沈殿などによって精製することができる。 While the reaction temperature varies depending on the raw material compound and the reaction reagent, it is carried out at 0 ° C. to 100 ° C., preferably 0 ° C. to 50 ° C.
While the reaction time varies depending on the reaction temperature, raw material compound, reaction reagent or the type of solvent used, it is generally 1 hour to 48 hours, preferably 2 hours to 5 hours.
After completion of the reaction, the target compound is allowed to cool, and while stirring under ice cooling, a solvent such as water, aqueous ammonia or methanol is added, and the precipitated solid is filtered or extracted. It can be obtained by adding a recrystallizable solvent such as toluene or ethyl acetate to the residue obtained after concentration and filtering and drying the precipitated solid. In addition, after filtering the depositing solid, it is preferable to wash | clean with toluene, ethyl acetate, water, etc.
If necessary, the obtained target compound can be purified by a conventional method such as recrystallization and reprecipitation.
製造方法3
式(2)で表される化合物またはその塩は、以下の合成経路3に従い製造することもできる。
合成経路3 Manufacturing method 3
The compound represented by the formula (2) or a salt thereof can also be produced according to the following synthesis route 3.
Synthesis route 3
式(2)で表される化合物またはその塩は、以下の合成経路3に従い製造することもできる。
合成経路3 Manufacturing method 3
The compound represented by the formula (2) or a salt thereof can also be produced according to the following synthesis route 3.
Synthesis route 3
すなわち、上記製造方法1の<工程2>に準じた製造方法を用いて式(1)で表される化合物またはその塩を2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させて式(4)で表される化合物またはその塩を得て、さらに上記製造方法1の<工程2>に準じた製造方法を用いて得られた式(4)で表される化合物またはその塩を2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させて式(2)で表される化合物またはその塩を製造することができる。
That is, the compound represented by the formula (1) or a salt thereof is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether by using the production method according to <Step 2> of the production method 1 above. 4) or a salt thereof, and a compound represented by formula (4) or a salt thereof obtained by using a production method according to <Step 2> of production method 1 above. A compound represented by the formula (2) or a salt thereof can be produced by reacting with 2-dialkoxypropane or isopropenyl alkyl ether.
製造方法4
式(3)で表される化合物またはその塩は、以下の合成経路4に従い製造することもできる。
合成経路4 Manufacturing method 4
The compound represented by the formula (3) or a salt thereof can also be produced according to the following synthesis route 4.
Synthesis route 4
式(3)で表される化合物またはその塩は、以下の合成経路4に従い製造することもできる。
合成経路4 Manufacturing method 4
The compound represented by the formula (3) or a salt thereof can also be produced according to the following synthesis route 4.
Synthesis route 4
すなわち、式(1)で表される化合物またはその塩を酸、塩基からなる群から選択される少なくとも1種の存在下で、式(a)R0Xで表される化合物またはその塩と反応させて、式(8)で表される化合物またはその塩が得られる。次いで、上記製造方法1の<工程2>に準じた製造方法を用いて、得られる式(8)で表される化合物またはその塩を2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させて式(3)で表される化合物またはその塩を製造することができる。なお、式(8)で表される化合物またはその塩から式(3)で表される化合物またはその塩を製造する反応が、反応途中で生成する式(4b)
で表される化合物またはその塩を介して行われてもよい。式(a)、(8)、(3)、(4b)中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示す。 That is, the compound represented by the formula (1) or a salt thereof is reacted with the compound represented by the formula (a) R 0 X or a salt thereof in the presence of at least one selected from the group consisting of an acid and a base. Thus, a compound represented by the formula (8) or a salt thereof is obtained. Next, the obtained compound represented by the formula (8) or a salt thereof is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether using the production method according to <Step 2> of the production method 1 above. Thus, the compound represented by the formula (3) or a salt thereof can be produced. In addition, the reaction for producing the compound represented by the formula (3) or the salt thereof from the compound represented by the formula (8) or a salt thereof is generated in the course of the reaction (4b)
It may be carried out via a compound represented by the formula: In the formulas (a), (8), (3) and (4b), R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group.
で表される化合物またはその塩を介して行われてもよい。式(a)、(8)、(3)、(4b)中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示す。 That is, the compound represented by the formula (1) or a salt thereof is reacted with the compound represented by the formula (a) R 0 X or a salt thereof in the presence of at least one selected from the group consisting of an acid and a base. Thus, a compound represented by the formula (8) or a salt thereof is obtained. Next, the obtained compound represented by the formula (8) or a salt thereof is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether using the production method according to <Step 2> of the production method 1 above. Thus, the compound represented by the formula (3) or a salt thereof can be produced. In addition, the reaction for producing the compound represented by the formula (3) or the salt thereof from the compound represented by the formula (8) or a salt thereof is generated in the course of the reaction (4b)
It may be carried out via a compound represented by the formula: In the formulas (a), (8), (3) and (4b), R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group.
製造方法5
化合物(2a)は、以下の合成経路5に従い製造することもできる。
合成経路5 Manufacturing method 5
Compound (2a) can also be produced according to the following synthesis route 5.
Synthesis route 5
化合物(2a)は、以下の合成経路5に従い製造することもできる。
合成経路5 Manufacturing method 5
Compound (2a) can also be produced according to the following synthesis route 5.
Synthesis route 5
すなわち、ハロゲン化物(9a)と対応するボロン酸(b)をDMF等の溶媒中、炭酸ナトリウム等の塩基とニ塩化ビス(トリフェニルホスフィン)パラジウム(II)等の触媒存在下反応させることにより、化合物(10a)が得られる。得られる化合物(10a)を水素雰囲気下、接触還元して化合物(11a)を得て、次いで上記製造方法1の<工程2>に準じた製造方法を用いて化合物(11a)を2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させて化合物(12a)が得られる。そして、得られる化合物(12a)を閉環させて化合物(2a)を製造することができる。
That is, by reacting the halide (9a) and the corresponding boronic acid (b) with a base such as sodium carbonate in the presence of a catalyst such as bis (triphenylphosphine) palladium (II) dichloride in a solvent such as DMF, Compound (10a) is obtained. The obtained compound (10a) is catalytically reduced in a hydrogen atmosphere to obtain the compound (11a), and then the compound (11a) is converted into 2,2-- using the production method according to <Step 2> of the above production method 1. Reaction with dialkoxypropane or isopropenyl alkyl ether gives compound (12a). And the compound (2a) can be manufactured by ring-closing the compound (12a) obtained.
製造方法6
化合物(2a)は、以下の合成経路6に従い製造することもできる。
合成経路6 Manufacturing method 6
Compound (2a) can also be produced according to the following synthesis route 6.
Synthesis route 6
化合物(2a)は、以下の合成経路6に従い製造することもできる。
合成経路6 Manufacturing method 6
Compound (2a) can also be produced according to the following synthesis route 6.
Synthesis route 6
すなわち、上記製造方法1の<工程2>に準じた製造方法を用いて化合物(13a)を2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させて化合物(14a)が得られる。得られる化合物(14a)のカルボキシル基をメチルエステル化して、化合物(15a)を得て、得られる化合物(15a)と対応するボロン酸(b)をDMF等の溶媒中、炭酸ナトリウム等の塩基とニ塩化ビス(トリフェニルホスフィン)パラジウム(II)等の触媒存在下反応させることにより、化合物(12a)が得られる。得られる化合物(12a)を閉環させて、化合物(2a)を製造することができる。また、化合物(15a)は、上記製造方法1の<工程2>に準じた製造方法を用いて化合物(16a)を2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させて得ることもできる。
That is, the compound (13a) is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether using the production method according to <Step 2> of the production method 1 to obtain the compound (14a). The carboxyl group of the obtained compound (14a) is methyl esterified to obtain the compound (15a), and the resulting compound (15a) and the corresponding boronic acid (b) are mixed with a base such as sodium carbonate in a solvent such as DMF. Compound (12a) is obtained by reacting in the presence of a catalyst such as bis (triphenylphosphine) palladium (II) dichloride. The resulting compound (12a) can be cyclized to produce compound (2a). Compound (15a) can also be obtained by reacting compound (16a) with 2,2-dialkoxypropane or isopropenyl alkyl ether using the production method according to <Step 2> of production method 1 above. .
製造方法7
化合物(7)で表される化合物またはその塩は、以下の合成経路7に従い製造することができる。
合成経路7 Manufacturing method 7
The compound represented by the compound (7) or a salt thereof can be produced according to the following synthesis route 7.
Synthesis route 7
化合物(7)で表される化合物またはその塩は、以下の合成経路7に従い製造することができる。
合成経路7 Manufacturing method 7
The compound represented by the compound (7) or a salt thereof can be produced according to the following synthesis route 7.
Synthesis route 7
すなわち、上記製造方法1の<工程2>に準じた製造方法を用いて式(6)で表される化合物またはその塩を2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させて製造することができる。
式(6)および式(7)中、R1は、ハロゲン原子、低級アルキル基、ヒドロキシ基、低級アルコキシ基、低級アルキルカルボニル基、カルボキシル基、アミノ基、ニトロ基またはシアノ基を挙げることができ、好ましくは水素原子である。pは0~4の整数を挙げることができ、好ましくは1~2である。
以下に、本発明の製造例を示す。なお、これらの例示は本発明をよりよく理解するためのものであり、本発明の範囲を限定するものではない。 That is, it is produced by reacting the compound represented by the formula (6) or a salt thereof with 2,2-dialkoxypropane or isopropenyl alkyl ether by using a production method according to <Step 2> of Production Method 1 above. be able to.
In Formula (6) and Formula (7), R 1 can include a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amino group, a nitro group, or a cyano group. , Preferably a hydrogen atom. p may be an integer of 0 to 4, preferably 1 to 2.
Below, the manufacture example of this invention is shown. In addition, these illustrations are for understanding this invention better, and do not limit the scope of the present invention.
式(6)および式(7)中、R1は、ハロゲン原子、低級アルキル基、ヒドロキシ基、低級アルコキシ基、低級アルキルカルボニル基、カルボキシル基、アミノ基、ニトロ基またはシアノ基を挙げることができ、好ましくは水素原子である。pは0~4の整数を挙げることができ、好ましくは1~2である。
以下に、本発明の製造例を示す。なお、これらの例示は本発明をよりよく理解するためのものであり、本発明の範囲を限定するものではない。 That is, it is produced by reacting the compound represented by the formula (6) or a salt thereof with 2,2-dialkoxypropane or isopropenyl alkyl ether by using a production method according to <Step 2> of Production Method 1 above. be able to.
In Formula (6) and Formula (7), R 1 can include a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amino group, a nitro group, or a cyano group. , Preferably a hydrogen atom. p may be an integer of 0 to 4, preferably 1 to 2.
Below, the manufacture example of this invention is shown. In addition, these illustrations are for understanding this invention better, and do not limit the scope of the present invention.
[製造例]
<8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン p-トルエンスルホン酸塩(1a)の製造>
8-アセトアミド-3-ヒドロキシ-6H-ベンゾ[c]クロメン-6-オン(5a)(60.0g、223mmol、国際公開2012/108455パンフレット)とエタノール(900ml)、水(120ml)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(127g、669mmol)を加え、内温79~81℃で17時間撹拌した。更にp-トルエンスルホン酸一水和物(42.3g、223mmol)を追加し内温79~81℃で5時間撹拌した。反応液を内温0~5℃で1時間撹拌し結晶をろ過で分離、エタノール(300ml)で洗浄後、50℃で減圧乾燥して標記化合物(77.1g、収率86.5%)を得た。 [Production example]
<Production of 8-amino-3-hydroxybenzo [c] chromen-6-one p-toluenesulfonate (1a)>
A mixture of 8-acetamido-3-hydroxy-6H-benzo [c] chromen-6-one (5a) (60.0 g, 223 mmol, WO 2012/108455 pamphlet), ethanol (900 ml) and water (120 ml) at room temperature Then, p-toluenesulfonic acid monohydrate (127 g, 669 mmol) was added, and the mixture was stirred at an internal temperature of 79 to 81 ° C. for 17 hours. Further, p-toluenesulfonic acid monohydrate (42.3 g, 223 mmol) was added, and the mixture was stirred at an internal temperature of 79 to 81 ° C. for 5 hours. The reaction solution was stirred for 1 hour at an internal temperature of 0 to 5 ° C., and the crystals were separated by filtration, washed with ethanol (300 ml) and dried under reduced pressure at 50 ° C. to give the title compound (77.1 g, yield 86.5%). Obtained.
<8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン p-トルエンスルホン酸塩(1a)の製造>
8-アセトアミド-3-ヒドロキシ-6H-ベンゾ[c]クロメン-6-オン(5a)(60.0g、223mmol、国際公開2012/108455パンフレット)とエタノール(900ml)、水(120ml)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(127g、669mmol)を加え、内温79~81℃で17時間撹拌した。更にp-トルエンスルホン酸一水和物(42.3g、223mmol)を追加し内温79~81℃で5時間撹拌した。反応液を内温0~5℃で1時間撹拌し結晶をろ過で分離、エタノール(300ml)で洗浄後、50℃で減圧乾燥して標記化合物(77.1g、収率86.5%)を得た。 [Production example]
<Production of 8-amino-3-hydroxybenzo [c] chromen-6-one p-toluenesulfonate (1a)>
A mixture of 8-acetamido-3-hydroxy-6H-benzo [c] chromen-6-one (5a) (60.0 g, 223 mmol, WO 2012/108455 pamphlet), ethanol (900 ml) and water (120 ml) at room temperature Then, p-toluenesulfonic acid monohydrate (127 g, 669 mmol) was added, and the mixture was stirred at an internal temperature of 79 to 81 ° C. for 17 hours. Further, p-toluenesulfonic acid monohydrate (42.3 g, 223 mmol) was added, and the mixture was stirred at an internal temperature of 79 to 81 ° C. for 5 hours. The reaction solution was stirred for 1 hour at an internal temperature of 0 to 5 ° C., and the crystals were separated by filtration, washed with ethanol (300 ml) and dried under reduced pressure at 50 ° C. to give the title compound (77.1 g, yield 86.5%). Obtained.
<8-ヒドロキシ-2,2,4-トリメチル-1,2-ジヒドロ-6-オキサ-1-アザクリセン-5-オン(2a)の製造1>
2,2-ジメトキシプロパン(59.0ml、482mmol)とピリジン(0.70ml、8.71mmol)と水(3.20ml、178mmol)の混液を室温にて撹拌し、8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン p-トルエンスルホン酸塩(1a)(3.51g、8.79mmol)を加え、耐圧条件下、外温105℃で72時間撹拌した。反応液を放冷冷却し濃縮後、残さにテトラヒドロフラン(17.5mL)、酢酸エチル(24.5mL)、水(21.0mL)加えて抽出した。水層を酢酸エチル(24.5ml)で抽出後、有機層を取り纏め、水(21.0ml)で2回洗浄し、4%炭酸水素ナトリウム水溶液(21.0ml)で洗浄し有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で数回精製することにより標記化合物(1.30g、収率48%)を得た。 <Production 1 of 8-hydroxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azacrisen-5-one (2a)>
A mixture of 2,2-dimethoxypropane (59.0 ml, 482 mmol), pyridine (0.70 ml, 8.71 mmol) and water (3.20 ml, 178 mmol) was stirred at room temperature, and 8-amino-3-hydroxybenzo [C] Chromen-6-one p-toluenesulfonate (1a) (3.51 g, 8.79 mmol) was added, and the mixture was stirred at an external temperature of 105 ° C. for 72 hours under pressure resistance. The reaction solution was allowed to cool and cooled, concentrated, and the residue was extracted with tetrahydrofuran (17.5 mL), ethyl acetate (24.5 mL), and water (21.0 mL). The aqueous layer was extracted with ethyl acetate (24.5 ml), and the organic layers were combined, washed twice with water (21.0 ml), washed with 4% aqueous sodium hydrogen carbonate solution (21.0 ml), and the organic layer was concentrated. . The concentrated residue was purified several times by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (1.30 g, yield 48%).
2,2-ジメトキシプロパン(59.0ml、482mmol)とピリジン(0.70ml、8.71mmol)と水(3.20ml、178mmol)の混液を室温にて撹拌し、8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン p-トルエンスルホン酸塩(1a)(3.51g、8.79mmol)を加え、耐圧条件下、外温105℃で72時間撹拌した。反応液を放冷冷却し濃縮後、残さにテトラヒドロフラン(17.5mL)、酢酸エチル(24.5mL)、水(21.0mL)加えて抽出した。水層を酢酸エチル(24.5ml)で抽出後、有機層を取り纏め、水(21.0ml)で2回洗浄し、4%炭酸水素ナトリウム水溶液(21.0ml)で洗浄し有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で数回精製することにより標記化合物(1.30g、収率48%)を得た。 <Production 1 of 8-hydroxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azacrisen-5-one (2a)>
A mixture of 2,2-dimethoxypropane (59.0 ml, 482 mmol), pyridine (0.70 ml, 8.71 mmol) and water (3.20 ml, 178 mmol) was stirred at room temperature, and 8-amino-3-hydroxybenzo [C] Chromen-6-one p-toluenesulfonate (1a) (3.51 g, 8.79 mmol) was added, and the mixture was stirred at an external temperature of 105 ° C. for 72 hours under pressure resistance. The reaction solution was allowed to cool and cooled, concentrated, and the residue was extracted with tetrahydrofuran (17.5 mL), ethyl acetate (24.5 mL), and water (21.0 mL). The aqueous layer was extracted with ethyl acetate (24.5 ml), and the organic layers were combined, washed twice with water (21.0 ml), washed with 4% aqueous sodium hydrogen carbonate solution (21.0 ml), and the organic layer was concentrated. . The concentrated residue was purified several times by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (1.30 g, yield 48%).
<8-(4-メトキシベンジルオキシ)-2,2,4-トリメチル-1,2-ジヒドロ-6-オキサ-1-アザクリセン-5-オン(3a)の製造1>
<Production 1 of 8- (4-methoxybenzyloxy) -2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3a)>
<Production 1 of 8- (4-methoxybenzyloxy) -2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3a)>
8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン(1b)(5.00g、22.0mmol)と2,2-ジメトキシプロパン(135.0ml、1102mmol)とピリジン(1.77ml、22.0mmol)と水(7.90ml、438mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(4.19g、22.0mmol)を加え、耐圧条件下、外温105℃で66時間10分間撹拌した。反応液を放冷冷却し濃縮後、残さに酢酸エチル-テトラヒドロフラン(3:2、100.0mL)、飽和炭酸水素ナトリウム水溶液(50.0mL)加えて抽出した。水層を酢酸エチル-テトラヒドロフラン(3:2、50.0mL)で2回抽出後、有機層を取り纏め、飽和炭酸水素ナトリウム水溶液(50.0mL)で3回洗浄し有機層を濃縮した。濃縮残さにN,N-ジメチルホルムアミド(60.0mL)を加え濃縮する操作を数回行い、ピリジンを除去した。濃縮残さが60.0mLになるようにN,N-ジメチルホルムアミドを加え、炭酸カリウム(7.61g、55.1mmol)、水(3.00mL)を加え、室温で撹拌した。この混液に4-メトキシベンジルクロリド(3.90mL、28.6mmol)を加え、外温40℃で3時間25分間撹拌した。反応液を氷冷にて撹拌し、水(300.0mL)加え、1時間15分間撹拌し、ろ過後、水(100.0mL)で洗浄した。粗体の標記化合物と酢酸エチル(300.0mL)の混液を外温85℃で撹拌し、ろ過し、ろ液を濃縮した。濃縮残さにトルエン(46.0mL)、酢酸エチル(12.0mL)加え、外温85%で1時間撹拌した。反応液を0℃にて18時間50分間撹拌し、ろ過後、トルエン(15.0mL)で洗浄し、50℃で減圧乾燥し、標記化合物(4.10g、収率44%)を得た。
8-amino-3-hydroxybenzo [c] chromen-6-one (1b) (5.00 g, 22.0 mmol), 2,2-dimethoxypropane (135.0 ml, 1102 mmol) and pyridine (1.77 ml, 22 0.0 mmol) and water (7.90 ml, 438 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (4.19 g, 22.0 mmol) was added, and the external temperature was 105 ° C. under pressure resistance. For 66 hours and 10 minutes. The reaction mixture was allowed to cool and cooled, concentrated, and the residue was extracted with ethyl acetate-tetrahydrofuran (3: 2, 100.0 mL) and saturated aqueous sodium hydrogen carbonate (50.0 mL). The aqueous layer was extracted twice with ethyl acetate-tetrahydrofuran (3: 2, 50.0 mL), and the organic layers were combined, washed three times with a saturated aqueous sodium hydrogen carbonate solution (50.0 mL), and the organic layer was concentrated. N, N-dimethylformamide (60.0 mL) was added to the concentrated residue and concentrated several times to remove pyridine. N, N-dimethylformamide was added so that the concentration residue was 60.0 mL, potassium carbonate (7.61 g, 55.1 mmol) and water (3.00 mL) were added, and the mixture was stirred at room temperature. 4-Methoxybenzyl chloride (3.90 mL, 28.6 mmol) was added to the mixture, and the mixture was stirred at an external temperature of 40 ° C. for 3 hours and 25 minutes. The reaction solution was stirred under ice-cooling, water (300.0 mL) was added, the mixture was stirred for 1 hour and 15 minutes, filtered, and washed with water (100.0 mL). A mixture of the crude title compound and ethyl acetate (300.0 mL) was stirred at an external temperature of 85 ° C., filtered, and the filtrate was concentrated. Toluene (46.0 mL) and ethyl acetate (12.0 mL) were added to the concentrated residue, and the mixture was stirred at an external temperature of 85% for 1 hour. The reaction solution was stirred at 0 ° C. for 18 hours and 50 minutes, filtered, washed with toluene (15.0 mL), and dried under reduced pressure at 50 ° C. to obtain the title compound (4.10 g, yield 44%).
<8-(4-メトキシベンジルオキシ)-2,2,4-トリメチル-1,2-ジヒドロ-6-オキサ-1-アザクリセン-5-オン(3a)の製造2>
<Production 2 of 8- (4-methoxybenzyloxy) -2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3a)>
<Production 2 of 8- (4-methoxybenzyloxy) -2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3a)>
2,2-ジメトキシプロパン(717.28g、6887mmol)とピリジン(9.90g、125.2mmol)と水(45.12g、2504mmol)の混液を室温にて撹拌し、8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オンp-トルエンスルホン酸塩(1a)(50.00g、125.2mmol)を加え、耐圧条件下、内温90.5~98.5℃で72時間撹拌した。反応液を放冷冷却し、減圧濃縮後、残渣に酢酸エチル(313g)、テトラヒドロフラン(222g)、水(300g)加えて分層した。有機層を水(300g)で2回、4%炭酸水素ナトリウム水溶液(300g)で洗浄後、テトラヒドロフラン(222g)加え、4%炭酸水素ナトリウム水溶液(302g)で洗浄した。有機層にN,N-ジメチルホルムアミド(327.30g)を加え、減圧濃縮した。濃縮後、残渣が327.05gになるようにN,N-ジメチルホルムアミドを加え、炭酸カリウム(42.51g、307.59mmol)、水(14.70g)を加え室温で撹拌した。この混液に4-メトキシベンジルクロリド(25.07g、160.08mmol)を加え、内温40-41℃で4時間撹拌した。反応液を室温に冷却し、酢酸エチル(232g)、テトラヒドロフラン(686g)、28%アンモニア水(705g)加え撹拌し分層した。水層に酢酸エチル(310g)を加え分層した。全ての有機層を纏め、5%食塩水(786g)で1回洗浄し、5%食塩水(393g)で2回洗浄し、水(400g)で1回洗浄し、有機層を減圧濃縮した。トルエン(213g)を加え減圧濃縮する操作を3回行い、濃縮残渣にトルエン(221.34g)、酢酸エチル(35.4g)を加え、内温84~90℃で31分間撹拌後、内温1~10℃で18時間撹拌し、析出した固体を濾過した。取得した湿晶とトルエン(128g)の混液を内温85℃で1時間13分間撹拌後、冷却した。内温1~10℃で2時間59分間撹拌後、濾過し、トルエン(20g)で3回洗浄し、50℃で2時間15分間減圧乾燥し、標記化合物(19.41g、収率36.3%)を得た。
A mixture of 2,2-dimethoxypropane (717.28 g, 6887 mmol), pyridine (9.90 g, 125.2 mmol) and water (45.12 g, 2504 mmol) was stirred at room temperature, and 8-amino-3-hydroxybenzo [C] Chromen-6-one p-toluenesulfonate (1a) (50.00 g, 125.2 mmol) was added, and the mixture was stirred at an internal temperature of 90.5 to 98.5 ° C. for 72 hours under pressure resistance. The reaction mixture was allowed to cool and cooled, concentrated under reduced pressure, and ethyl acetate (313 g), tetrahydrofuran (222 g), and water (300 g) were added to the residue to separate the layers. The organic layer was washed twice with water (300 g), 4% aqueous sodium hydrogen carbonate solution (300 g), tetrahydrofuran (222 g) was added, and the mixture was washed with 4% aqueous sodium hydrogen carbonate solution (302 g). N, N-dimethylformamide (327.30 g) was added to the organic layer, and the mixture was concentrated under reduced pressure. After concentration, N, N-dimethylformamide was added so that the residue was 327.05 g, potassium carbonate (42.51 g, 307.59 mmol) and water (14.70 g) were added, and the mixture was stirred at room temperature. 4-Methoxybenzyl chloride (25.07 g, 160.08 mmol) was added to the mixture, and the mixture was stirred at an internal temperature of 40-41 ° C. for 4 hours. The reaction mixture was cooled to room temperature, ethyl acetate (232 g), tetrahydrofuran (686 g), 28% aqueous ammonia (705 g) were added, and the mixture was stirred and separated. Ethyl acetate (310 g) was added to the aqueous layer and the layers were separated. All the organic layers were combined, washed once with 5% brine (786 g), washed twice with 5% brine (393 g), washed once with water (400 g), and the organic layer was concentrated under reduced pressure. Toluene (213 g) was added and concentrated under reduced pressure three times. Toluene (221.34 g) and ethyl acetate (35.4 g) were added to the concentrated residue, and the mixture was stirred at an internal temperature of 84 to 90 ° C. for 31 minutes. The mixture was stirred at ˜10 ° C. for 18 hours, and the precipitated solid was filtered. The obtained mixture of wet crystals and toluene (128 g) was stirred at an internal temperature of 85 ° C. for 1 hour and 13 minutes, and then cooled. After stirring at an internal temperature of 1 to 10 ° C. for 2 hours and 59 minutes, the mixture was filtered, washed with toluene (20 g) three times, and dried under reduced pressure at 50 ° C. for 2 hours and 15 minutes to give the title compound (19.41 g, yield 36.3). %).
<8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン(1b)の製造>
8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン p-トルエンスルホン酸塩(1a)(8.02g、20.1mmol)とメタノール(40.0ml)の混液を氷冷にて撹拌した。内温が3℃になったところで炭酸水素ナトリウム(2.02g、24.0mmol)を加え外温を室温に戻し2時間撹拌した。反応液中の固体をろ過し、水(30.0mL)で洗浄後、50℃で乾燥して標記化合物(4.58g、収率100%)を得た。 <Production of 8-amino-3-hydroxybenzo [c] chromen-6-one (1b)>
A mixture of 8-amino-3-hydroxybenzo [c] chromen-6-one p-toluenesulfonate (1a) (8.02 g, 20.1 mmol) and methanol (40.0 ml) was stirred with ice cooling. . When the internal temperature reached 3 ° C., sodium hydrogen carbonate (2.02 g, 24.0 mmol) was added and the external temperature was returned to room temperature and stirred for 2 hours. The solid in the reaction solution was filtered, washed with water (30.0 mL), and dried at 50 ° C. to obtain the title compound (4.58 g, yield 100%).
8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン p-トルエンスルホン酸塩(1a)(8.02g、20.1mmol)とメタノール(40.0ml)の混液を氷冷にて撹拌した。内温が3℃になったところで炭酸水素ナトリウム(2.02g、24.0mmol)を加え外温を室温に戻し2時間撹拌した。反応液中の固体をろ過し、水(30.0mL)で洗浄後、50℃で乾燥して標記化合物(4.58g、収率100%)を得た。 <Production of 8-amino-3-hydroxybenzo [c] chromen-6-one (1b)>
A mixture of 8-amino-3-hydroxybenzo [c] chromen-6-one p-toluenesulfonate (1a) (8.02 g, 20.1 mmol) and methanol (40.0 ml) was stirred with ice cooling. . When the internal temperature reached 3 ° C., sodium hydrogen carbonate (2.02 g, 24.0 mmol) was added and the external temperature was returned to room temperature and stirred for 2 hours. The solid in the reaction solution was filtered, washed with water (30.0 mL), and dried at 50 ° C. to obtain the title compound (4.58 g, yield 100%).
<8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ヒドロキシベンゾ[c]クロメン-6-オン(4a)の製造>
8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン(1b)(5.00g、22.0mmol)と2,2-ジメトキシプロパン(135ml、1100mmol)とピリジン(1.76ml、21.9mmol)と水(7.90ml、440mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(4.15g、21.8mmol)を加え、その懸濁液に1-メチル-2-ピロリドン(125ml)を加え撹拌溶解し、66時間40分間撹拌した。反応液を濃縮し、酢酸エチル(1000mL)、飽和重層水(500mL)加えて抽出した。水層を酢酸エチル(500ml)で2回抽出後、有機層を取り纏め、水(500ml)で3回洗浄後した。有機層を濃縮し、残さにクロロホルムを加え、ろ過後、ろ液を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(2.66g、収率37%)を得た。 <Production of 8- (1,1-dimethyl-3-oxobutylamino) -3-hydroxybenzo [c] chromen-6-one (4a)>
8-Amino-3-hydroxybenzo [c] chromen-6-one (1b) (5.00 g, 22.0 mmol), 2,2-dimethoxypropane (135 ml, 1100 mmol) and pyridine (1.76 ml, 21.9 mmol) ) And water (7.90 ml, 440 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (4.15 g, 21.8 mmol) was added, and 1-methyl-2 was added to the suspension. -Pyrrolidone (125 ml) was added and dissolved by stirring, and the mixture was stirred for 66 hours and 40 minutes. The reaction solution was concentrated and extracted by adding ethyl acetate (1000 mL) and saturated multistory water (500 mL). The aqueous layer was extracted twice with ethyl acetate (500 ml), and the organic layers were combined and washed three times with water (500 ml). The organic layer was concentrated, chloroform was added to the residue, the filtrate was concentrated after filtration. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (2.66 g, yield 37%).
8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン(1b)(5.00g、22.0mmol)と2,2-ジメトキシプロパン(135ml、1100mmol)とピリジン(1.76ml、21.9mmol)と水(7.90ml、440mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(4.15g、21.8mmol)を加え、その懸濁液に1-メチル-2-ピロリドン(125ml)を加え撹拌溶解し、66時間40分間撹拌した。反応液を濃縮し、酢酸エチル(1000mL)、飽和重層水(500mL)加えて抽出した。水層を酢酸エチル(500ml)で2回抽出後、有機層を取り纏め、水(500ml)で3回洗浄後した。有機層を濃縮し、残さにクロロホルムを加え、ろ過後、ろ液を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(2.66g、収率37%)を得た。 <Production of 8- (1,1-dimethyl-3-oxobutylamino) -3-hydroxybenzo [c] chromen-6-one (4a)>
8-Amino-3-hydroxybenzo [c] chromen-6-one (1b) (5.00 g, 22.0 mmol), 2,2-dimethoxypropane (135 ml, 1100 mmol) and pyridine (1.76 ml, 21.9 mmol) ) And water (7.90 ml, 440 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (4.15 g, 21.8 mmol) was added, and 1-methyl-2 was added to the suspension. -Pyrrolidone (125 ml) was added and dissolved by stirring, and the mixture was stirred for 66 hours and 40 minutes. The reaction solution was concentrated and extracted by adding ethyl acetate (1000 mL) and saturated multistory water (500 mL). The aqueous layer was extracted twice with ethyl acetate (500 ml), and the organic layers were combined and washed three times with water (500 ml). The organic layer was concentrated, chloroform was added to the residue, the filtrate was concentrated after filtration. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (2.66 g, yield 37%).
<8-ヒドロキシ-2,2,4-トリメチル-1,2-ジヒドロ-6-オキサ-1-アザクリセン-5-オン(2a)の製造2>
8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ヒドロキシベンゾ[c]クロメン-6-オン(4a)(0.76g、2.34mmol)と2,2-ジメトキシプロパン(16.0ml、131mmol)とピリジン(0.19ml、2.36mmol)と水(0.84ml、46.6mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(0.45g、2.36mmol)を加え、耐圧条件下、外温105℃で61.5時間撹拌した。反応液を放冷冷却し、酢酸エチル(5.50mL)、テトラヒドロフラン(4.00mL)、水(4.50mL)加えて抽出した。有機層を水(4.50ml)で洗浄後、水層を取り纏め、酢酸エチル(5.50ml)で抽出し、有機層を取り纏め、4%炭酸水素ナトリウム水溶液(4.50ml)で洗浄し、無水硫酸マグネシウムで乾燥後、有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(0.37g、収率51.2%)を得た。 <Production 2 of 8-hydroxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azacrisen-5-one (2a)>
8- (1,1-Dimethyl-3-oxobutylamino) -3-hydroxybenzo [c] chromen-6-one (4a) (0.76 g, 2.34 mmol) and 2,2-dimethoxypropane (16. A mixture of 0 ml, 131 mmol), pyridine (0.19 ml, 2.36 mmol) and water (0.84 ml, 46.6 mmol) was stirred at room temperature, and p-toluenesulfonic acid monohydrate (0.45 g, 2 .36 mmol) was added, and the mixture was stirred at an external temperature of 105 ° C. for 61.5 hours under pressure resistance. The reaction mixture was allowed to cool and cooled, and extracted by adding ethyl acetate (5.50 mL), tetrahydrofuran (4.00 mL), and water (4.50 mL). The organic layer was washed with water (4.50 ml), and the aqueous layer was collected and extracted with ethyl acetate (5.50 ml). The organic layer was collected, washed with 4% aqueous sodium hydrogen carbonate solution (4.50 ml), and anhydrous. After drying with magnesium sulfate, the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.37 g, yield 51.2%).
8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ヒドロキシベンゾ[c]クロメン-6-オン(4a)(0.76g、2.34mmol)と2,2-ジメトキシプロパン(16.0ml、131mmol)とピリジン(0.19ml、2.36mmol)と水(0.84ml、46.6mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(0.45g、2.36mmol)を加え、耐圧条件下、外温105℃で61.5時間撹拌した。反応液を放冷冷却し、酢酸エチル(5.50mL)、テトラヒドロフラン(4.00mL)、水(4.50mL)加えて抽出した。有機層を水(4.50ml)で洗浄後、水層を取り纏め、酢酸エチル(5.50ml)で抽出し、有機層を取り纏め、4%炭酸水素ナトリウム水溶液(4.50ml)で洗浄し、無水硫酸マグネシウムで乾燥後、有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(0.37g、収率51.2%)を得た。 <Production 2 of 8-hydroxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azacrisen-5-one (2a)>
8- (1,1-Dimethyl-3-oxobutylamino) -3-hydroxybenzo [c] chromen-6-one (4a) (0.76 g, 2.34 mmol) and 2,2-dimethoxypropane (16. A mixture of 0 ml, 131 mmol), pyridine (0.19 ml, 2.36 mmol) and water (0.84 ml, 46.6 mmol) was stirred at room temperature, and p-toluenesulfonic acid monohydrate (0.45 g, 2 .36 mmol) was added, and the mixture was stirred at an external temperature of 105 ° C. for 61.5 hours under pressure resistance. The reaction mixture was allowed to cool and cooled, and extracted by adding ethyl acetate (5.50 mL), tetrahydrofuran (4.00 mL), and water (4.50 mL). The organic layer was washed with water (4.50 ml), and the aqueous layer was collected and extracted with ethyl acetate (5.50 ml). The organic layer was collected, washed with 4% aqueous sodium hydrogen carbonate solution (4.50 ml), and anhydrous. After drying with magnesium sulfate, the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.37 g, yield 51.2%).
<8-アミノ-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン(8a)の製造>
8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン(1b)(2.00g、8.80mmol)と無水ジメチルホルムアミド(40.0ml)の混液を冷却外温氷冷にて撹拌した。内温が4℃になったところで60%水素化ナトリウム(0.42g、10.5mmol)、更に4-メトキシベンジルクロリド(1.40ml、10.3mmol)を加え外温を室温に戻し14時間55分撹拌した。反応液を放冷後氷冷下で撹拌し、水(40.0mL)加え43分間撹拌した後に、析出した固体をろ過した。ろ取物を更に水(20.0mL)で洗浄後、65℃で乾燥して標記化合物(2.87g、収率94%)を得た。 <Production of 8-amino-3- (4-methoxybenzyloxy) benzo [c] chromen-6-one (8a)>
A mixture of 8-amino-3-hydroxybenzo [c] chromen-6-one (1b) (2.00 g, 8.80 mmol) and anhydrous dimethylformamide (40.0 ml) was stirred with cooling at an external temperature and ice cooling. When the internal temperature reached 4 ° C., 60% sodium hydride (0.42 g, 10.5 mmol) and 4-methoxybenzyl chloride (1.40 ml, 10.3 mmol) were added, and the external temperature was returned to room temperature for 14 hours 55 Stir for minutes. The reaction mixture was allowed to cool and then stirred under ice-cooling, water (40.0 mL) was added and the mixture was stirred for 43 min, and the precipitated solid was filtered. The filtered product was further washed with water (20.0 mL) and dried at 65 ° C. to obtain the title compound (2.87 g, yield 94%).
8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン(1b)(2.00g、8.80mmol)と無水ジメチルホルムアミド(40.0ml)の混液を冷却外温氷冷にて撹拌した。内温が4℃になったところで60%水素化ナトリウム(0.42g、10.5mmol)、更に4-メトキシベンジルクロリド(1.40ml、10.3mmol)を加え外温を室温に戻し14時間55分撹拌した。反応液を放冷後氷冷下で撹拌し、水(40.0mL)加え43分間撹拌した後に、析出した固体をろ過した。ろ取物を更に水(20.0mL)で洗浄後、65℃で乾燥して標記化合物(2.87g、収率94%)を得た。 <Production of 8-amino-3- (4-methoxybenzyloxy) benzo [c] chromen-6-one (8a)>
A mixture of 8-amino-3-hydroxybenzo [c] chromen-6-one (1b) (2.00 g, 8.80 mmol) and anhydrous dimethylformamide (40.0 ml) was stirred with cooling at an external temperature and ice cooling. When the internal temperature reached 4 ° C., 60% sodium hydride (0.42 g, 10.5 mmol) and 4-methoxybenzyl chloride (1.40 ml, 10.3 mmol) were added, and the external temperature was returned to room temperature for 14 hours 55 Stir for minutes. The reaction mixture was allowed to cool and then stirred under ice-cooling, water (40.0 mL) was added and the mixture was stirred for 43 min, and the precipitated solid was filtered. The filtered product was further washed with water (20.0 mL) and dried at 65 ° C. to obtain the title compound (2.87 g, yield 94%).
<8-アミノ-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン(8b)の製造>
8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン(1b)(2.00g、8.80mmol)と無水ジメチルホルムアミド(40.0ml)の混液を冷却外温氷冷にて撹拌した。内温が0.4℃になったところで60%水素化ナトリウム(0.42g、10.5mmol)、更にベンジルクロロメチルエーテル(1.45ml、10.5mmol)を加え外温を室温に戻し2時間8分撹拌した。反応液を放冷後氷冷下で撹拌し、水(80.0mL)加え1時間撹拌した後に、析出した固体をろ過した。ろ取物を更に水(30.0mL)で洗浄後、50℃で乾燥した。取得物(3.24g)とメタノール(64.0ml)の混液を加熱還流し1時間撹拌した。混液を放冷後氷冷下で1時間5分間撹拌し、ろ過した。ろ取物を更にメタノール(5.00mL)で洗浄後、50℃で乾燥して標記化合物(2.59g、収率85%)を得た。 <Production of 8-amino-3-benzyloxymethoxybenzo [c] chromen-6-one (8b)>
A mixture of 8-amino-3-hydroxybenzo [c] chromen-6-one (1b) (2.00 g, 8.80 mmol) and anhydrous dimethylformamide (40.0 ml) was stirred with cooling at an external temperature and ice cooling. When the internal temperature reached 0.4 ° C., 60% sodium hydride (0.42 g, 10.5 mmol) and benzyl chloromethyl ether (1.45 ml, 10.5 mmol) were added, and the external temperature was returned to room temperature for 2 hours. Stir for 8 minutes. The reaction solution was allowed to cool and then stirred under ice-cooling. Water (80.0 mL) was added and stirred for 1 hour, and then the precipitated solid was filtered. The filtered product was further washed with water (30.0 mL) and dried at 50 ° C. A mixture of the obtained product (3.24 g) and methanol (64.0 ml) was heated to reflux and stirred for 1 hour. The mixture was allowed to cool, stirred for 1 hour and 5 minutes under ice cooling, and filtered. The filtered product was further washed with methanol (5.00 mL) and dried at 50 ° C. to obtain the title compound (2.59 g, yield 85%).
8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オン(1b)(2.00g、8.80mmol)と無水ジメチルホルムアミド(40.0ml)の混液を冷却外温氷冷にて撹拌した。内温が0.4℃になったところで60%水素化ナトリウム(0.42g、10.5mmol)、更にベンジルクロロメチルエーテル(1.45ml、10.5mmol)を加え外温を室温に戻し2時間8分撹拌した。反応液を放冷後氷冷下で撹拌し、水(80.0mL)加え1時間撹拌した後に、析出した固体をろ過した。ろ取物を更に水(30.0mL)で洗浄後、50℃で乾燥した。取得物(3.24g)とメタノール(64.0ml)の混液を加熱還流し1時間撹拌した。混液を放冷後氷冷下で1時間5分間撹拌し、ろ過した。ろ取物を更にメタノール(5.00mL)で洗浄後、50℃で乾燥して標記化合物(2.59g、収率85%)を得た。 <Production of 8-amino-3-benzyloxymethoxybenzo [c] chromen-6-one (8b)>
A mixture of 8-amino-3-hydroxybenzo [c] chromen-6-one (1b) (2.00 g, 8.80 mmol) and anhydrous dimethylformamide (40.0 ml) was stirred with cooling at an external temperature and ice cooling. When the internal temperature reached 0.4 ° C., 60% sodium hydride (0.42 g, 10.5 mmol) and benzyl chloromethyl ether (1.45 ml, 10.5 mmol) were added, and the external temperature was returned to room temperature for 2 hours. Stir for 8 minutes. The reaction solution was allowed to cool and then stirred under ice-cooling. Water (80.0 mL) was added and stirred for 1 hour, and then the precipitated solid was filtered. The filtered product was further washed with water (30.0 mL) and dried at 50 ° C. A mixture of the obtained product (3.24 g) and methanol (64.0 ml) was heated to reflux and stirred for 1 hour. The mixture was allowed to cool, stirred for 1 hour and 5 minutes under ice cooling, and filtered. The filtered product was further washed with methanol (5.00 mL) and dried at 50 ° C. to obtain the title compound (2.59 g, yield 85%).
<8-(4-メトキシベンジルオキシ)-2,2,4-トリメチル-1,2-ジヒドロ-6-オキサ-1-アザクリセン-5-オン(3a)の製造3>
8-アミノ-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン(8a)(0.83g、2.39mmol)と2,2-ジメトキシプロパン(16.0ml、131mmol)とピリジン(0.19ml、2.36mmol)と水(0.86ml、47.7mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(0.45g、2.37mmol)を加え、耐圧条件下、外温75℃で141時間35分間撹拌した。反応液を放冷冷却し濃縮後、残さに酢酸エチル(10.0mL)、テトラヒドロフラン(14.0mL)、水(12.0mL)加えて抽出した。水層を酢酸エチル(10.0ml)で抽出後、有機層を取り纏め、4%炭酸水素ナトリウム水溶液(12.0ml)で洗浄し有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(クロロホルム)で精製することにより粗体の標記化合物(0.32g)を得た。粗体にトルエン(3.20mL)、n-ヘプタン(3.20mL)加え、外温80℃で40分間撹拌し、外温4℃で冷却18時間20分間撹拌し、ろ過、トルエンおよびn-ヘプタンの混合溶媒(1:2、6.00mL)で洗浄し、標記化合物(0.24g、収率20%)を得た。 <Production 3 of 8- (4-methoxybenzyloxy) -2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3a)>
8-Amino-3- (4-methoxybenzyloxy) benzo [c] chromen-6-one (8a) (0.83 g, 2.39 mmol), 2,2-dimethoxypropane (16.0 ml, 131 mmol) and pyridine (0.19 ml, 2.36 mmol) and water (0.86 ml, 47.7 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (0.45 g, 2.37 mmol) was added, The mixture was stirred at an external temperature of 75 ° C. for 141 hours and 35 minutes under pressure resistance. The reaction solution was allowed to cool and cooled and concentrated, and the residue was extracted with ethyl acetate (10.0 mL), tetrahydrofuran (14.0 mL), and water (12.0 mL). The aqueous layer was extracted with ethyl acetate (10.0 ml), the organic layers were combined, washed with 4% aqueous sodium hydrogen carbonate solution (12.0 ml), and the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (chloroform) to obtain the crude title compound (0.32 g). Toluene (3.20 mL) and n-heptane (3.20 mL) were added to the crude product, stirred at an external temperature of 80 ° C. for 40 minutes, cooled at an external temperature of 4 ° C. for 18 hours and 20 minutes, filtered, toluene and n-heptane. Was washed with a mixed solvent (1: 2, 6.00 mL) to obtain the title compound (0.24 g, yield 20%).
8-アミノ-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン(8a)(0.83g、2.39mmol)と2,2-ジメトキシプロパン(16.0ml、131mmol)とピリジン(0.19ml、2.36mmol)と水(0.86ml、47.7mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(0.45g、2.37mmol)を加え、耐圧条件下、外温75℃で141時間35分間撹拌した。反応液を放冷冷却し濃縮後、残さに酢酸エチル(10.0mL)、テトラヒドロフラン(14.0mL)、水(12.0mL)加えて抽出した。水層を酢酸エチル(10.0ml)で抽出後、有機層を取り纏め、4%炭酸水素ナトリウム水溶液(12.0ml)で洗浄し有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(クロロホルム)で精製することにより粗体の標記化合物(0.32g)を得た。粗体にトルエン(3.20mL)、n-ヘプタン(3.20mL)加え、外温80℃で40分間撹拌し、外温4℃で冷却18時間20分間撹拌し、ろ過、トルエンおよびn-ヘプタンの混合溶媒(1:2、6.00mL)で洗浄し、標記化合物(0.24g、収率20%)を得た。 <Production 3 of 8- (4-methoxybenzyloxy) -2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3a)>
8-Amino-3- (4-methoxybenzyloxy) benzo [c] chromen-6-one (8a) (0.83 g, 2.39 mmol), 2,2-dimethoxypropane (16.0 ml, 131 mmol) and pyridine (0.19 ml, 2.36 mmol) and water (0.86 ml, 47.7 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (0.45 g, 2.37 mmol) was added, The mixture was stirred at an external temperature of 75 ° C. for 141 hours and 35 minutes under pressure resistance. The reaction solution was allowed to cool and cooled and concentrated, and the residue was extracted with ethyl acetate (10.0 mL), tetrahydrofuran (14.0 mL), and water (12.0 mL). The aqueous layer was extracted with ethyl acetate (10.0 ml), the organic layers were combined, washed with 4% aqueous sodium hydrogen carbonate solution (12.0 ml), and the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (chloroform) to obtain the crude title compound (0.32 g). Toluene (3.20 mL) and n-heptane (3.20 mL) were added to the crude product, stirred at an external temperature of 80 ° C. for 40 minutes, cooled at an external temperature of 4 ° C. for 18 hours and 20 minutes, filtered, toluene and n-heptane. Was washed with a mixed solvent (1: 2, 6.00 mL) to obtain the title compound (0.24 g, yield 20%).
<8-(1,1-ジメチル-3-オキソブチルアミノ)-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン(4b-1)の製造>
8-アミノ-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン(8a)(2.51g、7.23mmol)と2,2-ジメトキシプロパン(49.0ml、400mmol)とピリジン(0.58ml、7.22mmol)と水(7.90ml、144mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(1.37g、7.20mmol)を加え、その懸濁液に1-メチル-2-ピロリドン(35ml)を加え溶解し、71時間4分間撹拌した。反応液を濃縮し、酢酸エチル(50.0mL)、水(100mL)加えて抽出した。水層を酢酸エチル(50.0ml)で抽出後、有機層を取り纏め、酢酸エチル(100ml)、水(100ml)を加え抽出後、有機層に酢酸エチル(100ml)、テトラヒドロフラン(20ml)、水(100ml)を加え抽出し、有機層に酢酸エチル(100ml)、水(100ml)を加え抽出した。有機層を濃縮し、残差をテトラヒドロフランを加え、固体をろ過後、ろ液を濃縮した。濃縮残差に酢酸エチルを加え、固体をろ過後、ろ液を濃縮した。ろ過した固体にクロロホルムを加え溶解、濃縮し析出した結晶をろ過後、ろ液を濃縮した。濃縮残差にクロロホルムを加え溶解濃縮し、析出した結晶をろ過し、ろ液を濃縮した。各々の濃縮残差をシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製し各分画を合わせ標記化合物(1.17g、収率37%)を得た。 <Production of 8- (1,1-dimethyl-3-oxobutylamino) -3- (4-methoxybenzyloxy) benzo [c] chromen-6-one (4b-1)>
8-amino-3- (4-methoxybenzyloxy) benzo [c] chromen-6-one (8a) (2.51 g, 7.23 mmol), 2,2-dimethoxypropane (49.0 ml, 400 mmol) and pyridine (0.58 ml, 7.22 mmol) and water (7.90 ml, 144 mmol) were stirred at room temperature, and p-toluenesulfonic acid monohydrate (1.37 g, 7.20 mmol) was added. 1-Methyl-2-pyrrolidone (35 ml) was added to the suspension to dissolve it, and the mixture was stirred for 71 hours and 4 minutes. The reaction mixture was concentrated and extracted by adding ethyl acetate (50.0 mL) and water (100 mL). The aqueous layer was extracted with ethyl acetate (50.0 ml), and the organic layers were combined. After extraction by adding ethyl acetate (100 ml) and water (100 ml), the organic layer was mixed with ethyl acetate (100 ml), tetrahydrofuran (20 ml), water ( 100 ml) and extracted, and the organic layer was extracted with ethyl acetate (100 ml) and water (100 ml). The organic layer was concentrated, tetrahydrofuran was added to the residue, the solid was filtered, and the filtrate was concentrated. Ethyl acetate was added to the concentration residue, the solid was filtered, and the filtrate was concentrated. Chloroform was added to the filtered solid for dissolution and concentration, and the precipitated crystals were filtered, and then the filtrate was concentrated. Chloroform was added to the concentration residue and dissolved and concentrated, the precipitated crystals were filtered, and the filtrate was concentrated. Each concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane), and the fractions were combined to obtain the title compound (1.17 g, yield 37%).
8-アミノ-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン(8a)(2.51g、7.23mmol)と2,2-ジメトキシプロパン(49.0ml、400mmol)とピリジン(0.58ml、7.22mmol)と水(7.90ml、144mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(1.37g、7.20mmol)を加え、その懸濁液に1-メチル-2-ピロリドン(35ml)を加え溶解し、71時間4分間撹拌した。反応液を濃縮し、酢酸エチル(50.0mL)、水(100mL)加えて抽出した。水層を酢酸エチル(50.0ml)で抽出後、有機層を取り纏め、酢酸エチル(100ml)、水(100ml)を加え抽出後、有機層に酢酸エチル(100ml)、テトラヒドロフラン(20ml)、水(100ml)を加え抽出し、有機層に酢酸エチル(100ml)、水(100ml)を加え抽出した。有機層を濃縮し、残差をテトラヒドロフランを加え、固体をろ過後、ろ液を濃縮した。濃縮残差に酢酸エチルを加え、固体をろ過後、ろ液を濃縮した。ろ過した固体にクロロホルムを加え溶解、濃縮し析出した結晶をろ過後、ろ液を濃縮した。濃縮残差にクロロホルムを加え溶解濃縮し、析出した結晶をろ過し、ろ液を濃縮した。各々の濃縮残差をシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製し各分画を合わせ標記化合物(1.17g、収率37%)を得た。 <Production of 8- (1,1-dimethyl-3-oxobutylamino) -3- (4-methoxybenzyloxy) benzo [c] chromen-6-one (4b-1)>
8-amino-3- (4-methoxybenzyloxy) benzo [c] chromen-6-one (8a) (2.51 g, 7.23 mmol), 2,2-dimethoxypropane (49.0 ml, 400 mmol) and pyridine (0.58 ml, 7.22 mmol) and water (7.90 ml, 144 mmol) were stirred at room temperature, and p-toluenesulfonic acid monohydrate (1.37 g, 7.20 mmol) was added. 1-Methyl-2-pyrrolidone (35 ml) was added to the suspension to dissolve it, and the mixture was stirred for 71 hours and 4 minutes. The reaction mixture was concentrated and extracted by adding ethyl acetate (50.0 mL) and water (100 mL). The aqueous layer was extracted with ethyl acetate (50.0 ml), and the organic layers were combined. After extraction by adding ethyl acetate (100 ml) and water (100 ml), the organic layer was mixed with ethyl acetate (100 ml), tetrahydrofuran (20 ml), water ( 100 ml) and extracted, and the organic layer was extracted with ethyl acetate (100 ml) and water (100 ml). The organic layer was concentrated, tetrahydrofuran was added to the residue, the solid was filtered, and the filtrate was concentrated. Ethyl acetate was added to the concentration residue, the solid was filtered, and the filtrate was concentrated. Chloroform was added to the filtered solid for dissolution and concentration, and the precipitated crystals were filtered, and then the filtrate was concentrated. Chloroform was added to the concentration residue and dissolved and concentrated, the precipitated crystals were filtered, and the filtrate was concentrated. Each concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane), and the fractions were combined to obtain the title compound (1.17 g, yield 37%).
<8-(4-メトキシベンジルオキシ)-2,2,4-トリメチル-1,2-ジヒドロ-6-オキサ-1-アザクリセン-5-オン(3a)の製造4>
8-(1,1-ジメチル-3-オキソブチルアミノ)-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン(4b-1)(1.12g、2.51mmol)と1-メチル-2-ピロリドン(10.0ml)とピリジン(0.20ml、2.49mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(0.47g、2.47mmol)を加え、外温50℃で20時間20分間撹拌した。反応液を放冷冷却し、酢酸エチル(55.0mL)、水(55.0mL)加えて抽出した。水層を酢酸エチル(10.0ml)で抽出後、有機層を取り纏め、テトラヒドロフラン(30.0mL)加え、水(55.0ml)で2回洗浄し、4%炭酸水素ナトリウム水溶液(55.0ml)で2回洗浄し、有機層を濃縮した。濃縮残差にクロロホルム(22.0mL)加え、固体をろ過、クロロホルム(10.0mL)洗浄後、ろ液を濃縮した。濃縮残差をシリカゲルカラムクロマトグラフィー(クロロホルム)で精製し、引き続きシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより粗体の標記化合物(0.018g)を得た。粗体にトルエン-ノルマルヘプタン(0.36ml)を加え、固体をろ過、トルエン-ノルマルヘプタン(0.54ml)にて洗浄し、標記化合物(0.010g、収率0.95%)を得た。 <Production 4 of 8- (4-methoxybenzyloxy) -2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3a)>
8- (1,1-Dimethyl-3-oxobutylamino) -3- (4-methoxybenzyloxy) benzo [c] chromen-6-one (4b-1) (1.12 g, 2.51 mmol) and 1 -Methyl-2-pyrrolidone (10.0 ml) and pyridine (0.20 ml, 2.49 mmol) were stirred at room temperature, and p-toluenesulfonic acid monohydrate (0.47 g, 2.47 mmol) was added. In addition, the mixture was stirred at an external temperature of 50 ° C. for 20 hours and 20 minutes. The reaction solution was allowed to cool and cooled, and extracted by adding ethyl acetate (55.0 mL) and water (55.0 mL). The aqueous layer was extracted with ethyl acetate (10.0 ml), and the organic layer was collected. Tetrahydrofuran (30.0 ml) was added, washed twice with water (55.0 ml), and 4% aqueous sodium hydrogen carbonate solution (55.0 ml). And the organic layer was concentrated. Chloroform (22.0 mL) was added to the concentration residue, the solid was filtered, washed with chloroform (10.0 mL), and the filtrate was concentrated. The concentrated residue was purified by silica gel column chromatography (chloroform) and subsequently purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the crude title compound (0.018 g). Toluene-normal heptane (0.36 ml) was added to the crude product, and the solid was filtered and washed with toluene-normal heptane (0.54 ml) to obtain the title compound (0.010 g, yield 0.95%). .
8-(1,1-ジメチル-3-オキソブチルアミノ)-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン(4b-1)(1.12g、2.51mmol)と1-メチル-2-ピロリドン(10.0ml)とピリジン(0.20ml、2.49mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(0.47g、2.47mmol)を加え、外温50℃で20時間20分間撹拌した。反応液を放冷冷却し、酢酸エチル(55.0mL)、水(55.0mL)加えて抽出した。水層を酢酸エチル(10.0ml)で抽出後、有機層を取り纏め、テトラヒドロフラン(30.0mL)加え、水(55.0ml)で2回洗浄し、4%炭酸水素ナトリウム水溶液(55.0ml)で2回洗浄し、有機層を濃縮した。濃縮残差にクロロホルム(22.0mL)加え、固体をろ過、クロロホルム(10.0mL)洗浄後、ろ液を濃縮した。濃縮残差をシリカゲルカラムクロマトグラフィー(クロロホルム)で精製し、引き続きシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより粗体の標記化合物(0.018g)を得た。粗体にトルエン-ノルマルヘプタン(0.36ml)を加え、固体をろ過、トルエン-ノルマルヘプタン(0.54ml)にて洗浄し、標記化合物(0.010g、収率0.95%)を得た。 <Production 4 of 8- (4-methoxybenzyloxy) -2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3a)>
8- (1,1-Dimethyl-3-oxobutylamino) -3- (4-methoxybenzyloxy) benzo [c] chromen-6-one (4b-1) (1.12 g, 2.51 mmol) and 1 -Methyl-2-pyrrolidone (10.0 ml) and pyridine (0.20 ml, 2.49 mmol) were stirred at room temperature, and p-toluenesulfonic acid monohydrate (0.47 g, 2.47 mmol) was added. In addition, the mixture was stirred at an external temperature of 50 ° C. for 20 hours and 20 minutes. The reaction solution was allowed to cool and cooled, and extracted by adding ethyl acetate (55.0 mL) and water (55.0 mL). The aqueous layer was extracted with ethyl acetate (10.0 ml), and the organic layer was collected. Tetrahydrofuran (30.0 ml) was added, washed twice with water (55.0 ml), and 4% aqueous sodium hydrogen carbonate solution (55.0 ml). And the organic layer was concentrated. Chloroform (22.0 mL) was added to the concentration residue, the solid was filtered, washed with chloroform (10.0 mL), and the filtrate was concentrated. The concentrated residue was purified by silica gel column chromatography (chloroform) and subsequently purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the crude title compound (0.018 g). Toluene-normal heptane (0.36 ml) was added to the crude product, and the solid was filtered and washed with toluene-normal heptane (0.54 ml) to obtain the title compound (0.010 g, yield 0.95%). .
<8-ベンジルオキシメトキシ-2,2,4-トリメチル-1,2-ジヒドロ-6-オキサ-1-アザクリセン-5-オン(3b)の製造1>
8-アミノ-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン(8b)(1.00g、2.88mmol)と2,2-ジメトキシプロパン(19.4ml、158mmol)とピリジン(0.23ml、2.86mmol)と水(1.04ml、57.7mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(0.55g、2.89mmol)を加え、耐圧条件下、外温75℃で138時間44分間撹拌した。反応液を放冷冷却し濃縮後、残さに酢酸エチル(14.0mL)、テトラヒドロフラン(10.0mL)、水(12.0mL)加えて抽出した。水層を酢酸エチル(10.0ml)で抽出後、有機層を取り纏め、4%炭酸水素ナトリウム水溶液(12.0ml)で洗浄し有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(クロロホルム)で2回精製することにより粗体の標記化合物(0.43g)を得た。粗体にトルエン(2.10mL)、n-ヘプタン(4.20mL)加え、外温80℃で30分間撹拌し、外温4℃で冷却19時間撹拌し、ろ過、トルエンおよびn-ヘプタンの混合溶媒(1:2、4.00mL)で洗浄し、標記化合物(0.17g、収率14%)を得た。 <Production 1 of 8-benzyloxymethoxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3b)>
8-amino-3-benzyloxymethoxybenzo [c] chromen-6-one (8b) (1.00 g, 2.88 mmol), 2,2-dimethoxypropane (19.4 ml, 158 mmol) and pyridine (0.23 ml) 2.86 mmol) and water (1.04 ml, 57.7 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (0.55 g, 2.89 mmol) was added, The mixture was stirred at an external temperature of 75 ° C. for 138 hours and 44 minutes. The reaction mixture was allowed to cool and cooled, and concentrated, and the residue was extracted with ethyl acetate (14.0 mL), tetrahydrofuran (10.0 mL), and water (12.0 mL). The aqueous layer was extracted with ethyl acetate (10.0 ml), the organic layers were combined, washed with 4% aqueous sodium hydrogen carbonate solution (12.0 ml), and the organic layer was concentrated. The concentrated residue was purified twice by silica gel column chromatography (chloroform) to obtain the crude title compound (0.43 g). Toluene (2.10 mL) and n-heptane (4.20 mL) were added to the crude product, stirred at an external temperature of 80 ° C. for 30 minutes, cooled at an external temperature of 4 ° C. for 19 hours, filtered, and mixed with toluene and n-heptane. Washing with the solvent (1: 2, 4.00 mL) gave the title compound (0.17 g, 14% yield).
8-アミノ-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン(8b)(1.00g、2.88mmol)と2,2-ジメトキシプロパン(19.4ml、158mmol)とピリジン(0.23ml、2.86mmol)と水(1.04ml、57.7mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(0.55g、2.89mmol)を加え、耐圧条件下、外温75℃で138時間44分間撹拌した。反応液を放冷冷却し濃縮後、残さに酢酸エチル(14.0mL)、テトラヒドロフラン(10.0mL)、水(12.0mL)加えて抽出した。水層を酢酸エチル(10.0ml)で抽出後、有機層を取り纏め、4%炭酸水素ナトリウム水溶液(12.0ml)で洗浄し有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(クロロホルム)で2回精製することにより粗体の標記化合物(0.43g)を得た。粗体にトルエン(2.10mL)、n-ヘプタン(4.20mL)加え、外温80℃で30分間撹拌し、外温4℃で冷却19時間撹拌し、ろ過、トルエンおよびn-ヘプタンの混合溶媒(1:2、4.00mL)で洗浄し、標記化合物(0.17g、収率14%)を得た。 <Production 1 of 8-benzyloxymethoxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3b)>
8-amino-3-benzyloxymethoxybenzo [c] chromen-6-one (8b) (1.00 g, 2.88 mmol), 2,2-dimethoxypropane (19.4 ml, 158 mmol) and pyridine (0.23 ml) 2.86 mmol) and water (1.04 ml, 57.7 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (0.55 g, 2.89 mmol) was added, The mixture was stirred at an external temperature of 75 ° C. for 138 hours and 44 minutes. The reaction mixture was allowed to cool and cooled, and concentrated, and the residue was extracted with ethyl acetate (14.0 mL), tetrahydrofuran (10.0 mL), and water (12.0 mL). The aqueous layer was extracted with ethyl acetate (10.0 ml), the organic layers were combined, washed with 4% aqueous sodium hydrogen carbonate solution (12.0 ml), and the organic layer was concentrated. The concentrated residue was purified twice by silica gel column chromatography (chloroform) to obtain the crude title compound (0.43 g). Toluene (2.10 mL) and n-heptane (4.20 mL) were added to the crude product, stirred at an external temperature of 80 ° C. for 30 minutes, cooled at an external temperature of 4 ° C. for 19 hours, filtered, and mixed with toluene and n-heptane. Washing with the solvent (1: 2, 4.00 mL) gave the title compound (0.17 g, 14% yield).
<8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン(4c)の製造>
8-アミノ-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン(8b)(1.50g、4.32mmol)と2,2-ジメトキシプロパン(36.0ml、294mmol)とピリジン(0.43ml、5.35mmol)と水(1.94ml、108mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(1.03g、5.41mmol)を加え、その懸濁液に1-メチル-2-ピロリドン(10.0ml)を加え溶解し、67時間12分間撹拌した。反応液を濃縮し、酢酸エチル(30.0mL)、水(60.0mL)加えて抽出した。水層を酢酸エチル(30.0ml)で抽出後、有機層を取り纏め、酢酸エチル(30.0ml)、水(60.0ml)を加え抽出後、有機層に水(60.0ml)で3回洗浄した。有機層を濃縮し残差をシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(0.78g、収率33%)を得た。 <Production of 8- (1,1-dimethyl-3-oxobutylamino) -3-benzyloxymethoxybenzo [c] chromen-6-one (4c)>
8-amino-3-benzyloxymethoxybenzo [c] chromen-6-one (8b) (1.50 g, 4.32 mmol), 2,2-dimethoxypropane (36.0 ml, 294 mmol) and pyridine (0.43 ml) 5.35 mmol) and water (1.94 ml, 108 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (1.03 g, 5.41 mmol) was added, and -Methyl-2-pyrrolidone (10.0 ml) was added and dissolved, and the mixture was stirred for 67 hours and 12 minutes. The reaction mixture was concentrated and extracted by adding ethyl acetate (30.0 mL) and water (60.0 mL). The aqueous layer was extracted with ethyl acetate (30.0 ml), and the organic layers were combined. After extraction by adding ethyl acetate (30.0 ml) and water (60.0 ml), the organic layer was washed with water (60.0 ml) three times. Washed. The organic layer was concentrated and the residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.78 g, yield 33%).
8-アミノ-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン(8b)(1.50g、4.32mmol)と2,2-ジメトキシプロパン(36.0ml、294mmol)とピリジン(0.43ml、5.35mmol)と水(1.94ml、108mmol)の混液を室温にて撹拌し、p-トルエンスルホン酸一水和物(1.03g、5.41mmol)を加え、その懸濁液に1-メチル-2-ピロリドン(10.0ml)を加え溶解し、67時間12分間撹拌した。反応液を濃縮し、酢酸エチル(30.0mL)、水(60.0mL)加えて抽出した。水層を酢酸エチル(30.0ml)で抽出後、有機層を取り纏め、酢酸エチル(30.0ml)、水(60.0ml)を加え抽出後、有機層に水(60.0ml)で3回洗浄した。有機層を濃縮し残差をシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(0.78g、収率33%)を得た。 <Production of 8- (1,1-dimethyl-3-oxobutylamino) -3-benzyloxymethoxybenzo [c] chromen-6-one (4c)>
8-amino-3-benzyloxymethoxybenzo [c] chromen-6-one (8b) (1.50 g, 4.32 mmol), 2,2-dimethoxypropane (36.0 ml, 294 mmol) and pyridine (0.43 ml) 5.35 mmol) and water (1.94 ml, 108 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (1.03 g, 5.41 mmol) was added, and -Methyl-2-pyrrolidone (10.0 ml) was added and dissolved, and the mixture was stirred for 67 hours and 12 minutes. The reaction mixture was concentrated and extracted by adding ethyl acetate (30.0 mL) and water (60.0 mL). The aqueous layer was extracted with ethyl acetate (30.0 ml), and the organic layers were combined. After extraction by adding ethyl acetate (30.0 ml) and water (60.0 ml), the organic layer was washed with water (60.0 ml) three times. Washed. The organic layer was concentrated and the residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.78 g, yield 33%).
<8-ベンジルオキシメトキシ-2,2,4-トリメチル-1,2-ジヒドロ-6-オキサ-1-アザクリセン-5-オン(3b)の製造2>
8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン(4c)(0.79g、1.77mmol)と1-メチル-2-ピロリドン(16.0ml)とピリジン(0.15ml、1.87mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(0.36g、1.89mmol)を加え、外温50℃で23時間53分間撹拌した。反応液を放冷冷却し、酢酸エチル(40.0mL)、水(40.0mL)加えて抽出した。水層を酢酸エチル(8.0ml)で抽出後、有機層を取り纏め、水(40.0ml)で2回洗浄し、4%炭酸水素ナトリウム水溶液(40.0ml)で2回洗浄し、有機層を濃縮した。濃縮残差にクロロホルム(16.0mL)加え、固体をろ過、クロロホルム(5.0mL)洗浄後、ろ液を濃縮した。濃縮残差をシリカゲルカラムクロマトグラフィー(クロロホルム)で精製することにより標記化合物(0.0092g、収率1.15%)を得た。 <Production 2 of 8-benzyloxymethoxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3b)>
8- (1,1-Dimethyl-3-oxobutylamino) -3-benzyloxymethoxybenzo [c] chromen-6-one (4c) (0.79 g, 1.77 mmol) and 1-methyl-2-pyrrolidone (16.0 ml) and pyridine (0.15 ml, 1.87 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (0.36 g, 1.89 mmol) was added, and the external temperature was 50 ° C. For 23 hours 53 minutes. The reaction solution was allowed to cool and cooled, and extracted by adding ethyl acetate (40.0 mL) and water (40.0 mL). The aqueous layer was extracted with ethyl acetate (8.0 ml), and the organic layers were combined, washed twice with water (40.0 ml), washed twice with 4% aqueous sodium bicarbonate (40.0 ml), and the organic layer Was concentrated. Chloroform (16.0 mL) was added to the concentration residue, the solid was filtered, washed with chloroform (5.0 mL), and the filtrate was concentrated. The concentrated residue was purified by silica gel column chromatography (chloroform) to obtain the title compound (0.0092 g, yield 1.15%).
8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン(4c)(0.79g、1.77mmol)と1-メチル-2-ピロリドン(16.0ml)とピリジン(0.15ml、1.87mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(0.36g、1.89mmol)を加え、外温50℃で23時間53分間撹拌した。反応液を放冷冷却し、酢酸エチル(40.0mL)、水(40.0mL)加えて抽出した。水層を酢酸エチル(8.0ml)で抽出後、有機層を取り纏め、水(40.0ml)で2回洗浄し、4%炭酸水素ナトリウム水溶液(40.0ml)で2回洗浄し、有機層を濃縮した。濃縮残差にクロロホルム(16.0mL)加え、固体をろ過、クロロホルム(5.0mL)洗浄後、ろ液を濃縮した。濃縮残差をシリカゲルカラムクロマトグラフィー(クロロホルム)で精製することにより標記化合物(0.0092g、収率1.15%)を得た。 <Production 2 of 8-benzyloxymethoxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azachrysen-5-one (3b)>
8- (1,1-Dimethyl-3-oxobutylamino) -3-benzyloxymethoxybenzo [c] chromen-6-one (4c) (0.79 g, 1.77 mmol) and 1-methyl-2-pyrrolidone (16.0 ml) and pyridine (0.15 ml, 1.87 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (0.36 g, 1.89 mmol) was added, and the external temperature was 50 ° C. For 23 hours 53 minutes. The reaction solution was allowed to cool and cooled, and extracted by adding ethyl acetate (40.0 mL) and water (40.0 mL). The aqueous layer was extracted with ethyl acetate (8.0 ml), and the organic layers were combined, washed twice with water (40.0 ml), washed twice with 4% aqueous sodium bicarbonate (40.0 ml), and the organic layer Was concentrated. Chloroform (16.0 mL) was added to the concentration residue, the solid was filtered, washed with chloroform (5.0 mL), and the filtrate was concentrated. The concentrated residue was purified by silica gel column chromatography (chloroform) to obtain the title compound (0.0092 g, yield 1.15%).
<2-(2,4-ジメトキシフェニル)-5-アミノ安息香酸メチル(11a)の製造>
2-(2,4-ジメトキシフェニル)-5-ニトロ安息香酸メチル(4.00g、12.6mmol、国際公開2008/059865号パンフレット)とN,N-ジメチルホルムアミド(46.0ml)とメタノール(12.0ml)と10%パラジウム炭素(水分52.1%)(0.19g)の混液に室温にて撹拌し、水素ガスを3.0kgf/cm2条件下で4時間25分間撹拌した。反応液をセライトろ過し、メタノール、水(100.0mL)で洗浄した。ろ液に酢酸エチル(200.0mL)、水(100.0mL)加えて抽出した。水層を酢酸エチル(100.0mL)で2回抽出し、有機層を取り纏め、5%塩化ナトリウム水溶液(200.0ml)で6回洗浄し有機層を無水硫酸マグネシウムで乾燥後、濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(クロロホルム-メタノール)で2回精製することにより標記化合物(2.60g、収率72%)を得た。 <Production of methyl 2- (2,4-dimethoxyphenyl) -5-aminobenzoate (11a)>
Methyl 2- (2,4-dimethoxyphenyl) -5-nitrobenzoate (4.00 g, 12.6 mmol, WO 2008/059865 pamphlet), N, N-dimethylformamide (46.0 ml) and methanol (12 0.0 ml) and 10% palladium carbon (moisture 52.1%) (0.19 g) were stirred at room temperature, and hydrogen gas was stirred for 4 hours and 25 minutes under 3.0 kgf / cm 2 conditions. The reaction mixture was filtered through celite and washed with methanol and water (100.0 mL). The filtrate was extracted with ethyl acetate (200.0 mL) and water (100.0 mL). The aqueous layer was extracted twice with ethyl acetate (100.0 mL), the organic layers were combined, washed 6 times with 5% aqueous sodium chloride solution (200.0 ml), the organic layer was dried over anhydrous magnesium sulfate and concentrated. The concentrated residue was purified twice by silica gel column chromatography (chloroform-methanol) to obtain the title compound (2.60 g, yield 72%).
2-(2,4-ジメトキシフェニル)-5-ニトロ安息香酸メチル(4.00g、12.6mmol、国際公開2008/059865号パンフレット)とN,N-ジメチルホルムアミド(46.0ml)とメタノール(12.0ml)と10%パラジウム炭素(水分52.1%)(0.19g)の混液に室温にて撹拌し、水素ガスを3.0kgf/cm2条件下で4時間25分間撹拌した。反応液をセライトろ過し、メタノール、水(100.0mL)で洗浄した。ろ液に酢酸エチル(200.0mL)、水(100.0mL)加えて抽出した。水層を酢酸エチル(100.0mL)で2回抽出し、有機層を取り纏め、5%塩化ナトリウム水溶液(200.0ml)で6回洗浄し有機層を無水硫酸マグネシウムで乾燥後、濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(クロロホルム-メタノール)で2回精製することにより標記化合物(2.60g、収率72%)を得た。 <Production of methyl 2- (2,4-dimethoxyphenyl) -5-aminobenzoate (11a)>
Methyl 2- (2,4-dimethoxyphenyl) -5-nitrobenzoate (4.00 g, 12.6 mmol, WO 2008/059865 pamphlet), N, N-dimethylformamide (46.0 ml) and methanol (12 0.0 ml) and 10% palladium carbon (moisture 52.1%) (0.19 g) were stirred at room temperature, and hydrogen gas was stirred for 4 hours and 25 minutes under 3.0 kgf / cm 2 conditions. The reaction mixture was filtered through celite and washed with methanol and water (100.0 mL). The filtrate was extracted with ethyl acetate (200.0 mL) and water (100.0 mL). The aqueous layer was extracted twice with ethyl acetate (100.0 mL), the organic layers were combined, washed 6 times with 5% aqueous sodium chloride solution (200.0 ml), the organic layer was dried over anhydrous magnesium sulfate and concentrated. The concentrated residue was purified twice by silica gel column chromatography (chloroform-methanol) to obtain the title compound (2.60 g, yield 72%).
<6-(2,4-メトキシ)-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸メチル(12a)の製造>
2-(2,4-ジメトキシフェニル)-5-アミノ安息香酸メチル(11a)(2.64g、9.19mmol)と2,2-ジメトキシプロパン(60.0ml、490mmol)とピリジン(0.73ml、9.08mmol)と水(3.20ml、178mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(1.72g、9.04mmol)を加え、外温105℃で72時間撹拌した。反応液中の不溶物をろ過で除去し、ろ液を濃縮した。濃縮残さに酢酸エチル(26.0mL)、水(26.0mL)を加えて抽出した。水層を酢酸エチル(13.0mL)で2回抽出し、有機層を取り纏め、4%塩化ナトリウム水溶液(50.0ml)で2回洗浄し有機層を無水硫酸マグネシウムで乾燥後、濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(0.27g、収率8.1%)を得た。 <Production of methyl 6- (2,4-methoxy) -2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate (12a)>
Methyl 2- (2,4-dimethoxyphenyl) -5-aminobenzoate (11a) (2.64 g, 9.19 mmol), 2,2-dimethoxypropane (60.0 ml, 490 mmol) and pyridine (0.73 ml, 9.08 mmol) and water (3.20 ml, 178 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (1.72 g, 9.04 mmol) was added, and the external temperature was 105 ° C. for 72 hours. Stir. Insoluble matters in the reaction solution were removed by filtration, and the filtrate was concentrated. The concentrated residue was extracted with ethyl acetate (26.0 mL) and water (26.0 mL). The aqueous layer was extracted twice with ethyl acetate (13.0 mL), the organic layers were combined, washed twice with 4% aqueous sodium chloride solution (50.0 ml), and the organic layer was dried over anhydrous magnesium sulfate and concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.27 g, yield 8.1%).
2-(2,4-ジメトキシフェニル)-5-アミノ安息香酸メチル(11a)(2.64g、9.19mmol)と2,2-ジメトキシプロパン(60.0ml、490mmol)とピリジン(0.73ml、9.08mmol)と水(3.20ml、178mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(1.72g、9.04mmol)を加え、外温105℃で72時間撹拌した。反応液中の不溶物をろ過で除去し、ろ液を濃縮した。濃縮残さに酢酸エチル(26.0mL)、水(26.0mL)を加えて抽出した。水層を酢酸エチル(13.0mL)で2回抽出し、有機層を取り纏め、4%塩化ナトリウム水溶液(50.0ml)で2回洗浄し有機層を無水硫酸マグネシウムで乾燥後、濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(0.27g、収率8.1%)を得た。 <Production of methyl 6- (2,4-methoxy) -2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate (12a)>
Methyl 2- (2,4-dimethoxyphenyl) -5-aminobenzoate (11a) (2.64 g, 9.19 mmol), 2,2-dimethoxypropane (60.0 ml, 490 mmol) and pyridine (0.73 ml, 9.08 mmol) and water (3.20 ml, 178 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (1.72 g, 9.04 mmol) was added, and the external temperature was 105 ° C. for 72 hours. Stir. Insoluble matters in the reaction solution were removed by filtration, and the filtrate was concentrated. The concentrated residue was extracted with ethyl acetate (26.0 mL) and water (26.0 mL). The aqueous layer was extracted twice with ethyl acetate (13.0 mL), the organic layers were combined, washed twice with 4% aqueous sodium chloride solution (50.0 ml), and the organic layer was dried over anhydrous magnesium sulfate and concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.27 g, yield 8.1%).
<6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸(14a)および6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-7-カルボン酸の異性体混合物の製造>
5-アミノ-2-ブロモ安息香酸(13a)(5.00g、23.1mmol)と2,2-ジメトキシプロパン(156ml、1273mmol)とピリジン(1.86ml、23.1mmol)と水(8.40ml、466mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(4.40g、23.1mmol)を加え、外温100℃で48時間撹拌した。反応液を濃縮し、濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で3回精製し、引き続きシリカゲルカラムクロマトグラフィー(クロロホルム-メタノール)で2回精製することにより標記の異性体混合物(1.26g、収率18%)を得た。 <6-Bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid (14a) and 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-7-carvone Production of acid isomer mixture>
5-amino-2-bromobenzoic acid (13a) (5.00 g, 23.1 mmol), 2,2-dimethoxypropane (156 ml, 1273 mmol), pyridine (1.86 ml, 23.1 mmol) and water (8.40 ml) The mixture was stirred at room temperature, p-toluenesulfonic acid monohydrate (4.40 g, 23.1 mmol) was added, and the mixture was stirred at an external temperature of 100 ° C. for 48 hours. The reaction mixture was concentrated, and the concentrated residue was purified three times by silica gel column chromatography (ethyl acetate-hexane), and then purified twice by silica gel column chromatography (chloroform-methanol) to give the title isomer mixture (1. 26 g, yield 18%).
5-アミノ-2-ブロモ安息香酸(13a)(5.00g、23.1mmol)と2,2-ジメトキシプロパン(156ml、1273mmol)とピリジン(1.86ml、23.1mmol)と水(8.40ml、466mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(4.40g、23.1mmol)を加え、外温100℃で48時間撹拌した。反応液を濃縮し、濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で3回精製し、引き続きシリカゲルカラムクロマトグラフィー(クロロホルム-メタノール)で2回精製することにより標記の異性体混合物(1.26g、収率18%)を得た。 <6-Bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid (14a) and 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-7-carvone Production of acid isomer mixture>
5-amino-2-bromobenzoic acid (13a) (5.00 g, 23.1 mmol), 2,2-dimethoxypropane (156 ml, 1273 mmol), pyridine (1.86 ml, 23.1 mmol) and water (8.40 ml) The mixture was stirred at room temperature, p-toluenesulfonic acid monohydrate (4.40 g, 23.1 mmol) was added, and the mixture was stirred at an external temperature of 100 ° C. for 48 hours. The reaction mixture was concentrated, and the concentrated residue was purified three times by silica gel column chromatography (ethyl acetate-hexane), and then purified twice by silica gel column chromatography (chloroform-methanol) to give the title isomer mixture (1. 26 g, yield 18%).
<6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸(14a)の製造>
6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸(14a)および6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-7-カルボン酸の異性体混合物(1.00g、3.38mmol)と低水分溶剤メタノール(80.0ml)の混液を外温4℃にて撹拌し、塩化チオニル(2.30mL、31.7mmol)を加え73時間10分間撹拌した。反応液を濃縮し、酢酸エチル(80.0mL)、4%炭酸水素ナトリウム水溶液(180.0mL)加えて抽出した。水層を酢酸エチル(50.0ml)で抽出後、有機層を取り纏め、4%炭酸水素ナトリウム水溶液(100.0ml)で2回洗浄し、有機層を濃縮し、異性体化合物を得た。水層を取り纏め、濃塩酸(14.7mL)加え、酢酸エチル(400.0mL)で抽出し、濃縮することにより異性体が残留した標記化合物(0.56g)を得た。上記の操作を3回繰り返すことで標記化合物(0.26g、収率25%)を得た。 <Production of 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid (14a)>
6-Bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid (14a) and 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-7-carboxylic acid A mixture of isomers (1.00 g, 3.38 mmol) and low-moisture solvent methanol (80.0 ml) was stirred at an external temperature of 4 ° C., thionyl chloride (2.30 mL, 31.7 mmol) was added for 73 hours. Stir for 10 minutes. The reaction mixture was concentrated and extracted by adding ethyl acetate (80.0 mL) and 4% aqueous sodium hydrogen carbonate solution (180.0 mL). The aqueous layer was extracted with ethyl acetate (50.0 ml), the organic layers were combined, washed twice with 4% aqueous sodium hydrogen carbonate solution (100.0 ml), and the organic layer was concentrated to obtain an isomer compound. The aqueous layer was collected, concentrated hydrochloric acid (14.7 mL) was added, extracted with ethyl acetate (400.0 mL), and concentrated to obtain the title compound (0.56 g) in which the isomer remained. The above operation was repeated three times to obtain the title compound (0.26 g, yield 25%).
6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸(14a)および6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-7-カルボン酸の異性体混合物(1.00g、3.38mmol)と低水分溶剤メタノール(80.0ml)の混液を外温4℃にて撹拌し、塩化チオニル(2.30mL、31.7mmol)を加え73時間10分間撹拌した。反応液を濃縮し、酢酸エチル(80.0mL)、4%炭酸水素ナトリウム水溶液(180.0mL)加えて抽出した。水層を酢酸エチル(50.0ml)で抽出後、有機層を取り纏め、4%炭酸水素ナトリウム水溶液(100.0ml)で2回洗浄し、有機層を濃縮し、異性体化合物を得た。水層を取り纏め、濃塩酸(14.7mL)加え、酢酸エチル(400.0mL)で抽出し、濃縮することにより異性体が残留した標記化合物(0.56g)を得た。上記の操作を3回繰り返すことで標記化合物(0.26g、収率25%)を得た。 <Production of 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid (14a)>
6-Bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid (14a) and 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-7-carboxylic acid A mixture of isomers (1.00 g, 3.38 mmol) and low-moisture solvent methanol (80.0 ml) was stirred at an external temperature of 4 ° C., thionyl chloride (2.30 mL, 31.7 mmol) was added for 73 hours. Stir for 10 minutes. The reaction mixture was concentrated and extracted by adding ethyl acetate (80.0 mL) and 4% aqueous sodium hydrogen carbonate solution (180.0 mL). The aqueous layer was extracted with ethyl acetate (50.0 ml), the organic layers were combined, washed twice with 4% aqueous sodium hydrogen carbonate solution (100.0 ml), and the organic layer was concentrated to obtain an isomer compound. The aqueous layer was collected, concentrated hydrochloric acid (14.7 mL) was added, extracted with ethyl acetate (400.0 mL), and concentrated to obtain the title compound (0.56 g) in which the isomer remained. The above operation was repeated three times to obtain the title compound (0.26 g, yield 25%).
<6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸メチル(15a)の製造>
6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸(14a)(0.24g、0.81mmol)と低水分溶剤メタノール(20.0ml)の混液を氷冷にて撹拌し、塩化チオニル(18.6mL、257mmol)を加え、42時間50分間還流撹拌した。反応液を放冷冷却し濃縮後、酢酸エチル(20.0mL)、4%炭酸水素ナトリウム水溶液(20.0mL)加えて抽出し、有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(0.021g、収率8.6%)を得た。 <Production of methyl 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate (15a)>
A mixture of 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid (14a) (0.24 g, 0.81 mmol) and low moisture solvent methanol (20.0 ml) was ice-cooled. And thionyl chloride (18.6 mL, 257 mmol) was added and stirred at reflux for 42 hours and 50 minutes. The reaction mixture was allowed to cool and cooled, concentrated, extracted by adding ethyl acetate (20.0 mL) and 4% aqueous sodium hydrogen carbonate solution (20.0 mL), and the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.021 g, yield 8.6%).
6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸(14a)(0.24g、0.81mmol)と低水分溶剤メタノール(20.0ml)の混液を氷冷にて撹拌し、塩化チオニル(18.6mL、257mmol)を加え、42時間50分間還流撹拌した。反応液を放冷冷却し濃縮後、酢酸エチル(20.0mL)、4%炭酸水素ナトリウム水溶液(20.0mL)加えて抽出し、有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(0.021g、収率8.6%)を得た。 <Production of methyl 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate (15a)>
A mixture of 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid (14a) (0.24 g, 0.81 mmol) and low moisture solvent methanol (20.0 ml) was ice-cooled. And thionyl chloride (18.6 mL, 257 mmol) was added and stirred at reflux for 42 hours and 50 minutes. The reaction mixture was allowed to cool and cooled, concentrated, extracted by adding ethyl acetate (20.0 mL) and 4% aqueous sodium hydrogen carbonate solution (20.0 mL), and the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.021 g, yield 8.6%).
<6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸メチル(15a)および6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-7-カルボン酸メチルの異性体混合物の製造>
2-ブロモ-5-アミノ安息香酸メチル(16a)(4.00g、17.4mmol)と2,2-ジメトキシプロパン(120ml、979mmol)とピリジン(1.40ml、17.4mmol)と水(6.30ml、350mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(3.32g、17.5mmol)を加え、耐圧条件下外温105℃で65時間30分間撹拌した。反応液を放冷冷却し濃縮し、酢酸エチル(80.0mL)、水(80.0mL)加えて抽出した。有機層を水(80.0mL)で洗浄し、4%炭酸水素ナトリウム水溶液(80.0ml)で洗浄し有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で3回精製し、引き続きシリカゲルカラムクロマトグラフィー(クロロホルム)で2回精製することにより標記の異性体混合物(1.50g、収率28%)を得た。 <Methyl 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate (15a) and 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-7- Production of isomer mixture of methyl carboxylate>
Methyl 2-bromo-5-aminobenzoate (16a) (4.00 g, 17.4 mmol), 2,2-dimethoxypropane (120 ml, 979 mmol), pyridine (1.40 ml, 17.4 mmol) and water (6. 30 ml, 350 mmol) was stirred at room temperature, p-toluenesulfonic acid monohydrate (3.32 g, 17.5 mmol) was added, and the mixture was stirred at an external temperature of 105 ° C. for 65 hours and 30 minutes under pressure resistance. The reaction solution was allowed to cool and concentrated, and extracted by adding ethyl acetate (80.0 mL) and water (80.0 mL). The organic layer was washed with water (80.0 mL), washed with 4% aqueous sodium hydrogen carbonate solution (80.0 ml), and the organic layer was concentrated. The concentrated residue was purified three times by silica gel column chromatography (ethyl acetate-hexane) and then purified twice by silica gel column chromatography (chloroform) to obtain the title isomer mixture (1.50 g, yield 28%). Obtained.
2-ブロモ-5-アミノ安息香酸メチル(16a)(4.00g、17.4mmol)と2,2-ジメトキシプロパン(120ml、979mmol)とピリジン(1.40ml、17.4mmol)と水(6.30ml、350mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(3.32g、17.5mmol)を加え、耐圧条件下外温105℃で65時間30分間撹拌した。反応液を放冷冷却し濃縮し、酢酸エチル(80.0mL)、水(80.0mL)加えて抽出した。有機層を水(80.0mL)で洗浄し、4%炭酸水素ナトリウム水溶液(80.0ml)で洗浄し有機層を濃縮した。濃縮残さをシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で3回精製し、引き続きシリカゲルカラムクロマトグラフィー(クロロホルム)で2回精製することにより標記の異性体混合物(1.50g、収率28%)を得た。 <Methyl 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate (15a) and 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-7- Production of isomer mixture of methyl carboxylate>
Methyl 2-bromo-5-aminobenzoate (16a) (4.00 g, 17.4 mmol), 2,2-dimethoxypropane (120 ml, 979 mmol), pyridine (1.40 ml, 17.4 mmol) and water (6. 30 ml, 350 mmol) was stirred at room temperature, p-toluenesulfonic acid monohydrate (3.32 g, 17.5 mmol) was added, and the mixture was stirred at an external temperature of 105 ° C. for 65 hours and 30 minutes under pressure resistance. The reaction solution was allowed to cool and concentrated, and extracted by adding ethyl acetate (80.0 mL) and water (80.0 mL). The organic layer was washed with water (80.0 mL), washed with 4% aqueous sodium hydrogen carbonate solution (80.0 ml), and the organic layer was concentrated. The concentrated residue was purified three times by silica gel column chromatography (ethyl acetate-hexane) and then purified twice by silica gel column chromatography (chloroform) to obtain the title isomer mixture (1.50 g, yield 28%). Obtained.
<2-ブロモ-5-(1,1-ジメチル-3-オキソブチルアミノ)安息香酸メチル(17)の製造>
2-ブロモ-5-アミノ安息香酸メチル(16a)(4.00g、17.4mmol)と2,2-ジメトキシプロパン(120ml、979mmol)とピリジン(1.40ml、17.4mmol)と水(6.30ml、350mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(3.31g、17.4mmol)を加え71時間18分間撹拌した。反応液を濃縮し、酢酸エチル(80.0mL)、水(80.0mL)加えて抽出した。水層を酢酸エチル(80.0ml)で2回抽出後、有機層を取り纏め、4%炭酸水素ナトリウム水溶液(80.0ml)で洗浄し、有機層を濃縮した。濃縮残差をシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で3回精製することにより標記化合物(1.29g、収率23%)を得た。 <Production of methyl 2-bromo-5- (1,1-dimethyl-3-oxobutylamino) benzoate (17)>
Methyl 2-bromo-5-aminobenzoate (16a) (4.00 g, 17.4 mmol), 2,2-dimethoxypropane (120 ml, 979 mmol), pyridine (1.40 ml, 17.4 mmol) and water (6. 30 ml, 350 mmol) was stirred at room temperature, p-toluenesulfonic acid monohydrate (3.31 g, 17.4 mmol) was added, and the mixture was stirred for 71 hours and 18 minutes. The reaction mixture was concentrated and extracted by adding ethyl acetate (80.0 mL) and water (80.0 mL). The aqueous layer was extracted twice with ethyl acetate (80.0 ml), the organic layers were combined, washed with 4% aqueous sodium hydrogen carbonate solution (80.0 ml), and the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) three times to obtain the title compound (1.29 g, yield 23%).
2-ブロモ-5-アミノ安息香酸メチル(16a)(4.00g、17.4mmol)と2,2-ジメトキシプロパン(120ml、979mmol)とピリジン(1.40ml、17.4mmol)と水(6.30ml、350mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(3.31g、17.4mmol)を加え71時間18分間撹拌した。反応液を濃縮し、酢酸エチル(80.0mL)、水(80.0mL)加えて抽出した。水層を酢酸エチル(80.0ml)で2回抽出後、有機層を取り纏め、4%炭酸水素ナトリウム水溶液(80.0ml)で洗浄し、有機層を濃縮した。濃縮残差をシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で3回精製することにより標記化合物(1.29g、収率23%)を得た。 <Production of methyl 2-bromo-5- (1,1-dimethyl-3-oxobutylamino) benzoate (17)>
Methyl 2-bromo-5-aminobenzoate (16a) (4.00 g, 17.4 mmol), 2,2-dimethoxypropane (120 ml, 979 mmol), pyridine (1.40 ml, 17.4 mmol) and water (6. 30 ml, 350 mmol) was stirred at room temperature, p-toluenesulfonic acid monohydrate (3.31 g, 17.4 mmol) was added, and the mixture was stirred for 71 hours and 18 minutes. The reaction mixture was concentrated and extracted by adding ethyl acetate (80.0 mL) and water (80.0 mL). The aqueous layer was extracted twice with ethyl acetate (80.0 ml), the organic layers were combined, washed with 4% aqueous sodium hydrogen carbonate solution (80.0 ml), and the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) three times to obtain the title compound (1.29 g, yield 23%).
<6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリンー5-カルボン酸メチル(15a)の製造>
2-ブロモ-5-(1,1-ジメチル-3-オキソブチルアミノ)安息香酸メチル(17)(1.00g、3.05mmol)と低水分溶剤メタノール(10.0ml)とピリジン(0.25ml、3.11mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(0.57g、3.00mmol)を加え、外温50℃で17時間15分間撹拌した。反応液を室温放冷し濃縮後、酢酸エチル(15.0mL)、水(10.0mL)加えて抽出した。有機層を4%炭酸水素ナトリウム水溶液(10.0ml)で抽出後、有機層を濃縮した。濃縮残差をシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(0.0095g、収率1.00%)を得た。 <Production of methyl 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate (15a)>
Methyl 2-bromo-5- (1,1-dimethyl-3-oxobutylamino) benzoate (17) (1.00 g, 3.05 mmol), low moisture solvent methanol (10.0 ml) and pyridine (0.25 ml) 3.11 mmol) was stirred at room temperature, p-toluenesulfonic acid monohydrate (0.57 g, 3.00 mmol) was added, and the mixture was stirred at an external temperature of 50 ° C. for 17 hours and 15 minutes. The reaction mixture was allowed to cool to room temperature, concentrated, and extracted with ethyl acetate (15.0 mL) and water (10.0 mL). The organic layer was extracted with 4% aqueous sodium hydrogen carbonate solution (10.0 ml), and then the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.0095 g, yield 1.00%).
2-ブロモ-5-(1,1-ジメチル-3-オキソブチルアミノ)安息香酸メチル(17)(1.00g、3.05mmol)と低水分溶剤メタノール(10.0ml)とピリジン(0.25ml、3.11mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(0.57g、3.00mmol)を加え、外温50℃で17時間15分間撹拌した。反応液を室温放冷し濃縮後、酢酸エチル(15.0mL)、水(10.0mL)加えて抽出した。有機層を4%炭酸水素ナトリウム水溶液(10.0ml)で抽出後、有機層を濃縮した。濃縮残差をシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(0.0095g、収率1.00%)を得た。 <Production of methyl 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate (15a)>
Methyl 2-bromo-5- (1,1-dimethyl-3-oxobutylamino) benzoate (17) (1.00 g, 3.05 mmol), low moisture solvent methanol (10.0 ml) and pyridine (0.25 ml) 3.11 mmol) was stirred at room temperature, p-toluenesulfonic acid monohydrate (0.57 g, 3.00 mmol) was added, and the mixture was stirred at an external temperature of 50 ° C. for 17 hours and 15 minutes. The reaction mixture was allowed to cool to room temperature, concentrated, and extracted with ethyl acetate (15.0 mL) and water (10.0 mL). The organic layer was extracted with 4% aqueous sodium hydrogen carbonate solution (10.0 ml), and then the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (0.0095 g, yield 1.00%).
<2,2,4-トリメチル-1,2-ジヒドロキノリン(7a)の製造>
アニリン(6a)(0.980mL、10.7mmol)と2,2-ジメトキシプロパン(66ml、537mmol)とピリジン(0.860ml、10.7mmol)と水(3.90ml、216mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(2.04g、10.7mmol)を加え、外温50℃で22時間撹拌した。反応液を濃縮し、濃縮残差をシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(1.18g、収率63.2%)を得た。 <Production of 2,2,4-trimethyl-1,2-dihydroquinoline (7a)>
A mixture of aniline (6a) (0.980 mL, 10.7 mmol), 2,2-dimethoxypropane (66 ml, 537 mmol), pyridine (0.860 ml, 10.7 mmol) and water (3.90 ml, 216 mmol) was brought to room temperature. Then, p-toluenesulfonic acid monohydrate (2.04 g, 10.7 mmol) was added, and the mixture was stirred at an external temperature of 50 ° C. for 22 hours. The reaction mixture was concentrated, and the concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (1.18 g, yield 63.2%).
アニリン(6a)(0.980mL、10.7mmol)と2,2-ジメトキシプロパン(66ml、537mmol)とピリジン(0.860ml、10.7mmol)と水(3.90ml、216mmol)の混液に室温にて撹拌し、p-トルエンスルホン酸一水和物(2.04g、10.7mmol)を加え、外温50℃で22時間撹拌した。反応液を濃縮し、濃縮残差をシリカゲルカラムクロマトグラフィー(酢酸エチル-ヘキサン)で精製することにより標記化合物(1.18g、収率63.2%)を得た。 <Production of 2,2,4-trimethyl-1,2-dihydroquinoline (7a)>
A mixture of aniline (6a) (0.980 mL, 10.7 mmol), 2,2-dimethoxypropane (66 ml, 537 mmol), pyridine (0.860 ml, 10.7 mmol) and water (3.90 ml, 216 mmol) was brought to room temperature. Then, p-toluenesulfonic acid monohydrate (2.04 g, 10.7 mmol) was added, and the mixture was stirred at an external temperature of 50 ° C. for 22 hours. The reaction mixture was concentrated, and the concentrated residue was purified by silica gel column chromatography (ethyl acetate-hexane) to obtain the title compound (1.18 g, yield 63.2%).
本発明によれば、グルココルチコイド受容体結合活性を有する1,2-ジヒドロキノリン誘導体の合成中間体を工業的に製造することができ、有用である。
また、これらはグルココルチコイド受容体が関与する疾患、すなわち、糖尿病、肥満等の代謝異常疾患、腸炎、慢性閉塞性肺疾患等の炎症性疾患、関節リウマチ、膠原病等の自己免疫疾患、喘息、アトピー性皮膚炎、アレルギー性鼻炎等のアレルギー性疾患、精神病、アルツハイマー、薬物使用障害等の中枢神経系疾患、高血圧、高カルシウム血症、高インシュリン血症、高脂血症等の心血管系疾患、神経・免疫・内分泌のバランス異常をきたすホメオスタシス関連疾患、緑内障等の予防または治療に有用である。 According to the present invention, a synthetic intermediate of a 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity can be produced industrially and is useful.
In addition, these are diseases involving glucocorticoid receptors, that is, metabolic disorders such as diabetes and obesity, inflammatory diseases such as enteritis and chronic obstructive pulmonary disease, rheumatoid arthritis, autoimmune diseases such as collagen disease, asthma, Allergic diseases such as atopic dermatitis and allergic rhinitis, central nervous system diseases such as psychosis, Alzheimer, drug use disorders, cardiovascular diseases such as hypertension, hypercalcemia, hyperinsulinemia, hyperlipidemia It is useful for the prevention or treatment of homeostasis-related diseases and glaucoma that cause abnormal balance of nerve, immunity and endocrine.
また、これらはグルココルチコイド受容体が関与する疾患、すなわち、糖尿病、肥満等の代謝異常疾患、腸炎、慢性閉塞性肺疾患等の炎症性疾患、関節リウマチ、膠原病等の自己免疫疾患、喘息、アトピー性皮膚炎、アレルギー性鼻炎等のアレルギー性疾患、精神病、アルツハイマー、薬物使用障害等の中枢神経系疾患、高血圧、高カルシウム血症、高インシュリン血症、高脂血症等の心血管系疾患、神経・免疫・内分泌のバランス異常をきたすホメオスタシス関連疾患、緑内障等の予防または治療に有用である。 According to the present invention, a synthetic intermediate of a 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity can be produced industrially and is useful.
In addition, these are diseases involving glucocorticoid receptors, that is, metabolic disorders such as diabetes and obesity, inflammatory diseases such as enteritis and chronic obstructive pulmonary disease, rheumatoid arthritis, autoimmune diseases such as collagen disease, asthma, Allergic diseases such as atopic dermatitis and allergic rhinitis, central nervous system diseases such as psychosis, Alzheimer, drug use disorders, cardiovascular diseases such as hypertension, hypercalcemia, hyperinsulinemia, hyperlipidemia It is useful for the prevention or treatment of homeostasis-related diseases and glaucoma that cause abnormal balance of nerve, immunity and endocrine.
Claims (9)
- 式(1)
で表される化合物またはその塩を、
(A)p-トルエンスルホン酸、p-トルエンスルホン酸ピリジニウム、臭化水素酸およびピリジン臭化水素酸塩からなる群より選択される酸及び/又は
(B)ピリジンおよびN,N-ジメチルアニリンからなる群より選択される塩基、及び
(C)水の存在下、
2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させることを特徴とする、
式(2)
で表される化合物またはその塩の製造方法。 Formula (1)
Or a salt thereof,
(A) an acid selected from the group consisting of p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrobromic acid and pyridine hydrobromide and / or (B) from pyridine and N, N-dimethylaniline A base selected from the group consisting of: (C) in the presence of water;
Reacting with 2,2-dialkoxypropane or isopropenyl alkyl ether,
Formula (2)
Or a salt thereof. - 請求項1に記載の方法により、
式(2)で表される化合物またはその塩を得、次いで当該式(2)で表される化合物またはその塩を、酸及び塩基からなる群から選択される少なくとも1種の存在下で、式(a)R0X
[式中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示し、Xは脱離基を示す。]
で表される化合物またはその塩と反応させることを特徴とする、
式(3)
[式(3)中、R0はp-メトキシベンジル基またはベンジルオキシメチル基を示す。]
で表される化合物またはその塩の製造方法。 According to the method of claim 1,
A compound represented by formula (2) or a salt thereof is obtained, and then the compound represented by formula (2) or a salt thereof is represented by the formula in the presence of at least one selected from the group consisting of an acid and a base. (A) R 0 X
[Wherein R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group, and X represents a leaving group. ]
Characterized by reacting with a compound represented by the formula:
Formula (3)
[In the formula (3), R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group. ]
Or a salt thereof. - 請求項1記載の式(1)で表される化合物またはその塩から式(2)で表される化合物またはその塩を製造する反応が、反応途中で生成する式(4)で表される化合物またはその塩を介して行われる請求項1又は2記載の製造方法。
式(4)
A compound represented by the formula (4) produced in the course of the reaction for producing a compound represented by the formula (2) or a salt thereof from the compound represented by the formula (1) or a salt thereof according to claim 1 Or the manufacturing method of Claim 1 or 2 performed via the salt.
Formula (4)
- 式(1)で表される化合物またはその塩が、
式(5)
で表される化合物またはその塩を、p-トルエンスルホン酸、塩酸または臭素酸と反応させて製造される請求項1~3のいずれか1記載の製造方法。 The compound represented by the formula (1) or a salt thereof is
Formula (5)
The production method according to any one of claims 1 to 3, wherein the compound represented by the formula or a salt thereof is produced by reacting with a p-toluenesulfonic acid, hydrochloric acid or bromic acid. - 式(1)で表される化合物の塩が、式(1)で表される化合物のp-トルエンスルホン酸塩、塩酸塩または臭素酸塩である請求項1~4のいずれか1記載の製造方法。 The production according to any one of claims 1 to 4, wherein the salt of the compound represented by the formula (1) is p-toluenesulfonate, hydrochloride or bromate of the compound represented by the formula (1). Method.
- 式(6)
[式中、R1は、ハロゲン原子、低級アルキル基、ヒドロキシ基、低級アルコキシ基、低級アルキルカルボニル基、カルボキシル基、アミノ基、ニトロ基またはシアノ基を示し;pは0~4の整数を示す。]
で表される化合物またはその塩を、
(A)p-トルエンスルホン酸、p-トルエンスルホン酸ピリジニウム、臭化水素酸およびピリジン臭化水素酸塩からなる群より選択される酸及び/又は
(B)ピリジンおよびN,N-ジメチルアニリンからなる群より選択される塩基、及び
(C)水の存在下、
2,2-ジアルコキシプロパンまたはイソプロペニルアルキルエーテルと反応させることを特徴とする、
式(7)
[式中、R1は、ハロゲン原子、低級アルキル基、ヒドロキシ基、低級アルコキシ基、低級アルキルカルボニル基、カルボキシル基、アミノ基、ニトロ基またはシアノ基を示し;pは0~4の整数を示す。]
で表される化合物またはその塩の製造方法; Formula (6)
[Wherein R 1 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amino group, a nitro group, or a cyano group; p represents an integer of 0 to 4 . ]
Or a salt thereof,
(A) an acid selected from the group consisting of p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrobromic acid and pyridine hydrobromide and / or (B) from pyridine and N, N-dimethylaniline A base selected from the group consisting of: (C) in the presence of water;
Reacting with 2,2-dialkoxypropane or isopropenyl alkyl ether,
Formula (7)
[Wherein R 1 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amino group, a nitro group, or a cyano group; p represents an integer of 0 to 4 . ]
A method for producing a compound represented by the formula: - 2,2-ジアルコキシプロパンが2,2-ジメトキシプロパンである請求項1~6のいずれか1記載の製造方法。 The production method according to any one of claims 1 to 6, wherein the 2,2-dialkoxypropane is 2,2-dimethoxypropane.
- イソプロペニルアルキルエーテルがイソプロペニルメチルエーテルである請求項1~6のいずれか1記載の製造方法。 The method according to any one of claims 1 to 6, wherein the isopropenyl alkyl ether is isopropenyl methyl ether.
- ・8-アミノ-3-ヒドロキシベンゾ[c]クロメン-6-オンのp-トルエンスルホン酸塩、
・8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ヒドロキシベンゾ[c]クロメン-6-オン、
・8-アミノ-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン、
・8-アミノ-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン、
・8-(1,1-ジメチル-3-オキソブチルアミノ)-3-(4-メトキシベンジルオキシ)ベンゾ[c]クロメン-6-オン、
・8-(1,1-ジメチル-3-オキソブチルアミノ)-3-ベンジルオキシメトキシベンゾ[c]クロメン-6-オン、
・2-(2,4-ジメトキシフェニル)-5-アミノ安息香酸メチル、
・6-(2,4-メトキシ)-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸メチル、
・6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸、
・6-ブロモ-2,2,4-トリメチル-1,2-ジヒドロキノリン-5-カルボン酸メチル、
・2-ブロモ-5-(1,1-ジメチル-3-オキソブチルアミノ)安息香酸メチル
から選択される化合物またはその塩。 -P-toluenesulfonate of 8-amino-3-hydroxybenzo [c] chromen-6-one,
8- (1,1-dimethyl-3-oxobutylamino) -3-hydroxybenzo [c] chromen-6-one,
8-amino-3- (4-methoxybenzyloxy) benzo [c] chromen-6-one,
8-amino-3-benzyloxymethoxybenzo [c] chromen-6-one,
8- (1,1-dimethyl-3-oxobutylamino) -3- (4-methoxybenzyloxy) benzo [c] chromen-6-one,
8- (1,1-dimethyl-3-oxobutylamino) -3-benzyloxymethoxybenzo [c] chromen-6-one,
-Methyl 2- (2,4-dimethoxyphenyl) -5-aminobenzoate,
6- (2,4-methoxy) -2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate methyl,
6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylic acid,
-Methyl 6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline-5-carboxylate,
A compound selected from methyl 2-bromo-5- (1,1-dimethyl-3-oxobutylamino) benzoate or a salt thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012278428 | 2012-12-20 | ||
JP2012-278428 | 2012-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014098046A1 true WO2014098046A1 (en) | 2014-06-26 |
Family
ID=50978374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2013/083666 WO2014098046A1 (en) | 2012-12-20 | 2013-12-16 | Method for producing 1,2-dihydroquinoline synthetic intermediate |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2014139161A (en) |
TW (1) | TW201431860A (en) |
WO (1) | WO2014098046A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018230713A1 (en) | 2017-06-16 | 2018-12-20 | 学校法人同志社 | Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent |
US11433090B2 (en) | 2017-06-16 | 2022-09-06 | The Doshisha | mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008059865A1 (en) * | 2006-11-14 | 2008-05-22 | Santen Pharmaceutical Co., Ltd. | Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
WO2013108921A1 (en) * | 2012-01-20 | 2013-07-25 | 参天製薬株式会社 | Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof |
-
2013
- 2013-12-12 JP JP2013256811A patent/JP2014139161A/en active Pending
- 2013-12-16 WO PCT/JP2013/083666 patent/WO2014098046A1/en active Application Filing
- 2013-12-19 TW TW102147141A patent/TW201431860A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008059865A1 (en) * | 2006-11-14 | 2008-05-22 | Santen Pharmaceutical Co., Ltd. | Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
WO2013108921A1 (en) * | 2012-01-20 | 2013-07-25 | 参天製薬株式会社 | Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof |
Non-Patent Citations (4)
Title |
---|
ANDREW V. ANZALONE, ET AL.: "ACommon Diaryl Ether Intermediate for the Gram-Scale Synthesis of Oxazine and Xanthene Fluorophores", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 52, no. 2, 7 January 2013 (2013-01-07), pages 650 - 654 * |
J.S. YADAV, ET AL.: "Bi(OTf)3-catalyzed condensation of 2,2-DMP with aromatic amines: A rapid synthesis of 2,2,4-trimethyl-1,2-dihydroquinolines", JOURNAL OF MOLECULAR CATALYSIS A: CHEMICAL, vol. 271, no. 1-2, 18 June 2007 (2007-06-18), pages 161 - 163, XP022070243 * |
RANU B C; HAJRA A; DEY S S; JANA U: "Efficient microwave-assisted synthesis of quinolines and dihydroquinolines under solvent-free conditions", TETRAHEDRON, vol. 59, no. 6, 3 February 2003 (2003-02-03), pages 813 - 819, XP004404939 * |
THEOCLITOU M-E; ROBINSON L A: "Novel facile synthesis of 2,2,4 substituted 1,2-dihydroquinolines via a modified Skraup reaction", TETRAHEDRON LETTERS, vol. 43, no. 21, 20 May 2002 (2002-05-20), pages 3907 - 3910, XP004352436 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018230713A1 (en) | 2017-06-16 | 2018-12-20 | 学校法人同志社 | Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent |
US11433090B2 (en) | 2017-06-16 | 2022-09-06 | The Doshisha | mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2014139161A (en) | 2014-07-31 |
TW201431860A (en) | 2014-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8153801B2 (en) | Process and intermediates for preparing integrase inhibitors | |
EP3189053B1 (en) | An improved process for the preparation of apixaban and intermediates thereof | |
US8168787B2 (en) | Process for the preparation of imatinib and intermediates thereof | |
US8436200B2 (en) | Process for making (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-flouro-4- iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione and intermediates thereof | |
WO2014098046A1 (en) | Method for producing 1,2-dihydroquinoline synthetic intermediate | |
WO2013108921A1 (en) | Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof | |
WO2015020204A1 (en) | Production method for 3, 3-dimethyl-3, 4-dihydro-1h-quinoxaline-2-one derivative and intermediate for said production method | |
JP2011523659A (en) | Method for synthesizing levocetirizine and intermediate used therefor | |
KR101149821B1 (en) | Novel synthetic method of diphenylacetate derivatives | |
JP7032903B2 (en) | Method for producing a sulfonamide compound | |
KR101041277B1 (en) | Process for producing quinolonecarboxylic acid derivative | |
WO2004083213A1 (en) | 4,6-dihydrofuro[3,4-d]imidazole-6-one derivatives and their salts and process for the preparation of the same | |
US20080182987A1 (en) | Method For Producing 2-(4-Methyl-2-Phenylpiperazine-1-Yl)-3-Cyanopiridine | |
TWI845992B (en) | A method for preparing a hepatitis B virus nucleocapsid inhibitor | |
WO2017043563A1 (en) | Method for producing pyridinecarboxamide | |
EP1754701A1 (en) | Sulfonyloxy derivatives | |
JP6004307B2 (en) | 3- (2- (1-Benzothiophen-5-yl) ethoxy) propionic acid salt or hydrate thereof and process for producing the same | |
JP4449211B2 (en) | 6- (1-fluoroethyl) -5-iodo-4-pyrimidone and process for producing the same | |
US20120142932A1 (en) | Method for manufacturing 4-(5-methylpyridin-2-ylamino)piperidine-1-carboxylic acid derivative | |
WO2006025480A1 (en) | 7-substituted carbostyril derivative and method for producing same | |
Matsuoka et al. | 7-SUBSTITUTED 6-FLUORO-I-METHYLENE-4-OXO-4H-[l, 31-THIAZETO [3, 2-alQUIN0LINE-3-CARBOXYLIC ACID DERIVATIVES | |
JP2007269796A (en) | Method for producing tetrahydro-pyridoazepin-8-one compound | |
WO2015019928A1 (en) | Method for synthesizing binaphthyldiamine derivative | |
JPH02169A (en) | Production of azetidinone derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13865594 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13865594 Country of ref document: EP Kind code of ref document: A1 |